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DBU I ,8-diazabicyclo[5 .4.O]undec-7-ene 
DCM dichioromethane 
DMAD dimethyl acetylenedicarboxylate 
DMAP dimethylaminopyridine 
DMF N, N-diinethylformarnide 
DMSO dimethylsulfoxide 
ether diethyl ether 
equiv. equivalent 
FAB fast atom bombardment 
FMO frontier molecular orbital 
g grams 
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hr hour 
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J coupling constant 
LDA lithium diisopropylamide 
lit, literature 
LUMO lowest unoccupied molecular orbital 
m multiplet 
M moles per litre 




MHz mega hertz 
min minute 
mmole millimole 
nip melting point 
rn/z mass to charge ratio 
nd not determined 
NMNO 4-methylmorpholine N-oxide 
NMR nuclear magnetic resonance 




TDI tolyene-2, 4-dimsocyanate 
THF tetrahydrofuran 




Nitrile oxide chemistry has been investigated as a route to C-glycosides. This approach 
involves the generation and cycloaddition reactions of pyranosyl nitrite oxides with olefinic 
and acetylenic dipolarophiles, and manipulation of the resulting cycloadducts. 
Three methods for the generation of pyranosyl nitrile oxide have been utilised: firstly 
isocyanate-induced dehydration of pyranosylnitromethanes (the Mukaiyama approach); 
secondly hypochlorite-mediated oxidation of pyranosyl aldoximes, and finally base-
catalysed dehydrohalogenation of pyranosyl hydroximoyl chlorides. The pyranosyl 
aldoximes derived from D-mannose, D-glucose, D-xylose and L-fucose were synthesised via 
stannate (II) mediated reduction of the corresponding pyranosylnitromethane (80-90%), 
whilst direct chlorination of the aldoximes gave the hydroximoyl chlorides (80-95%). 
The efficiency of nitrile oxide generation by all three methods was illustrated by the high 
yields of 3 ,4-(dipyranosyl)- 1 ,2,5-oxadiazole-2-oxides (furoxans) obtained by dimerisation on 
generation in the absence of a dipolarophite. For example, 3,4-(2,3,4,6-tetra-O-acetyl-3-D-
mannopyranosyl)- 1 ,2,5-oxadiazole-2-oxide (164) was prepared from 2,3 ,4,6-tetra-O-acetyl-
3-D-mannopyranosylnitromethane (122) in a 90% yield. The D-glucose, D-xylose and L-
fucose derived analogues were synthesised in high yields (79 - 96%) utilising all three 
methods. 
Where compatible, the Mukaiyama approach gave cycloadducts in good yields (>75%) (e.g. 
on reaction with methylenecyclohexane and styrene). However, for low boiling or thermally 
unstable dipolarophiles or for dipolarophiles with functional groups incompatible with the 
isocyanate dehydrating agent (e.g. dimethyl acetylenedicarboxylate, allyl alcohol), 
cycloadditions were carried out successfully using pyranosyl aldoximes and pyranosyl 
hydroximoyl chlorides as precursors. The cycloaddition reactions with achiral alkenes 
proceeded with low levels of diastereoselectivity (d.e. < 10%), in contrast to the 
cycloaddition of chiral alkenes where significant m-facial selectivity was observed (d.e. 40-
80%). 
The chemistry of the dipyranosyl furoxans has also been investigated. Hydrogenation of 3,4-
(2,3,4-tri-O-acetyl--D-xylopyranosyl)-furoxan (178) in the presence of Raney nickel 
yielded the corresponding dipyranosyl-1,2-dioxime (191) in 77% yield. Preliminary studies 
vi 
of the chemistry of this class of dioxime have been carried out, for example dehydration to 
the 1 ,2,5-oxadiazo!e (furazan) and re-oxidation to the dipyranosyl furoxan. Attempts at 
complexation of these novel chiral ligands with nickel show promising results. 
Attempts to functionalise the 4-position of the isoxazoline ring by treatment with base (e.g. 
BuLi, LDA), followed by addition of an electrophile, led to the unexpected formation of 
glycals. For example, reaction of 5-(spirocyclohexyl)-3 -(2,3 :4,6-di-O-isopropyl-f3-D-
mannopyranosyl)-2-isoxazoline (155) with BuLi afforded 5-(Spirocyclohexyl)-3 -(4,6-0-
isopropyl idine-2-deoxy- I ,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxazol me (200) in a 
94% yield. The proposed mechanism involves deprotonation of the anomeric position, 
followed by elimination and hydrolysis of the resulting hemiketal. 
Vii 
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1 	Introduction 
The work presented in this thesis involves the development of a novel route to carbon-linked 
glycosides (C-glycosides). C-glycosides, e.g. (1), are analogous to glycosides, e.g. (2), but 
with the exo-glycoside oxygen replaced by carbon. The approach used makes use of nitrile 
oxide / isoxazoline chemistry with particular emphasis on methods of nitrile oxide 
generation and their subsequent 1,3-dipolar cycloaddition reactions. The introduction is in 
three parts. Firstly, a brief overview of nitrile oxide and isoxazoline chemistry is given. In 
the second section the interest in C-glycosides and their potential applications is discussed, 
and finally the principal literature routes to C-glycosides are surveyed. 
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1.1 Nitrile oxide chemistry 
1.1.1 Background 
Nitrile oxides belong to the family of 1,3-dipoles. The chemistry of 1,3-dipoles, first 
classified by Huisgen1 , is vast and has been comprehensively reviewed in the two volume 
monograph entitled '1,3-Dipolar Cycloadditions' edited by Padwa.2 Nitrile oxides, in their 
own right, are much researched and have been shown to be valuable tools in a wide range of 
synthesis, from natural products to polymer chemistry. Only a brief overview of their 
chemistry will be given here. More detailed discussion can be found in 'The Nitrile Oxides' 
by Grundmann and GrUnanger,3 'Nitrile Oxides, Nitrones and Nitronates in Organic 
Synthesis' by Torssell4 and in the review 'Recent Advances in Synthetic Applications of 
Nitrile Oxide Cycloadditions' by Kanemasa and Tsuge.5 
Nitrile oxides belong to the nitrilium betaine class of 1,3-dipoles. They are usually 
represented by a zwitterionic octet structure (3). However, they are more accurately 
described as a hybrid of the possible resonance forms (3)-(8) (Scheme 1). 
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Scheme I 
Most nitrite oxides are transient species which dimerise to 1 ,2,5-oxadiazole 2-oxides 
(furoxans), although there are a few examples of isolable nitrite oxides such as 
(9)6,  (1O) 
and (11)8  which are resistant to dimerisation, an effect attributable to steric factors. For 
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1.1.2 Generation of nitrite oxides 
There are four common precursors to nitrite oxides (3). These are outlined in Scheme 2. A 
popular entry point to nitrile oxides is the Mukaiyama9 dehydration of primary nitro 
compounds (12) using an isocyanate as dehydrating agent and a catalytic amount of base. 
Alternative dehydrating agents have been reported including acid chlorides,'0 anhydrides," 
phosphorous oxychloride,'2 p-toluenesulfonic acid, 13  and di-tert-butyl dicarbonate.'4 An 
alternative route involves the dehydrohalogenation of hydroximoyl halides (13), commonly 
carried out by treatment with base, usually triethylamine,15 or potassium fluoride. 
16  Thermal 
generation is also possible by heating in an inert solvent. 
17,18  The conversion of aldoximes 
(14) to nitrile oxides is another common strategy. The reaction often involves in situ 
synthesis of the hydroximoyl halides using alkaline sodium hypochlorite,19 but other reagents 
such as iodosylbenzene2° and trichloroisocyanuric acid 2' have been employed. Often the 
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aldoxirne is converted to the hydroximoyl chloride using chlorine gas 
22 or milder methods 
such as NC S'23 followed by base-catalysed dehydrohalogenation. Direct dehydrogenation for 
syn aldoxirnes using lead tetraacetate24 has also been reported. 
A less common route to nitrile oxides is thermal cycloreversion of the furoxan dimers (15).25 
This often requires temperatures greater than 200 °C. However, for ring strained furoxans 
(e.g. trimethylenefuroxan26) and furoxans with bulky substituents, such as di-t-butyl(2-
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Scheme 2 
1.1.3 Reactions of nitrite oxides 
Nitrile oxides undergo a wide variety of reactions, as outlined in Scheme 3. In the absence of 
other reactants nitrile oxides tend to dimerise to furoxans.3 These furoxans can also be 
observed as by-products in cycloaddition reactions. Alternative dimers, 1,2,4-oxadiazole 4-
oxides 21 (16) and 1,4,2,5-dioxadiazines29 (17) are occasionally observed. For example, 
generation of benzonitrile oxide in the presence of pyridine or boron triflouride affords 3,6-
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More stable nitrite oxides may undergo thermal rearrangement at temperatures greater than 
110°C to give isocyanates (18). For example, heating benzonitrile oxide in xylene quickly to 
110°C causes partial conversion to phenyl isocyanate with diphenylfuroxan as the major 
product .30 
The nitrile oxide can undergo 1,3-additions with nucleophiles to yield substituted oximes 
(19). Appropriate nucleophiles include thiols,3' alcohols32, amines33 and more recently 
organornetallic species such as Grignard reagents. 34 
The most important synthetic application of nitrile oxides are their 1,3-dipolar cycloaddition 
reactions with unsaturated system, i.e. double (C=C, C=N, CS, C=O) and triple (CC, 
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1.2 	Synthetic applications of nitrile oxide / isoxazoline chemistry. 
The 1,3-dipolar cycloaddition reaction is a valuable route to 5-membered heterocycles. Of 
particular synthetic interest is the 1,3-dipolar cycloaddition of nitrile oxides with alkenes and 
alkynes to give 2-isoxazolines and isoxazoles respectively. This interest lies in the fact that 
these heterocycles contain masked functionalities which can be released at various points in 
the synthetic route. Thus, the nitrile oxide I isoxazoline route has been applied to a wide 
range of synthetic challenges such as natural product synthesis.35 The strategy involves three 
key steps. The first is the cycloaddition step, followed by modification of the isoxazoline 
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1.2.1 Cyctoadditions of nitrite oxides to alkenes 
The first stage of the nitrite oxide / isoxazoline approach involves the cyctoaddition of the 
nitrite oxide with an alkene. The steric outcome of the reaction depends on the nature of the 
dipolarophile. Alkenes which are mono-substituted or 1,1-disubstituted normally react 
regiospecificatty to give 5-substituted adducts. This is not the case, however, when a 
strongly electron withdrawing group is attached to the alkene when a mixture of 5- and 4-
substituted products are seen. I ,2-Disubstituted alkenes show much less regiospeci fi city, 
whilst more functionatised alkenes often prove to be much less reactive. 
The origin of the regioselectivity effects can be rationalised by frontier molecular orbital 
(FMO) theory.36  The formation of the transition state is brought about by interaction of the 
FMO's, the highest occupied molecular orbital (HOMO) and the lowest unoccupied 
molecular orbital (LUMO) of the reactants. The interaction of the FMO's for dipoles and 
dipolarophiles have been classified by Sustmann37  into three groups. For dipolarophiles with 
conjugating (C) or electron donating (D) groups the dominant interaction is Sustmann type 
III between the HOMO of the dipolarophile and the LUMO of the dipole (Figure 1). 
LUMO 	000R—C—N-0 
U'% 0  
/ 	I 	 5-Substituted product 
HOMO 
Figure 1 
However, the introduction of an electron withdrawing group (W) towers the energy of both 
the HOMO and the LUMO of the dipolarophile. Thus, Sustrnann type II, interaction of the 






Cycloaddition reactions are believed to be a concerted 
38 process and proceed with the 
retention of the dipolarophile stereochemistry. Thus, for a dipolarophile with two faces open 
to attack, two stereoisomers for each regiosiorner are obtained (Scheme 5). 
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The control of absolute stereochemistry in 1,3-dipolar cycloadditions is becoming an 
increasing area of interest. 39 The most frequently applied strategy is the use of chiral 
auxiliaries either attached to the alkene, e.g. (26) 0  or less frequently to the dipole. 
39 
Investigation of the effect of microwave technology is also taking place. 
41  Stereoselectivity 
can also be inferred by the stereochemistry of the reactants (e.g. chiral alkenes).42 
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Kanernasa et a143  have documented important effects of Mg(I1) on the course of the nitrite 
oxide cycloaddition of benzonitrile oxide with an allylic alkoxide. The effects described 
include increased rate of cycloaddition and a stabilisation of the reactive nitrite oxide by 
coordination of the magnesium ion to the Lewis basic oxygen. More importantly it is 
reported that for the cycloaddition with chiral allylic alcohols significant syn-
stereoselectivity (99:1 syn:anti) is observed. These observations have been applied to 
cycloadditions in natural product synthesis. 
44 
1.2.2 Modification of the isoxazoline ring 
The synthetic utility of isoxazolines is increased by their ability to undergo substitution 
reactions prior to ring opening (Scheme 6). Jager el a145' 
46  have developed methods for 
substituting the 4-position of the isoxazoline ring. This involves treatment with a strong base, 
lithium di-isopropylamide (LDA) or butyllithium (BuLi) at -78°C followed by the trapping 
of the carbanion (27) with an electrophile to give the substituted isoxazoline (28). A variety 
of electrophiles have been used and the stereochemistry of the reaction investigated 
.45  If the 
carbanion is left to warm to room temperature in the absence of an electrophile ring opening 
to the a,3-unsaturated oxime (29) can occur. 
8 
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1.2.3 Ring Opening 
Cleavage of the N-U bond of the heterocycle releases a variety of fuctionalities depending on 
the conditions used (Scheme 7)47  Commonly, hydrogenolysis using a hydrogenation catalyst 
such as Pd/C or Raney nickel47  in aqueous conditions is employed to give the synthetically 
important f3-hydroxyketone (31). Alternative methods of ring opening include treatment with 
titanium trichloride,45 molybdenum hexacarbonyl,49 ozone and samarium iodide.5 ' This 
strategy offers an alternative to the aldol condensation and indeed has some advantages. 
Problems such as cross and self aldol reactions, reversibility and non-selective enolate 
formation are less applicable to the isoxazoline route. The two routes also differ in which C-
C bond is created as illustrated in Figure 3 
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The 3-hydroxyketone provides access to the a-enone (32) via dehydration and the 1,3-diol 
(33) by reduction. An alternative product, the y-aminoalcohol (34) can be obtained by ring 
cleavage under non-aqueous conditions52 using lithium aluminium hydride (LIAIH4)53 or 
hydrogenation with a catalyst. Jager et at53 have developed a stereoselective route to - 
arninoalcohols using LiA1H4, although the diastereoselectivity observed is heavily dependant 
on the substituents present on the isoxazoline ring. f3-Hydroxy nitrile (35) can be obtained by 
base deprotonation of 3-unsubstituted isoxazolines54 or thermal decarboxylation55 of 
isoxazoline-3-carboxylic acids. 
The isoxazoline can also be oxidised to isoxazole (36) using a variety of reagents 
16 including 
iodine .57  Isoxazoles can alternatively be obtained by the cycloaddition reaction of nitrile 
10 
Introduction 
oxides with alkynes. As with isoxazolines, isoxazoles contain masked functionalities 
including 1,3-diketones (37) and 13-keto nitriles.57 
1.2.4 Examples of synthetic applications of nitrile oxide / isoxazoline chemistry 
The synthetic potential of 2-isoxazolines has been exploited in the synthesis of a wide range 
of natural products and their analogues.58  Recently, Carreira and co-workers59 have used this 
approach to synthesise building blocks for polyketide-derived natural products. A specific 
example is the epothilone class of natural products, 44  which have similar properties as Taxol. 
The key component in the synthesis (38) was created by the stereospecific reaction of (39) 
and allylic alcohol (40) using the conditions reported by Kanemasa,43  discussed previously, 
followed by a Wadsworth-Emmons coupling as outlined in scheme 8. 
/OH 
Et JCI + 
Eto OH 	 Me 	Me 
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39 	 I) PrOH, EtMgBr, CH2Cl2. 	40 
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Scheme 8 
Another example is reported by McGarvey and co-workers in their synthesis of the heptaene 
and 	pseudoheptaene subfamily of the polyene macrolide antibiotics. 60 This class of 





I) (Bu3Sn)2O, tBUOCI ii) Mo(CO)6, 10% H20/MeCN Xn = 
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activity. The key intermediate, the amphotericin polyol segment (42), was created by the 
cycloaddition of (43) and (44) and subsequent ring opening of the resultant isoxazoline 
(Scheme 9). 













The nitrile oxide I isoxazoline approach has also been applied to macrocycle synthesis, 61 
carbohydrate chemistry,62 alkaloids,63 and amino acids.64 
Research is currently underway investigating the application of nitrile oxide chemistry on the 
solid phase as it is believed to offer a number of advantages including the easy removal of 
dimerisation side products.65 66,67 
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1.3 	Glycosidase inhibition 
1.3.1 Introduction 
Carbohydrates play a critical role in biological events such as intracellular communication 
and cell-mediated processes. These events are often controlled by glycosidases and 
glycosyltransferases and thus inhibition of these enzymes may find therapeutic applications 
in the treatment of various diseases. With this goal in mind much research is taking place 
into finding possible inhibitors. The dominant strategy involves the use of mimicry. Most 
success has been found with alkaloids but C-glycoside chemistry also shows promise. 
1.3.2 Glycosidases - Mechanism of hydrolysis 
The hydrolysis of glycosidic linkages in most carbohydrate-containing molecules in nature 
are carried out by glycoside hydrolases (glycosidases). The classification68 of these enzymes 
is based on several criteria: 
I) 	the anomeric configuration of the substrate 
whether the configuration at the anomeric position is retained upon hydrolysis 
if the substrate is a pyranose or furanose ring 
The mode of action can be considered as nucleophilic substitution at the saturated carbon of 
the anomeric centre. An important categorisation of glycosidases is whether there is retention 
or inversion of the anomeric centre. The mechanisms 
69  for both were proposed by Koshland, 
with retention of configuration being explained by a three step double displacement (Scheme 
10). The first step involves protonation of the glycosidic oxygen by an enzyme acid catalyst 
group, followed by displacement of the glycone by an enzyme bound carboxylate anion to 
form a covalently bonded intermediate (45). Finally, the carboxylate group is displaced by 


















Inverting glycosidases invoke a single displacement mechanism involving protonation of the 
glycosidic oxygen followed by displacement of the glycone by attack of water (Scheme 11). 
The reaction proceeds through a glycosyl cation-like transition state. Unlike the double 





1.3.3 Glycosidase inhibitors 
The possible therapeutic application of glycosidase inhibitors has led to the synthesis of 
compounds with the potential to act as inhibitors. A number of inhibitors have also been 
isolated from Nature. In depth reviews of this area have been published by Elbein,70 
Winchester 71,72  and Fleet", so only a brief survey will be shown here. 
Alkaloids7073 that mimic the structure of monosaccharides are now believed to be 
widespread in plants and micro-organisms, and these sugar mimics inhibit glycosidases due 
to their structural resemblance to the sugar moiety of the natural substrate. These compounds 
contain nitrogen in the ring instead of oxygen and can be classified into five structural 
classes: polyhydroxylated piperidines, pyrrolidines, indolizidines, pyrrolizidines and 
notropanes. One of the first glycosidase inhibitors discovered was the polyhydroxylated 








Another class of compound, which has shown promising inhibitory properties, are C-
glycosides. These mimic 0-glycosides by replacing the exoglycosidic oxygen with carbon. 
C-glycosides have been found in nature, for example the aryl C-glycoside vineomycinone 
B275 (47). A subclass of C-glycosides are C-disaccharides where two sugar rings are linked 
via a carbon bridge instead of oxygen. These are often found as subunits of macromolecules 
such as palytoxin.76 A related class are C-nucleosides in which the usual C-N bond of 
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All three classes have been shown to display inhibitory qualities. Schmidt et a177 have 
synthesised a diastereomeric pair of amino substituted 3-benzyl-C-glycosides which show 
inhibition of f3-glucosidase from sweet almonds. It is interesting to note that (49a) has a 
similar activity to 1-deoxynojirirnycin, whilst (49b) has an activity two orders of magnitude 
lower. 
1.3.4 Mode of action of glycosidase inhibitors. 
The good inhibitory qualities of the alkaloid compounds has been attributed to their ability to 
mimic the cation-like transition state.78 This is indicated by the pH dependency of the 
inhibition. At physiological pH, the ring nitrogen is protonated and thus mimics the 







::::: .luIIIIIIN _< 
104 
Introduction 
1.4 	Applications of glycosidase inhibitors 
Glycosidases are involved in a wide range of important biological processes. The potential to 
modify these processes by inhibition of the glycosidases has possible cell biological and 
therapeutic applications. Winchester and Fleet72 have reviewed the biomedical and 
biotechnological applications of glycosidase-inhibiting mimics, so only a brief summary will 
be given here. 
1.4.1 Diabetes and anti-obesity 
Digestive glycosidases found in the cell membrane of the small intestine are oligo- and 
disaccharidases. These enzymes digest dietary carbohydrate to monosaccharides which are 
absorbed through the intestinal wall. Inhibition of all or some of these activities could 
regulate the absorption of carbohydrate with possibility for application in the treatment of 
diabetes and obesity. Acarbose79 (50) was introduced by Bayer in 1990 for the treatment of 
diabetes. 
HOH2C 






The treatment of obesity may be possible using the sucrase / maltase inhibitor AO- 128" (51) 
which has been shown to reduce fat accumulation in the abdominal cavity, which is 











Other therapies for diabetes may come from inhibition of lysosomal73 and processing 
glycosidases.73  
1.4.2 Treatment of cancer 
There is growing evidence that carbohydrate residues on cell-surface glycoconjugates play 
an important role in the metastatic spread of tumours. Metastasis is the process by which 
cancer cells invade the blood vessels or lymphatic system and are transported round the body 
to set up secondary turnours. The prevention of these secondary tumours is of great 
importance in the treatment of cancer. Cancerous cells are known to be more heavily 
glycosylated than normal and it is believed that this is linked to metastasis." The use of 
glycosidase-inhibiting sugar mimics to prevent the formation of N-linked oligosaccharides 
associated with cancer cells and to inhibit the catabolic glycosidases that trim these surface 
glycoconjugates is being actively pursued as a therapeutic strategy for cancer. Swainsonine82 
(52) has shown dramatic inhibition of melanoma cell colonisation in mice whilst 
castanospermine83  (53) has been shown to exhibit antimetastatic activity by inhibiting 
platelet aggregation of metastatic cells as well as reducing adhesion of tumour cells to the 
vascular endothelium. 
1.4.3 Antiviral activity 
Many animal viruses contain an outer envelope, which is composed of one or more viral 
glycoprotein. These are often essential proteins that are required in the viral life cycle, either 
in virion assembly and secretion and/or infectivity. As processing of these glycoproteins 
occurs through the cellular machinery, processing glycosidase inhibitors have been used to 
study the role of the N-linked oligosachharides in several viral systems. ct-Glucosidase 
19 
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inhibitors such as castanospermine84 (53) are potent inhibitors of HIV replication and thus 
may have a role to play in the treatment of this condition. 
1.4.4 Insect antifeedants 
The use of glycosidase inhibitors as selective insecticides is being investigated in the 
agrochemical industry. The inhibition of intestinal disaccharidases are known to have toxic 
effects on specific insect species. For example, (2R,5R)-bis(dihydroxyrnethyl)-(3R,4R)-





Amino-sugar compounds have been used to deter insects from feeding, therefore offering 
possible applications in crop protection. Castanospermine85 (44) and DMDP86 (51) have both 
been found to act as locust antifeedants. 
1.5 	Other carbohydrate based therapeutics 
As well as glycosidase inhibition, other possible carbohydrate therapeutics are under 
investigation with possible applications in the treatment of various disease states. The 
binding of sialyl Lewis X (55) to selectins is believed to play an important role in 
inflammatory reponses.87 Thus, it is hoped that low molecular weight sialyl Lewis X mimics 
may counteract excess inflammation. As yet no drug has reached the market but a number 




The first carbohydrate-based drug to find widespread application in humans was the 
glycosylaminoglycan heparin,88  which has been used in the treatment of thrombosis since 
1937. Heparin increases the activity of antithrombin 111, which suppresses enzymes that 
promote coagulation. A number of low-molecular weight heparins, which have greater 
bioavailability, are currently on the market. 
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1.6 	Synthesis of C-glycosides 
With the realisation that C-glycosides have potential therapeutic applications and also with 
their stability to enzymic degradation in vivo making them excellent candidates for 
examining carbohydrate-protein interactions, a wide range of synthetic strategies for C-
glycoside synthesis have been adopted. The first synthesis was reported in 1950 by Hurd et 
a!89  and involved reaction of various Grignard reagents with tetra-0-acetyl glucopyranosyl 
chloride. A vast array of different approaches to C-glycosides has been reported since then 
and a number of reviews of the area are available. 
90-92  Thus, only a brief overview of the area 
will be given here. 
1.6.1 Electrophilic sugars in C-glycoside synthesis 
The most common method for carbon-carbon bond formation at the anomeric carbon 
involves nucleophilic attack on this electrophilic centre (Scheme 12). A wide range of 
leaving groups have been employed such as carboxylate and halides in conjunction with 
various nucleophiles, including organometallic reagents. The reaction is often mediated by a 
Lewis acid. 
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Allevi et af3  have reported the reaction of silyl enol ethers with glucose derivatives (56) to 
give C-glycosides (57) as shown in Scheme 13. 
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1.6.2 Rearrangement reactions 
The electrophilic nature of the anomeric position is utilised in the synthesis of aromatic C-
glycosides via O>C rearrangements. This approach has been used by Toshima et af 4  
(Scheme 14). They found that treatment of the protected sugar (58) with a Lewis acid and 2-
naphthol gave the O-glycoside, which rearranged to the C-glycoside (59). Good yields were 








Recently, Seeberger and co-workers 95  have used this rearrangement methodology to 
synthesise the naturally occurring C-glycoside, bergenin (60). This compound has been 
found in extracts of Macaranga peltata used in Indian folk medicine. This short and simple 
synthetic approach involves the synthesis of the 0-glycoside (61) which rearranges to the C-
glycoside (62). Palladium catalysed carbonylation followed by deprotection and 










i)TMSOTf, CH2Cl2,-20°C - RT, ii) Tf20, Lulidine, DMAP, iii) CO, Pd(OAc)2, KOAc, DMSO, 
iv) H2, Pd(OH)2, MeOH, v) MeOH, SOCl2 
Scheme 15 
1.6.3 Glycals 
Glycals have been extensively used in the synthesis of C-glycosides. One of the original 
examples was reported by Fraser-Reid and Dawe96 in which they examined the reaction of 
tri-O-acetyl glucal (63) using a variety of different conditions. They found the optimum 











In an attempt to increase yields and stereoselectivities, various Lewis acid activators have 
been investigated. Recently, Schmidt et al, 
97  have reported a highly stereoselective synthesis 








1.6.4 Carbonyl addition reactions 
The electrophilic natures of sugar lactones and formyl C-glycosides have been utilised in the 
synthesis of C-glycosides. The synthesis of C-glycosides from sugar lactones usually 
involves the addition of an organometallic reagent and this has proved a reliable method for 
the synthesis of 3-C-glycosides. Much of the work in this area was pioneered by Kishi et 
aL98 Treatment of the sugar lactone (64) with either an allyl Grignard or a lithio ester, 
followed by selective reduction with triethylsilane gave -ally1-C-glycoside (65) (Scheme 
18). 
BrMgCH2CHCH2 B 
) Et3SiH, BF3.OEt2 








The first synthesis of a C-disaccharide, reported by Sina and Rouzad,99 involved the 
addition of an anionic sugar species (66) to a sugar lactone (64) to give a 
disaccharide (67) (Scheme 19). This methodology has been extended by Sina 101 to the 
synthesis of C-oligosaccharides. 
OH 
Et3SiJ-I, BF3.Et20, MeCN 





Dondoni and co-workers10 ' have utilised sugar lactones (64) as a route to formyl C-
glycosides by reaction with 2-lithiothiazole (Scheme 19). Acetylation of the resultant 
anomeric hydroxyl followed by removal of the ester and finally cleavage of the thiazole ring 
(68) yields the desired formyl C-glycoside (69). Dondoni'°2 has utilised (69) as a building 






















(i) 2-lithiothiazole, (ii) Ac20, (iii) Et3SiH, TMSOTf, RT, MeCN, (iv) MeCN, MeOTi (v) 
NaBH4, (vi) HgCl2-H20, (vii)i-PiOH, Et3N 
Scheme 20 
1.6.5 Wittig approach 
Wittig reactions have been widely used for the synthesis of C-glycosides. In the 1980's 
Masamune, Sharpless and co-workers 103 reported the use of asymmetric epoxidation to gain 
both a- and -C-glycosides from an open chain Wittig product (Scheme 21), for example the 
a-hydroxymethyl compound (73). Standard Wittig conditions gave the open chain derivative 
(70). Following protection of the free hydroxyl group and hydrolysis of the ester, 
epoxidation was achieved using the Sharpless conditions to give both isomers (71) 
depending on the chirality of the catalyst. Desilylation caused cyclisation to the C-glycoside 




























2) NaBH4 	 OBn 
1) Na104 
73 	 OH 
Scheme 21 
Dondoni and co-workers 102  have utilised their formyl C-glycoside to form a number of a-
and 13-(1--.6')-C-disaccharides by reaction with a sugar derived phosphate ester. The 


















More recently, Chapleur et all 114  have described a Wittig olefination on a sugar derived 
lactone (Scheme 23). The reaction involves treatment of the lactone (64) with cyanomethyl 
triphenyiphosphorane, prepared from the commercially available phosphonium chloride. The 
use of microwave activation dramatically reduced the length of reaction time from 16 hours 
in refluxing toluene to under 10 minutes. 
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1.6.6 Anomeric carbanions 
The normal electrophilic character of the anomeric centre has been reversed by a number of 
groups to produce nucleophilic sugars (Figure 5). This is often aided by the presence of a 







One of the most commonly used stabilising groups is the nitro group and much of the work 
in this area has been pioneered by Vasella and co-workers' 







A variation on this theme is the use of pyranosylnitromethanes in C-glycoside synthesis. 
This involves generation of an anion on the exocyclic carbon a- to the anomeric position 
(Scheme 25) and its subsequent use in a nitroaldol reaction. Pyranosylnitromethanes have 
been synthesised in two steps from the parent sugar by a number of groups including KölI 








Martin and Lai107  used the nitroaldol reaction (Scheme 26) in the synthesis of the D-Glc-C-
-(1 —.6)-D-Gal derivative (75). Reaction of the pyranosylnitromethane (76) with aldehyde 
(77) gave the adduct (78) as a mixture of diastereomers. The nitroaldol product was 
converted to the nitroalkene (79) by elimination of acetic acid, and subsequent reduction, 
radical denitration and deacetylation gave the required 3-(1-->6)-linked C-disaccharide (75). 
Formyl C-glycosides, such as those synthesised by Dondoni,10 ' have been utilised by 


















(i) KF, CH3CN, 18-crown-6; (ii) Ae20, Pyridine; (iii) NaBH4; (iv) Bu3SnU, AIBN, Heat; 




More recently BeMiller and co-workers109  have synthesised C-(1---+2)-disaccharides using a 
variation on this nitroaldol approach (Scheme 27). The electrophilic partner in this case is 
not an aldehyde but a nitroalkene (80) which undergoes a Michael-type reaction with the 
nucleophulic partner, the pyranosylnitrornethane (81). The reaction produces a mixture of 
diastereoisomers (82). Treatment of one of these isomers with tributyltin hydride gave 
regioselective reduction to the oxime (83) which on deprotection gave the 2-0-13-D-
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Scheme 27 
1.6.7 Other approaches 
1.6.7.1 Metathesis 
Postema and co-workers"' have employed olefin metathesis as a route to C-glycosides and 
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Scheme 28 
The first step involves coupling of an acid with an alcohol followed by methylenation of the 
ester carbonyl. Ring closing metathesis leads to the C-disaccharide glycal which can be 
manipulated to give the desired product. One of the examples reported by Postema involves 
coupling (85), derived from D-xylose and (86). Coupling of (85) and (86) using DCC lead to 
the ester (87) which was methylenated (88) using the method of Utimito et al." Ring 
closing metathesis was achieved using Schrock's catalyst to give the glycal (89) which was 
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(i) DCC, 4-DMAP; (ii) TiCI4, Zn Dust, PbCl2, TMEDA, CH213r2, (iii) Schrock catalyst, toluene, 60 C; 
(iv) H2, Pd/C, Et3N 
Scheme 29 
1.6.7.2 Radical addition 
Free radical chemistry has found specific application in the formation of a-C-glycosides. 
Much of the original work was carried out by Giese and co-workers 
112 and involved 
generation of anomeric radicals from glycosyl halides as highlighted by the synthesis of the 
C-disaccharide (90) (Scheme 30). The key steps were addition of the glycosyl derived 
































Recently, Little and Parrish' 13  have reported a novel approach to anomeric radical formation 
involving titanocene-mediated cleavage of epoxides (Scheme 31). Treatment of tri-O-benzyl 
glucal (93) with dimethyldioxirane afforded the 1 ,2-anhydro sugar (94) which afforded the 






BnO CH2C12, 0 	Bn 
93 
Cp2TiCl2, Mn, THF, rt, 15 mm 
95 
Scheme 31 
1.6.7.3 Palladium mediated approaches to C-glycosides 
The synthetic utility of palladium chemistry has been adopted in C-glycoside synthesis. An 
example of work by Miwa and Yougai,' 4 in which they examined the palladium catalysed 
reaction of dicarbonyl compounds with various glycals, is shown in Scheme 32. 
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AcO  Ac Pd(PhCN)2C12 > 	
Acetylacetone 
OAc 	 83% 
Scheme 32 
1.6.7.4 Cycloaddition reactions 
The application of cycloaddition reactions to C-glycoside preparation is fairly recent. One 
such reaction is the hetero Diels-Alder cycloaddition where a carbonyl group acts as 
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Scheme 33 
Schmidt and co-workers' 15  have utilised this methodology in the synthesis of aryl C-
glycosides (Scheme 34). Under high pressure at 60°C the diene (96) and dienophile (97) 
underwent the hetero Diels-Alder cycloaddition to give adduct (98) which was deacteylated, 
benzylated and desulfurizated. Finally hydroboration followed by oxidative work up gave 
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Scheme 34 
Kozikowski et all 16 have used nitrite oxide chemistry in the synthesis of C-nucleoside 
analogues (Scheme 35). Starting from the furanosylnitromethane (100), the nitrite oxide 
(101) was generated by isocyanate-mediated dehydration and trapped with the alkene (102). 
Subsequent ring opening of the isoxazoline formed (103), and cyclisation and aromatisation 


















i) KCN, MeOH; (ii) Raney Ni. 112  B(OH)3, MeOH, H20 
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This nitrile oxide / isoxazoline approach used by Kozikowski has also been adopted by Paton 
and co-workers 117  for the synthesis of (1—>2) and (1—>3) linked C-disaccharides (Scheme 
36). The approach involves generation of pyranosyl nitrile oxides (106) by dehydration of 
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An alternative approach to C-glycosides using nitrite oxide / isoxazote chemistry has 
recently been reported by Hauser and Hu"8  (Scheme 37). In this route it is the sugar ring that 
is constructed via the cyctoaddition reaction and subsequent manipulation. In the first step, 
the cyctoaddition reaction gave the isoxazole (109), which was ring opened to the 1,3-
diketone. This underwent an in situ cyctisation to give the arylpyranone (110). Treatment 
with Mn(OAc)4  introduced the acetate group and hydrogenation under the conditions of Tins 
et al"9  gave reduction of the enone. Following reduction and acetylation the C-aryl 








1) NCS, CH2C12, 2) H2, Ni(R), CH30H, H20,3) HCI, TIff, 4) Mn(OAc)3, 5) H2, Pd/C, 




The successful application of cycloaddition chemistry to the synthesis of C-glycosides, as 
highlighted by the above examples, and previous work in the group, have prompted an 
investigation of nitrite oxide I isoxazoline chemistry as a route to C-glycosides. The findings 
are discussed in the following section. 
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2 	Results and discussion 
2.1 	Programme of research 
Recently, there has been renewed interest in the study of carbohydrate chemistry. This 
research is driven by discoveries such as the importance of cell surface carbohydrates in key 
molecular recognition events with protein receptors.73 The hydrolytic instability of 
glycosides, however, makes their study much less straightforward and also reduces the 
likelihood of carbohydrate-based therapeutics due to their sensitivity to enzymatic cleavage 
and chemical hydrolysis. A possible solution to these problems is the use of C-glycosides, 
which are analogues of glycosides but with the exo-glycosidic oxygen replaced by carbon. 
These compounds may mimic glycosides but be resistant to degradation. One of the 
potential applications of C-glycosides is as glycosidase inhibitors. Inhibitors of this type 
have been shown to exhibit both antiviral 14  and antiturnour activity82 and have possible 
therapeutic application in the treatment of diabetes 
.79  C-glycosides are also seen as chiral 
building blocks for macromolecules such as palytoxin76 which contain C-disaccharide 
subunits, and interest in the synthesis of C-glycosides has been furthered by the discovery of 
naturally occurring C-nucleosides. 
A number of synthetic approaches to C-glycosides have been developed indicating the wide 
range of chemistry applicable to carbohydrates. Most strategies are based on the natural 
electrophilic nature of the anomeric centre, but Wittig reactions, 
103 palladium-mediated 
coupling, 114  radical addition reactions' 7 and cycloaddition chemistry"6 have all been used 
(section 1.6). The successful application of cycloaddition chemistry has led to an 
investigation in this thesis of this approach to C-glycosides which should allow scope for the 
introduction of a wide variety of fuctionalisation. 
2.1.1 Synthetic strategy 
Nitrile Oxide Cycloaddition chemistry (NOC) has been shown over the past few decades to 
be a valuable route to a variety of synthetic targets including natural products 
.
58 An 
attractive feature is the possibility of regio- and stereochemical control. The proposed route 
is shown in the retrosynthetic analysis (Scheme 38). 
43 





R 	 + 
R 
Scheme 38 
The first step of the NOC route involves a [3+2] cycloaddition of the pyranosylnitrile oxide, 
with the functionality at the anomeric position, to a dipolarophile, usually an alkene 
(Scheme 39). The product of the cycloaddition is the key intermediate, the 
pyranosylisoxazoline, formed with predictable regio- and stereoselectivity. These 2-
isoxazolines are sufficiently stable to allow modification of substituents, and substitution at 
the 4-position of the isoxazoline ring, thus increasing the range of functionality available. 
However, the main synthetic utility of the isoxazoline is the ability to cleave the N-O bond 
to release either the -hydroxyketone (112), y-aininoalcohol (113) or a-enone (114), 
depending on the conditions used. Thus a wide range of C-glycosides should be accessible. 
The NOC methodology has already been used in the synthesis of higher monoaccharides,12° 
iminosugars63  and 1,3-linked C-disaccharides.1 
17 
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Scheme 39 
The prime objective of the work described in this thesis was to investigate routes to 
pyranosylnitrile oxides and their subsequent cycloaddition reactions. Other goals included 
study of possible manipulation reactions and optimisation of the conditions required for ring 
opening of the carbohydrate isoxazolines. 
The pyranosylnitrile oxides chosen for study were derived from D-glucose (115, 116), D-
mannose (117, 118), D-xylose (119) and L-fucose (120). These were generated either 
directly or indirectly from the corresponding 2,6-anhydro-1-deoxy-1-nitrOalditotS. The 
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dipolarophiles were mainly commercially available achiral alkenes. Model reactions were 
carried out using methylenecyclohexane as the isoxazoline formed would be a single isomer. 
This dipolarophile could also be used in the synthesis of C-glycosides similar to the 
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Results and Discussion 
2.2 	Synthesis of nitrite oxide precursors 
The first step of the NOC route involves cycloaddition of pyranosylnitrile oxides, thus 
precursors to these nitrile oxides were required. The existing route to pyranosylnitrile oxides 
had involved Mukaiyama-type9  dehydration of pyranosylnitromethanes, so the synthesis of a 
number of these compounds was undertaken. Of those chosen, the D-glucose, D-mannose 
and D-xylose-derived nitromethyl sugars were selected due to the commercial availability of 
the starting materials, the parent monosaccharides, and the common nature of these 
monosaccharides in biological systems. L-Fucose was chosen as it is an important 
component in partial structures of bacterial polysaccharides '2 ' and glycoproteins.'22 
Previous work within the group, 123,124,12' had shown that acetylated pyranosylnitromethanes 
provide access to pyranosylnitrile oxides and that an acetate-protection strategy had been 
widely successful. Thus, per-acetylated 2,6-anhydro-1 -deoxy-nitroalditols were prepared 
from the corresponding aldoses using a modified version of the procedure of Köll et all 
06  as 
outlined for the mannose-derived compound (122) in Scheme 41. 
2.2.1 Synthesis of acetylated 2,6-anhydro-1-deoxy-nitroalditOls 
Tetra-0-acetyl-3-D-mannopyranosylnitrOmethane (122) was synthesised in three steps from 
D-maiinose (123) as outlined in Scheme 41. In the first stage, base catalysed addition of 
nitromethane to D-mannose in its acyclic form gave the nitroalditol (124) as described by 
Fischer and Sowden.'26  The product was not isolated but converted directly to the 3-
mannopyranosylnitromethane (125) by heating in water. The mechanism is believed to 
involve dehydration to the c-nitro olefin (126) followed by thermal cyclisation. Acid 
catalysed acetylation yielded the title compound (122) (31%). 
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(I) CI-13NO2, NaOMe, MeOH; (ii) H20, reflux, (iii) Ac20, CF3SO3H 
Scheme 41 
There are two possible chair conformations for each of the a- and f3-anomers. Of the four 
possible chair arrangements (Figure 6) the 3-isomer in the 5C2 conformation is the structure 
with the least number of substituents in the axial position. The 3-anomer would be predicted 
to be formed preferentially over the a-anomer during the cyclisation step, as in the a-isomer 
the nitromethyl group or the C-6 substituent is in the axial position. 
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The predicted 5C2 conformation is supported by the 1 H NMR coupling constant data. Table I 
shows the 3J couplings for the ring protons of the acetylated mannopyranosylnitromethane 
(122). The J23  coupling of 0.8 Hz is indicative of the equatorial-axial coupling seen for the 
3-anomer, as is the J34  of 3.4 Hz. The value of 10.0 Hz for the J45 and J56 couplings are in 
agreement with the two di-axial couplings. Sowden127 has shown that the P:(x ratio during 
the cyclisation is in the order of 50:1. 
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Coupling 	J/Hz 
2,3 	 0.8 
H OAc 
3,4 	 3.4 
AcO 
AcO 
4,5 	 10.0 H2 	
NO2 
H 122 
5,6 	 10.0 
Table 1: Coupling constants for (122) 
The peracetylated glucose-derived nitromethyl compound (127) was prepared in similar 













Results and Discussion 
The relatively low yields for the formation of the nitromethyl compounds (122) and (127) 
were disappointing, thus the experimental procedure was modified. The first change made 
was to not isolate the 2,6-anhydro-1-deoxy-nitroalditol, but to acetylate the crude reaction 
mixture and obtain the product directly (Scheme 42). This worked well for both tri-O-acetyl- 
3Dxylopyranosylnitrornethane 	(128) 	(68%) 	and 	tri-O-acetyl-.13-L- 
fucoypyranosylnitromethane (129) (70%) with recrystallisation giving the products without 
the need for further purification. An added advantage of this method is the removal for the 
need to carry out liquid/liquid extraction required to isolate the unprotected 2,6-anhydro-1-
deoxy-nitroalditol. This is a time consuming process requiring the use of large amounts of 
solvent. 
For both (128) and (129) no cc-isomer was isolated. This observation can be explained using 
the same reasoning as for 	 (122). For tri-0- 
acetyl-f3-L-fucopyranosylnitromethane (129) the least hindered arrangement is the 2C5 
conformation of the 13-isomer. A J23  coupling constant of 9.2 Hz confirms the diaxial 
geometry supporting the assignment of the 3-configuration. The large coupling constant, 9.8 
Hz, for J14  is as expected for the diaxial arrangement, whilst the small 2.7 Hz coupling for 
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Figure 7 
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2.2.3 Alternative protection strategies 
To increase the scope of possible reactions of pyranosylnitrile oxides and their derivatives, 
it was decided to investigate alternative protection strategies. Study of the literature showed 
two possible base-stable alternatives: actetals and benzyl ethers in the form of 3,4:5,7-di-0-
isopropylidene3Dmannopyraflosylnitromethafle (130)128  and 3,4,5 ,7-tetra-O-benzyl-13-D- 
glucosylnitrornethane (131)."9 







2.2.3.1 Synthesis of 3,4: 
(130) 
Acetonation of pyranosylnitromethanes was first reported by BeMiller et al .
12
' They 
describe the synthesis of various di-O-isopropylidene protected nitromethyl sugars. For 
example (130) was synthesised from 3DmannopyranosyInitromethane (125) (Scheme 43). 
HO 	 NO2 
CH2=C(OCH3)CH3  




Initial attempts at acetonation with 3D-mannopyranosylnitromethane (125) using the 
conditions reported by BeMiller et al afforded the desired product (130), but in consistently 
low yield (<50%) with column chromatography required to isolate the product. However, 
modification of the reported experimental procedure allowed kinetically controlled 
acetonation via treatment of the parent 3Dmannopyranosylnitromethane (125) with an 
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excess of 2-methoxypropene and a catalytic amount of 4-toluenesulfonic acid (Scheme 43). 
The product (130) was isolated by recrystallisation as a white solid in 81% yield and 
characterised using 1 H and '3C NMR spectroscopy. 
Fusion of the dioxolane at C(2)-C(3) causes distortion of the pyranose ring from the usual 
chair conformation. This is evident by comparing the coupling constants in the 'H NMR 
spectra for 3,4:5 ,7-di-O-isopropyl ideneI3DmannopyranoSYlflitrOmethane (130) and 
3,4,5 ,7tetraO_acetyl-p-D_mannopyranOsYlflitrometl1afle (122) (Table 2). These show 
significant variation in some of the coupling constants caused by a slight flattening of the 
pyranose ring due to constraints caused by the fused I ,3-dioxane and 1 ,3-dioxalane rings. 
Thus, the structure deviates from the ideal 5C2  arrangement. The couplings between the 2-3 
and 3-4 protons show the greatest deviation due to these being the site of ring fusion. The 
spectrum also contains peaks at 1.31, 1.39, 1.47, and 1.51 ppm corresponding to the 
expected four Cl-T3  groups of the isopropylidene protection. The 
3j  values, shown in Table 2, 
are in agreement with the predicted structure; the 3-isomer with a distorted 5C2 
conformation. Two small couplings are seen for .12,3 and .13,4 (2.5 and 5.4 Hz), whilst two 
large couplings are seen for 45 and .J56  (7.9 and 10.0 Hz) due to two diaxial couplings. The 
13C spectrum contains peaks at 18.6, 26.2, 28.1 and 28.8 ppm corresponding to the four CH3 
groups and quaternary peaks at 99.6 ppm and 110.3 ppm corresponding to the 6-membered 
I ,3-dioxane ring and 5-membered I ,3-dioxolane ring respectively. 
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H 	 H 
122 
J/ Hz J1 Hz 
J111 	 13.0 Jl_11 14.1 
JVL 	9.8 J1 _2 9.9 
1.2 J1 , 2 2.9 
J23 	0.7 J23  2.5 
J3_4 	3.4 J3_4 5.4 
J45 	10.0 J4_5 7.9 
10.0 J56  10.1 
2.3 J6_7 5.7 
5.7 J6_7, 10.1 
J77, 	12.4 J7_7, 10.9 
Table 2: Comparison of coupling constants between (122) and (130) 
2.2.3.2 Synthesis of 	 (13 1) 
This compound was synthesised in three steps from a-methyl glucoside (132) as outlined in 
Scheme 44. The first step involved protection of the free hydroxyl groups as benzyl ethers 























(i) NaH, BnBr, (ii) Glacial Acetic acid, 2M H2SO4, (iii) CH3NO2, I ,2-diarninoethane 
Scheme 44 
Treatment of methyl c-D-g1ucopyranoside (132) with sodium hydride and benzyl bromide 
gave an oil that was purified by column chromatography to afford methyl 2,3:4,6-tetra-0-
benzyl-a-D-glucopyranoside (133) in 52% yield. Excess benzyl bromide was removed from 
the reaction mixture by addition of triethylamine. The benzyl triethyl ammonium bromide 
formed was removed by an aqueous wash. The couplings in the 'H NMR were in agreement 
with the predicted structure with a J,,2  value of 3.6 Hz consistent with the equatorial-axial 
arrangement of the a-anomer. 
Hydrolysis of the acetal was achieved by heating (133) at 90 °C for 18 hrs in the presence of 
2M H2SO4 and glacial acetic acid. The product (134) was obtained as a white crystalline 
solid in 33% yield and 'H NMR spectroscopy showed that a mixture of anomers had been 
obtained. 
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The target compound (131) was synthesised from (134) using the procedure of Stick et a1129 
involving treatment with 1,2-diaminoethane and nitromethane with heating to 80°C for 14 
days. The product, 2,3 	 (131), was 
isolated by dry flash chromatography as a clear oil (72%) that solidified on standing. Only 
the 13-isomer of the product was obtained, this being confirmed by the J2,3 coupling of 9.8 
Hz. 
2.3 	Alternative sources of pyranosylnitrile oxides 
As mentioned before, the previous route to pyranosylnitrile oxides involved isocyanate-
induced dehydration of nitromethyl sugars using a modification of the Mukaiyama method.9 
This, in general, has proved to be an excellent approach as the pyranosylnitrile oxides are 
generated in good yields from cheap readily available starting materials. However, there are 
a number of features of the reaction which make it incompatible with certain dipolarophiles. 
For instance, the reaction requires prolonged reaction times at elevated temperatures. Thus, 
low boiling or thermally unstable dipolarophiles, e.g. DMAD which polymerises at high 
temperatures, are not compatible with the route. Also, the isocyanate used as dehydrating 
agent can undergo side reactions with certain functional groups found in the dipolarophiles; 
for example it would react with alcohols to afford urethanes. To avoid these problems, 
attempts were made to find alternative sources. 
The most common literature routes to nitrile oxides are shown in Scheme 45. They involve 
the aforementioned isocyanate-induced dehydration of nitrornethylcompounds, oxidation of 
aldoximes and dehydrochlorination of hydroximoyl chlorides. It was therefore decided to 












Results and Discussion 
2.3.1 Synthesis of pyranosylaldoximes 
A search of the literature showed that the only examples of sugar-derived aldoxirnes with 
the oximic group at the anomeric position were C-furanosyl aldoximes (135). The first 
example was reported by Moffat et al 
130 in 1973. This route involved a three step synthesis 
of the formyl C-furanoside (136) followed by oximation (Scheme 46). 
Ph 
BnOH2C 	Br 	BnOH2C 	CN 
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BnO 136 " OBn BnO" 
-4 
i) Hg(CN)2, ii) Raney Nickel, PhNI-I(CH2)2NHPH NaH2P02, HOAc-Py-H20, iii) p-TsOH, AcOH, 
iv) H2NOH.HCI, EtOH, Pyridine 
Scheme 46 
A similar approach has been reported by Popsavin et a113' which also involves conversion of 
the formyl C-furanoside (136) to the oxime. Vassella et al 
132 have published the synthesis of 
(137) as a by-product in the synthesis of a cyclic nitrone. 
Me/111111 	 \CHNOH 
BnO 137 OBn 
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Oximation of formyl C-glycosides was considered as a route to pyranosylaldoximes 
(Scheme 47).There are a number of routes in the literature to formyl C-glycosides including 
work by Dondoni and co-workers101  (see section 1.6.4). However, none of the syntheses are 
straightforward often requiring multiple steps, expensive reagents and/or forcing conditions. 
Also, once prepared the aldehyde is prone to oxidation and hydration as well as elimination. 









The method selected was based on the observation by Bartra et a1133 that primary aliphatic 
nitro compounds can be reduced to aldoximes by stannate(II) complexes generated from 
SnCl2  (Scheme 48). The reaction is reported to be suitable for a wide range of aliphatic and 
aromatic nitro-compounds and offers excellent yields and rapid reaction times under mild 
conditions. Therefore, it was considered to be a good candidate for use with the 
pyranosylnitromethyl sugars. A major attraction of this route was that the oxirne would be 
synthesised from the previously prepared pyranosylnitrornethyl compound. 
PhSH 




The aforementioned stannate(II) complex, [Et3NH][Sn(SPh)3] is generated in situ from 
tin(II) chloride, thiophenol and triethylamine. Attempts to isolate this species by Bartra et 
al 133  led to Sn(SPh)2  precipitation, indicating a rapid equilibrium between the reagents and 
the tin complex (Scheme 49). 
Sn(SPh)2 + PhSH + Et3N 	- 	Et3NH 	[Sn(SPh)3] 
Scheme 49 
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The proposed mechanism is outlined in Scheme 50. The fact that the oxime is not further 
reduced, along with Bartra's'33  observation that nitrosobenzene is reduced even more rapidly 
than nitrobenzene under the reaction conditions, support the proposed mechanism. 
Reduction to the corresponding hydroxylamine is only seen for secondary nitroalkanes in 
apolar solvents. For primary nitro-compounds further reduction is prevented by rapid nitroso 











The method of Bartra'33 was tested on 
(122) with treatment with tin(II) chloride, triethylamine and thiophenol affording the D-
mannose derived aldoxime (138) (Scheme 51). The product was separated from tin-based 
by-products and other impurities by chromatography and isolated in 84% yield as a mixture 
of E:Z isomers in a 70:30 ratio. The 'H NMR spectrum of the products shows a doublet for 
each of the isomers due to the 1-H proton at 7.30 ppm (E-isomer) and 6.69 ppm (Z) isomer. 
The assignment of geometry was made by comparison with literature valures,'34 and the 
isomer ratio determined from the integrals of these signals. There are also characteristic OH 
signals in the 'H NMR at 8.53 ppm (E-isomer) and 7.79 ppm (Z-isomer) corresponding to 
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the N0H of each isomer. The couplings of the sugar ring protons are similar to those of the 
parent nitromethyl compound. The '3C NMR spectra shows a diagnostic peak at 146.1 ppm 
(E-isomer) and 147.2 ppm (Z-isomer) corresponding to the CH=NOH. 
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AcO 	 NO2 









The structure of (138), and the 3-configuration at the anomeric centre in particular, was 
confirmed by X-ray crystallography (Figure 8). A noteworthy feature of the crystal structure 
is the disorder in the region of the oxime moiety. There are two distinct arrangements 
represented by 0(1 )-N( 1 )-C( I )-C(2) and 0(1 ')-N( I ')-C( 1 )-C(2), corresponding to the Z- and 
E-oxime configurations. Thus both isomers detected in solution by NMR spectroscopy are 
incorporated within the crystal lattice. The ratio in the crystal, however, is 75 Z 25 E, 
whereas the E-isomer predominates in solution. 
The structure of the sugar ring is as expected for a 3-D-mannopyranosyl compound. The 
Crerner and Pople puckering parameters"' [Q = 0.580 A, 0 = 3.50, = 228.70] for the six-
membered ring comprising C(2)-C(3)-C(4)-C(5)-C(6)-0(6) show that it adopts a 
predominantly 5C2  conformation. In particular, the 0 value of 3.5° is close to the theoretical 
value for the chair conformation (0 = 0°). This arrangement is reflected in the 'H NMR 
couplings involving the ring hydrogens [J23  1.1, J3,4 3.3, J45 10.1, J5,6 10.0 Hz]. For the 
oxime moiety, the observed 'H NMR couplings of 5.5 and 4.1 Hz between 1-H of the oxime 
and 2-H of the pyranose ring are also consistent with the torsion angles in the crystal of 
129.8° and 144.8° for H(1)-C(1)-C(2)-H(2) and H(1')-C(1)-C(2)-H(2), suggesting that for 
both isomers the conformation in solution is broadly similar to that in the crystal. 
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Figure 8 
The peracetylated and perbenzylated glucose-derived oximes (139) and (140), along with 
the L-fucose-derived oxime (141) and the D-mannose-derived oxime (142) were prepared 
similarly from the corresponding pyranosylnitromethanes as summarised in Table 3. 
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Table 3: Synthesis of pyranosylaldoximes 
During the course of this work an alternative route to pyanose-1-carbaldoximes was reported 
by BeMiller, Petrus et al. 134  Whilst attempting the denitration of a selection of per-0-
acetylated43-glycopyranosylnitrornethanes, it was discovered that the nitro group was not 
replaced by a hydrogen atom but instead underwent reduction to yield the corresponding 
oxime (Scheme 52). The conditions employed were heating in benzene for 3-6 hrs in the 
presence of tributlytin hydride and 1,1 '-azobis(cyclohexanecarbonitrile) (ABCN). 
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The mechanism for this reaction is believed to involve an addition-elimination, as outlined 
in Scheme 53, with initial formation of the alkyl(trialkyltinoxy)nitrOXYl radical by addition 
of the tributlytin radical to the nitro compound. Elimination of the nitroso compound 











In comparison to the Bartra route, the two approaches have some similarities. Both have 
pyranosylnitromethanes as precursors to the oxime and both use tin based reductions. The 
method of BeMiller et al, 
114  however, appears to have no major advantage over the Bartra 
approach 133  providing the oximes in similar yields. Indeed, the elevated temperatures 
required for the BeMiller method may prove restrictive. 
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Very recently Dondoni et al, 
136  in response to our publication describing the reduction of 
pyranosylnitrornethanes using the Bartra 	 have reported the conversion of 
formyl C-glycosides to pyranose-1-carbaldoximes (Scheme 54). Their approach utilises the 
thiazole route to formyl C-glycosides. 
101 
transform to CT-b 





Dondoni claims this approach is advantageous with respect to the Bartra method as 
conversion of the formyl C-glycoside to the oxime uses the usual mild conditions, 
hydroxylamine hydrochloride and sodium carbonate, and allows access to both the a- and 3-
configurations. Access to both configurations is certainly useful, but the methodology 
described by Dondoni 
136 requires a number of extra steps with expensive reagents and 
forceful conditions, and as a route to 3pyranose1carba1doximes is considered to be less 
efficient. 
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2.3.2 Synthesis of pyranosyl hydroximoyl chlorides. 
Generation of nitrile oxides from aldoximes often involves conversion to the hydroximoyl 
chloride by direct chlorination or milder methods such as NCS followed by 
dehydrochlorination. The synthesis of pyranosyl hydroximoyl chlorides was, therefore, 
attempted. Direct chlorination was found to work well with formation of the hydroximoyl 
chloride being achieved by bubbling chlorine gas through the pyranosyl oxime in 
chloroform at -78°C. As the reaction proceeded there was a characteristic colour change 
from colourless, through blue, to green, this indicating the presence of the nitroso tautorner. 
Warming to room temperature and removal of solvent in vacuo gave the hydroximoyl 





















The mannose derived hydroximoyl chloride (143) was synthesised from tetra-0-acetyl-/3--D-
mannopyranosyl oxime (138) as a single isomer in 87% yield. There are a number of 
features in the 'H NMR which differ from that of the starting oxime. Firstly, the signal due 
to of the oxime 1-H is no longer present due to the displacement of hydrogen with chlorine. 
Thus, the signal for 2-H is simplified to a doublet at around 5.2 ppm, the signal being moved 
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4.3 ppm in oxime). Also, the broad signal due to the NOH moves from 8.53 to 8.80 ppm. 
There is little change in the pyranose ring proton signals. In the 13C spectrum the peak 
corresponding to C-I was shown by the DEPT spectra to have changed from a C-H to a 
quaternary carbon and moved from 146.1 ppm to 134.6 ppm. 
There are two characteristic parent ion signals in the mass spectrum of the compound at 
410.08545 amu and 412.06859 amu corresponding to the presence of the two isotopes of 
chlorine and thus the two molecular formulae: C151-121N01035C1 and C151-12 NO1037Cl. The 
intensity of the signals suggested a —3:1 ratio of the products which is in agreement with the 
natural abundance of the two isotopes. 
The peracetylated and perbenzylated glucose-derived compounds (144), synthesised from 
oxime (139) and (145), synthesised from oxime (140) were prepared in 95 % and 82% 
yields respectively. These compounds were characterised by 1 H and 13C NMR spectroscopy 





2.4 	Generation of pyranosylnitrile oxides and cycloaddition reactions 
One of the features of nitrile oxides is their tendency to be short lived species, undergoing 
dimerisation to furoxan if left unreacted. Thus, they are usually generated in situ from 
suitable precursors in the presence of the other reactant, in this case the dipolarophile. 
Previously, the only method of pyranosylnitrile oxide generation had been via the 
dehydration of pyranosylnitromethanes.117  This route provides an efficient method of nitrile 
oxide generation but suffers from a number of disadvantages, thus alternative sources of 
were investigated, namely the pyranosylaldoxime and hydroximoyl chloride. 
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2.4.1 Isocyanate-induced dehydration of pyranosylnitromethanes 
The method adopted for dehydration of pyranosylnitromethanes to pyranosylnitrile oxides 
was based on that of Mukaiyama9  and is illustrated for the D-rnannose derived compound 
(122)(Scherne 56). This involves heating the nitrornethyl compound to high temperature (Ca 
110 °C) for 7 days. Modifications of the approach were made with phenyl isocyanate being 
replaced by 2,4-tolylene di-isocyanate (TDI) as dehydrating agent. The advantage of using 
TDI is that the by-product formed is a polymeric urea, which can simply be removed by 
filtration unlike the diphenyl urea formed when phenylisocyanate is used. Excess 2,4-
tolylene di-isocyanate can also be removed by the addition of 1 ,2-diaminoethane, which 
reacts to form another poylmeric urea. 









Results and Discussion 
The proposed mechanism for the reaction is shown in Scheme 57 below. It involves initial 
deprotonation to form the nitronate anion which then reacts with the isocyanate. Collapse of 
the resulting adduct and loss of CO2 generates the nitrile oxide along with amine. This latter 
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Scheme 57 
2.4.2 Alternative routes 
The Mukaiyama approach has a number of inherent drawbacks: (1) it requires prolonged 
reaction times at elevated temperatures, which means that reactions with thermally unstable 
dipolarophiles and low boiling dipolarophiles (b.p < 60°C) are impossible, (2) the use of 
isocyanate as dehydrating agent is incompatible with hydroxyl or amino functional groups. 
Thus, any such groups within either the pyranosylnitromethane or the dipolarophile must be 
protected to prevent reaction with the isocyanate. To circumvent these problems two other 
sources have been investigated. The pyranosylaldoxime and hydroximoy! chloride. 
2.4.3 Generation of pyranosylnitrile oxides from pyranosylaldoximes. 
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The conversion of aldoximes to nitrile oxides is a well known reaction. A number of 
reagents have been used, but the most common is alkaline sodium hypochlorite and the 
method of Lee et al' 9  was adopted. The pyranosylaldoxime was generated from the 
pyranosylnitromethane as described in section 2.3.1 (Scheme 58). 
NO2 	
NOH 
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Scheme 58 
2.4.4 Conversion of pyranosylhydroximoyl chlorides to pyranosylnitrile oxides 
An envisaged problem of using pyranosylaldoximes as precursors to pyranosylnitrile oxides 
was the lack of control over the rate of nitrile oxide formation. Thus, high levels of 
dimerisation were possible. With this in mind, a further source of pyranosylnitrile oxides 
was investigated' the hydroximoyl chloride. The pyranosylhydroximoyl chloride was 
synthesised from the aldoxime as described in section 2.3.2. 
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Generation of the nitrile oxide was achieved using classic Huisgen conditions" involving 
base-induced dehydrohalogenation (Scheme 59). An attractive feature of this route is that by 
controlling the rate of base addition, the rate of nitrite oxide generation can be regulated. 
Thus, the concentration of nitrile oxide can be kept to a minimum thus, reducing 
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Scheme 59 
Three routes to pyranosylnitrile oxides were now available; by dehydration of the 
pyranosylnitromethane (method A), oxidation of pyranosylaldoximes (method B) and 
dehydrohalogenation of pyranosythydroximoyl chlorides (method Q. The three methods are 
described below. 
Method A: To the nitrile oxide precursor as a solution in toluene were added TDI, 
dipotarophile and triethylamine and the reaction mixture heated at reflux for 7 days. The 
appearance of a yellow polymeric solid, the urea, showed that generation of nitrile oxide 
was taking place. Excess TDI was removed by reaction with diaminoethane and the resulting 
polymer and other polymeric ureas removed by filtration. Excess alkene was removed by 
either evaporation in vacuo or chromatography. Where diastereomers were produced the 
isomer ratio was determined by 'H NMR spectroscopy. 
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Method B: The conversion of the oxime was carried out in a two phase system of 
dichioromethane and water, with aqueous sodium hypochiorite as oxidant. The oxime, 
dipolarophile and a catalytic amount of triethylamine were added and the mixture stirred 
vigorously. Aqueous sodium hypochiorite was added drop-wise. The product was isolated 
by extraction into dichlorornethane and removal of solvent in vacuo. 
Method C: The hydroximoyl chloride was dissolved in dry ether along with an excess of the 
dipolarophile and cooled to 0 °C. A solution of triethylamine in dry ether was added using 
syringe pump over a 24 hour period. The reaction mixture was allowed to warm to room 
temperature and stirred for a further 2 hours. These conditions were employed to keep the 
concentration of the nitrile oxide at a minimum and thus minimise dirnerisation to furoxan. 
Formation of a white precipitate, triethylamine hydrochloride, showed the reaction had 
taken place. This was removed by aqueous work up. Excess alkene was removed by 
evaporation in vacuo or column chromatography, which was required to remove traces of 
furoxan. 
To investigate the general applicability of all three generation strategies a single 
dipolarophile, styrene, was reacted with 	 oxide 
(117) generated by the three methods, A, B and C (Scheme 60). Styrene was chosen due to 
its high reactivity and ease of removal. 
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2.4.5 Cycloaddition reaction of 3,4,5,7- tetraOacetyI-fl-D-mannopyraflOSYlflitriIe 









Cycloaddition of the D-mannose derived nitrile oxide (117) to styrene was carried out using 
methods A, B and C. In all cases an inseparable mixture of (5R)- and (5S)-5-phenyl-3-
(2,3:4,6 tetra- Oacetyl-/3-D-mannopyranosyl)-2-isoXaZOline (146) was obtained. The yields 
and isomer ratios are summarised in Table 4. The isomer ratios were determined by 1H 
NMR by comparison of the signals for the anomeric position and showed the reaction to 
have little diastereoselectivity. The configuration at the 5-position of the individual isomers 
was not determined. 
72 
Results and Discussion 
Method of nitrile oxide 
generation 
Yield Isomer Ratios 
Method A-Mukaiyama 95% 56:44 
Method B-Hypochlorite 85% 53:47 
Method C-Dehydrohalogenation 95% 56:44 
Table 4: Summary of (146) formation 
The hII NMR spectrum of the products appears as a superimposed combination of the 
signals of the two diastereoisomers at nearly all positions. Characteristic features include 
eight singlet peaks between 1.72 and 2.10 ppm corresponding to the four CH3 groups of the 
acetate protection in each diastereomer. Peaks at 2.96 and 3.44 ppm correspond to the 4a-H 
and 4b-H of the isoxazoline ring. These have the gerninal coupling to each other and a 
vicinal coupling to 5-H. Thus both appear as a doublet of doublet for each diastereomer. All 
ring protons have the expected coupling constants with the f3 configuration being confirmed 
by J12  of 1.3 Hz corresponding to the axial-equatorial arrangement. 
The '3C NMR spectrum in conjunction with DEPT experiments confirms the structure. 
There are two diagnostic signals: (i) a CH2  signal at 43.2 ppm corresponding to C-4 for the 
isoxazoline ring and (ii) a quaternary peak at 154.9 ppm due to C-3, the C=N, of the 
isoxazoline ring. The 13C spectrum also shows the presence of the two diastereomers in 
similar amounts. Many of the peaks 'double up', for example the C-S position of the 
heterocycle shows two peaks of similar intensity at 81.2 and 81.8 ppm. 
None of the possible 4-substituted regio-isomer was detected. Thus the cycloaddition 
appeared to occur regiospecifically. This regiospecificity is observed in most other 
cycloaddition reactions to mono-substituted alkenes and can be explained by FMO theory 
(Figure 9). This class of cycloaddition falls into the Sustmann37  Type III where the dominant 
interaction is between the LUMO of the dipole and the HOMO of the dipolarophile. 
Maximum overlap of orbitals is achieved with the dipolarophile in an orientation leading to 
the 5-substituted product. Steric bulk of the dipolarophile may also disfavour the 4-
substituted product. 
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	 4-Substituted product 
Figure 9 
The lack of disatereoselectivity is not unexpected and there is literature precedent for this 
observation. 123  One explanation for this lack of diastereoselectivity is the distance between 
the newly formed chiral centre and existing chiral centre (Figure 10). Thus, there is very 





* existing chiral centre 
* * newly formed chiral centre 
Figure 10 
As can be seen in Table 4 the studied reactions proceeded in good yield giving products with 
similar diastereoisomer ratios. The slight fall in yield for the approach using the 
pyranosylaldoxime (the hypochlorite method) can be explained by incomplete conversion of 
the oxime to the nitrile oxide. These results indicate that all three methods of nitrile oxide 
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generation are efficient. Although not applicable in all cases, the dehydration of 
pyranosylnitromethanes provides access to pyranosyl isoxazolines in the least number of 
steps and thus is often the method of choice. A number of cycloadditions were carried out 
using this generation strategy to allow the synthesis of interesting isoxazolines and to 
investigate further the efficiency of the approach. 
2.5. 	Cycloaddition using the Mukaiyama approach 
2.5.1 D-Glucose derived nitrile oxides 
2.5.1.1 Cycloaddition 	reactions 	of 	3,4,5,7tetra-0aCCtyl-f3-D-glUcOPYrafl0SYl- 
formonitrile oxide (115) 
The cycloaddition of the glucose derived nitrile oxide (115) with methylenecyclohexane was 
carried out in using method A, but at reduced temperature (90°C) due to the boiling point of 
the dipolarophile (102-103°C) (Scheme 61). The use of a 1, 1 -disubstituted alkene led to the 
formation of a single isomer. The isoxazoline (147) was isolated as a white solid in 79% 
yield. The lack of diastereorners gave much simplified spectra enabling easier assignment. In 
the 'H NMR spectrum the 4a-H and 4b-H of the isoxazoline ring appear as doublets with a 
geminal coupling constant of 17.1 Hz, whilst the cyclohexane ring protons appear as 
complex set of multiplets between 1.22 and 1.67 ppm. The sugar ring protons are at similar 
chemical shifts with almost identical couplings to those of the nitrile oxide precursor with 
the 3-configuration is confirmed by the J,',' of 10.0 Hz caused by the diaxial arrangement. 
The main diagnostic peaks in the 13C spectrum relate to the isoxazoline ring with signals at 
42.2, 87.5 and 154.1 ppm corresponding to the CH2 at C-4, the quaternary at C-S and the 
C=N quaternary at C-3, respectively. 
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Scheme 61 
Within the group the nitrile oxide / isoxazoline route has been used as a method of C-
disaccharide synthesis.' 7  A prerequisite for this is the use of sugar-derived alkenes as the 






With the possibility of C-disaccharide synthesis in mind the cycloaddition of the glucose-
derived nitrile oxide (115) with the glucose-derived alkene, 3-O-acetyl-5,6-dideoxy-1,2-O-
isopropylidene-a-D-xylo-hex-5-enofurafloSe (149) was carried out using method A. The 
sugar alkene (149), supplied by A. R. March, 
123  was synthesised in 4 steps from the 
commercially available 1,2:5 ,6-di-O-isopropyl idene-D-glucose. The product (148) was 
isolated as a mixture of diastereomers from unreacted alkene by column chromatography in 
79% overall yield and the isomer ratio determined by 'H NMR to be 75:25. The major 
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isomer was isolated by repeat recrystallisation from ethanol. This isomer, assigned the 
eyrtho stereochemistry, was characterised by 'H and '3C NMR as well as comparison with 
an authentic sample. An interesting feature of the 'H NMR is the .J23 value of 0 Hz, 
consistent with the expected dihedral angle of 900. Unlike the cycloaddition reaction with 
styrene, significant diastereoselectvity is observed for this example. This it-facial selectivity, 
which leads to the erythro product being favoured, is known for chiral enol ethers' 
38 and has 
been explained using Honk's 'inside alkoxy effect' 
.139 The lack of diastereoselectivity seen 
for the styrene adduct has been explained previously (section 2.5) and an explanation for the 
significant selectivity for the reaction of the sugar alkene involves the proximity of the 
newly formed chiral centre to the existing chiral centre (Figure 11). Thus, there is a greater 
influence on the stereochernical outcome of the reaction. 
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2.5.1.2 Cycloadditions reactions of 3,4,5,7-tetra-0-benzy!--D-
glucopyranosylformonitrile oxide (116) 
Generation of the novel 	 oxide (116) 
was studied by cycloaddition of (116) with methylenecyclohexane using method A (Scheme 
63). Methylenecyclohexane was chosen due to its reactivity, ease of removal on completion 
of reaction and the lack of isomerism in the product. Isoxazoline (150) was isolated by dry 
flash chromatography from unidentified impurities as a clear oil, which solidified on 
standing, in 80% yield. The 'H NMR showed the presence of the benzyl protection with 
signals between 4.57 and 4.99 ppm corresponding to the four CH2  groups and between 7.18 
and 7.35 ppm indicating the four phenyl rings. A signal at 2.71 due to two overlapping 
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doublets was assigned to the 4a-H and 4b-H of the isoxazoline ring, whilst the J 2 value of 
9.6 Hz confirmed the 3-configuration. The sugar ring protons found in the range 3.45 to 
3.88 ppm were poorly resolved, making full assignment impossible. In the '3C NMR spectra 
the signals due to the C-3, C-4 and C-S positions of the isoxazoline ring proved diagnostic. 
These appeared at 156.2, 48.9 and 86.6 ppm respectively. The compound was further 
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Scheme 63 
The glucose-derived nitrile oxide (116) was also reacted with styrene using method A 
(Scheme 63). The products (151) were obtained as a pair of diastereomers (80%) as a yellow 
oil which solidified on standing. The isomer ratio was determined by '3C NMR to be 
approximately 53:47 and (15 1) was identified by 1H and 13C NMR with diagnostic peaks in 
13C spectrum corresponding to the isoxazoline ring carbons. 
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2.5.2 D-Mannose derived nitrile oxides 
Previous work within the group had concentrated on D-glucose and D-xylose-derived nitrile 
oxides. To investigate further the reaction of pyranosylnitrile oxides, cycloaddition reactions 
of mannose-derived nitrile oxides with various dipolarophiles were investigated. 
2.5.2.1 Cycloadditions of 
oxide (117) 
The cycloaddition reactions of the mannose-derived nitrile oxide (117) with oct-1-ene and 
methylenecyclohexane were carried out using method A (Scheme 64). Reaction with oct-i - 
ene gave a pair of inseparable diastereomers (152) in a 51:49 ratio as determined by 13C 
NMR spectroscopy. The combined yield was 72%. Reaction with methylenecyclohexane 
afforded isoxazoline (153) (88%). All products were characterised by 'H and '3C NMR 










The cycloaddition of the mannose-derived nitrile oxide (117) with oct-1-yne was carried out 
using method A to determine whether the route was applicable to the synthesis of 
isoxazoles. The isoxazole (154) was obtained as a clear oil in 78% yield and, as expected, 
only one regioisomer was formed. The 
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ppm due to the 4-H of the isoxazole ring. There is a large contrast between the position of 
the 4-H signal in this isoxazole and the corresponding isoxazoline (5.97 cf 2.8 ppm). The 
13C spectrum displayed the same effect with the 4-CH of the isoxazole at 99.5 ppm 
compared, to 45.4 ppm for the CH2  group in the corresponding isoxazoline. The two other 
isoxazole ring carbons gave peaks at 159.9 ppm and 174.0 ppm due to C-3 and C-5 
respectively. 
2.5.2.2 Cycloadditions 	of 	3,4:5,7di0isoprOPYIideneflDmafln0PYhbosYI- 
formonitrile oxide (118) (Scheme 65) 
Scheme 65 
The cycloaddition reaction of methylenecyclohexane with the novel mannose-derived nitrile 
oxide (118) was carried out using method A to investigate the applicability of 
nitromethylcompound (130) as a precursor. Isoxazoline (155) was isolated in 84% yield as a 
single regioisomer. The 1 H spectrum contained four singlets between 1.28 - 1.50 ppm 
corresponding to the CH3  of the isopropylidene protection. The usual overlapping doublets 
were seen at 2.80 ppm due to the 4a- and 4b-H protons of the isoxazoline ring with a 
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geminal coupling of 17.2 Hz and, the 3-stereochemistry was confirmed by the J1 ,2 coupling 
of 2.7 Hz. This value is larger than that for the acetate protected pyranosyl isoxazoline, 
indicating the flattening of the ring caused by the presence of the fused I ,3-dioxane and 1,3-
dioxalane rings. The coupling of the ring protons is similar to the parent nitromethyl 
compound denoting the slightly flattened 4C1 conformation. The 13C NMR spectrum showed 
the presence of four methyl groups from the acetal protection at 18.6, 26.1, 28.2, and 28.8 
ppm. The signals at 18.6 and 28.8 are assigned to the 1,3-dioxane ring whilst the other two 
at 28.2 and 28.8 are due to 1,3-dioxolane.128  There is significant differences in the chemical 
shifts of the ketal quaternary peaks with the 1,3-dioxane peak at 99.5 ppm whilst the 1,3-
dioxolane is found at 109.8 ppm. The other signals in the spectrum are as expected and 
include a characteristic peak at 156.6 ppm due to the C=N of the isoxazoline. 
Further cycloaddition reactions of the mannose-derived nitrite oxide (118) with styrene, oct-
1-ene, oct-1-yne and phenylacetylene were carried using method A and yielded isoxazolines 
(156) and (157) as mixtures of diastereomers, and isoxazoles (158) and (159) respectively. 
The results are summarised in Table 5. 
Compound Yield / % Isomer ratio 
(156) 79 53:47 
(157) 53 56:44 
(158) 80 n/a 
(159) 80 n/a 
Table 5: Formation of cycloadducts (156) - (159) 
2.5.3 Cycloadditions of 3,4,5tri-O-acetyl-fl-D-xylopyranOSyI-1-flitrile oxide 
Due to the relatively high yields for the formation of 3,4,5-tri-O-acetyl-18-D-
xylopyranosylnitromethane, its use as a precursor to nitrile oxides was adopted. Thus, the 
xylose-derived nitrile oxide (119) was generated and reacted with methylenecyclohexane 
employing the conditions outlined in method A. Isoxazoline (160) was obtained as a white 
solid in 78% yield. The 11-1 NMR showed three singlets between 2.01 and 2.04 ppm 
corresponding to the CH3  groups of the acetate protection. The 4a- and 4b-H of the 
isoxazoline ring at 2.73 ppm show the characteristic geminal coupling of 17.2 Hz. A triplet 
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at 3.36 ppm and a doublet of doublets at 4.14 ppm correspond to the 5a'- and 5b'-H of the 
pyranose ring and, the 13-conformation is confirmed by the J,,2 value of 9.9 Hz. The 13C 
NMR showed three signals at 21.0 to 21.1 ppm and three more at 170.2 to 170.3 ppm due to 
the acetate protection. The diagnostic isoxazoline signals occurred at 42.8, 87.8 and 154.8 
corresponding to C-4, C-S and C-3 respectively. 
+ 	- 
o 	CN—O 










The cycloaddition of the xylose-derived nitrite oxide (119) with styrene gave a pair of 
diastereomeric isoxazolines (161) in 60% yield. The isomer ratio was determined by 13C 
NMR spectroscopy to be 55:45 with (161) being identified by 'H and '3C NMR 
spectroscopy. 
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2.6 Generation of pyranosytnitrile oxides from pyranosylaldoximes and 
subsequent cycloaddition reactions 
To investigate further the use of the pyranosylaldoxime as a precursor to the pyranosylnitrile 
oxide, the cycloaddition reactions of 3,4,5 ,7tetraOacety!-,8-D-glUcoPYrafloSYt 1 -nitrite 
oxide 	(115) 	with 	rnet!iylenecyclohexane 	and 	3,4,5 ,7di-O_isopropyhidene-,B-D- 
mannopyranosyl-1-nitrile oxide (118) with methylenecyclohexane were attempted using the 
conditions described in method B (Scheme 67). Isoxazoline (147) and isoxazoline (155) 
were obtained in 62 % and 52%, respectively, and were characterised by comparison with 
authentic samples. In both cases considerable amounts of furoxan by-product were obtained 
(e.g. furoxan (162) form (115)). This confirms the expected drawback of 
pyranosylaldoximes as precursors to pyranosyh nitrile oxides. As there is no means of 
controlling the rate of nitrile oxide formation, high concentrations can occur, favouring 













Results and Discussion 
2.7 	Generation of pyranosylnitrile oxides from pyranosylhydroximoyl chlorides 
and subsequent cycloaddition reactions 
The high levels of dimerisation by-product observed using the pyranosylaldoximes as 
precursor made the hydroximoyl chloride precursor an attractive alternative source of nitrile 
oxides. As generation is achieved using base catalysed dehydrohalogenation, slow addition 
of base would lead to low concentrations of nitrile oxide and thus reduce dimerisation. To 
test this hypothesis the cycloaddition reactions of 3,4,3, I-tetra-U-acewl-/)-L)-
mannopyranosyl-1-nitrile oxide (117), generated from the hydroximoyl chloride precursor, 
with DMAD, ethyl propiolate, oct-I -ene, cyclohex-2-enone, ethyl cyanoformate, 
phenylacetylene and allyl alcohol were attempted. 
2.7.1 Cycloadditions of 	 oxide 
(117) 
The tendency for DMAD to polymerise at elevated temperatures prevented its use in 
cycloaddition reactions using the Mukalyama procedure.9  It had also proved problematic 
when reacted with the aldoxime precursor. 
123 Thus, using method C, the cycloaddition of the 
D-mannose based nitrite oxide (117) with DMAD was undertaken (Scheme 68). Isoxazole 
(163), as a yellow oil (70%), was isolated from furoxan by-product (164) (15%) by 
chromatography. In the 13C spectrum, the isoxazole peaks at 156.1 and 1 14.5 for C-3 and C-
4 agree with expected values! 23  The C-5 peak is among those of the methyl esters (CO2CH3) 
around 160 ppm. 
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164 
Unlike DMAD, ethyl propiolate is asymmetric and two regioisomeric adducts are possible. 
To investigate the regioselectivity of the cycloaddition reaction, the cycloaddition of the D-
mannose based nitrile oxide (117) with ethyl propiolate was carried out using method C. 
Three products were isolated from the reaction mixture spots. Furoxan (164) was obtained 
in 10% yield along with an inseparable pair of regioisomers, 3-(2,3:4,6-tetra-O-acetyl-1@-D- 
mannopyranosyl)-5-ethylester-isoxazOle 	(165a) 	and 	3-(2,3 :4,6-tetra-O-acetyl-/3-D- 
mannopyranosyl)-4-ethylester-isoxaZote (165b) in a combined 79% yield. The ratio of 
regioisomers was determined by comparison of the integrals in the 1 H NMR of the 4-H and 
5-1-I isoxazole ring protons for the 2 isomers. The signals were at 7.25 and 6.37 ppm and the 
ratio was determined to be 7:1 in favour of the 5-substituted product. The product was 
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characterised by 'H and '3C NMR spectroscopy and by high-resolution mass spectrometry. 
There is literature precedent for such regio-isomersim.'4°  The cycloaddition of benzonitrile 
oxide and methyl propiolate exhibits two regioisorners in a 72:28 ratio. 
140 Previous 
cycloadditions reactions attempted had been regioselective. The reason for regioisomerism 
when ethyl propiolate is used as dipolarophile can be explained by considering the 
Sustmann37  classification. The introduction of an electron withdrawing group (W) lowers 
the energy of both the HOMO and the LUMO of the dipolarophile. Thus, as well as the 
dominant Sustmann type III interaction which affords the 5-substituted product, interaction 
of the LUMO-dipolarophile and HOMO-dipole (Sustrnann type II) is now possible allowing 
some 4-substituted product to be observed (Figure 12). The low steric demand of the ester 
group also favours formation of the 4-substituted product. 
EtO2C LUMO 	
Et02C" U 
V ? 	 Sugar 
HOMO Sugar—C —N- 0 
4-substituted product 
Figure 12 
The cycloaddition of the D-mannose based nitrile oxide (117) with oct-1-ene (Scheme 69) 
was carried out using method C. A pair of inseparable diastereomeric isoxazolines (166) 
were isolated in 87% combined yield, in a 51:49 ratio as determined from the '3C spectrum 
with characterisation of (166) achieved by 'H and '3C NMR spectroscopy as well as 
comparison with an authentic sample. Furoxan (164) was obtained as a by-product in a 11% 
yield. 
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A more in-depth study on the regioselectivity of cycloaddition reactions was achieved by 
reaction of the D-mannose based nitrile oxide (117) with cyclohex-2-enone, carried out 
using method C. A pair of inseparable diastereomeric isoxazolines (167) were isolated from 
an unknown side product in 79% yield, but no regioisomerism was detected. The 
diastereoisomer ratio was determined to be 55:45. The 'H NMR of the compound shows a 
doublet at 3.75 ppm due to the 7a-H proton, which only couples to the 3a-H proton. The 
other protons from the cylohexanone ring appear as a complex multiplet between 1.79 and 
2.54 ppm, whilst the 3a-H appears as a multiplet at 4.87 ppm. The '3C NW shows two 
diagnostic C-H peaks at 59.6 and 81.8 ppm corresponding to C-3a and C-7a of the 
isoxazoline ring. There is also the C=N at 152.9 ppm and a peak at 205.7 ppm due to 
carbonyl group on the cyclohexyl ring. 
Previous attempts within the group to react pyranosylnitrile oxides with ethyl cyanoformate 
had failed. Therefore, the cycloaddition of the D-mannose based nitrile oxide (117) with 
ethyl cyanoformate was attempted, using method C. Although a small amount of what was 
believed to be the desired product was obtained the dominant product was furoxan (164) in 
58% yield. This indicates the low reactivity of ethyl cyanoformate towards pyranosylnitrile 
oxides. In an attempt to form the cycloadduct, the reaction was repeated at elevated 
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temperature. 3,4,5 ,7-Tetra-O-acetyl-fi-D-mannOpyraflOSYl hydroximoyl chloride (143) was 
added to the dipolarophile in THF, heated to 70°C and then triethylarnine in THF added 
over a 24 hour period. The I ,2,4-oxadiazole (168) was obtained as a single isomer in a 15% 
yield but the dominant product was again furoxan (164) obtained in 65% yield. (168) was 
identified by 'H NMR which showed peaks at 1.43 ppm and 4.50 ppm for the CH3CH2 
group and movement of the l'-H signal to higher chemical shift (4.6-5.0 ppm) possibly 
due to the increased inductive effect of the heterocyclic ring. In the 13C spectrum there 
where peaks at 14.4 and 63.0 ppm due to the CH2CH3  group and at 125.9 and 154.0 due to 
C-S and C-3 of the heterocyclic ring. 
To determine if temperature had any effect on the regioselectivity of reactions, D-mannose 
derived nitrile oxide (117) was reacted with cyclohex-2-enone at elevated temperature using 
the method described for ethyl cyanoformate. It was hoped that an increase in reaction 
temperature may favour the formation of the 4-substituted isomer. The TLC of the reaction 
mixture showed three spots. After chromatography two main products were isolated: the 
furoxan (25%) and a white crystalline solid which was determined to be the pyranosylnitrile 
(169) (58 %). The formation of these nitrites as by-products has been seen previously in the 
group although no explanation for there formation has been forthcoming. The nitrile was 
characterised by 'H and '3C NMR. 
D-Mannose derived nitrile oxide (117) was reacted with phenylacetylene in accordance with 
the method C (Scheme 70). The isoxazole (170) was obtained as a white crystalline solid in 
37% yield whilst furoxan (164) was also obtained in a 35% yield. The 'H NMR showed a 
diagnostic singlet at 6.56 ppm due to the 4-H of the isoxazole and the 13C spectrum showed 
peaks at 160.7, 98.3 and 169.9 ppm due to C-3, C-4 and C-S of the isoxazole ring. 
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One of the inherent drawbacks of the Mukaiyama route to nitrile oxides is the use of 
isocyanate-dehydrating agents due to their possible reaction with any hydroxyl and amine 
functional groups in the reagents. To test the tolerance of the hydroximoyl chloride 
approach to functionality, the D-mannose derived nitrile oxide (117) was reacted with allyl 
alcohol using method C. Three products were isolated by chromatography, (171) as a 
mixture of inseparable diastereomers in approximately 50:50 ratio and 30% overall yield 
and furoxan (164) (14%). The 'H NMR of the product showed the characteristic signals at 
around 3.0 ppm due to the 4a-I-1 and 4b-H protons of the isoxazoline ring and a broad singlet 
at 6.96 ppm due to the OH. In the '3C NMR there were the characteristic isoxazoline peaks 
at 156.6, 36.9 and 81.0 ppm for C-3, C-4 and C-S respectively. 
2.7.2 Summary 
The scope of cycloaddition reactions of pyranosylnitrile oxides has been increased with the 
introduction of the two new precursors, pyranosylaldoximes and pyranosyihydroximoyl 
chlorides. Both provide efficient routes to the nitrile oxide with the hydroximoyl chloride 
approach allowing minimisation of furoxan production. The Mukaiyama approach is also an 
efficient method of nitrile oxide generation and does not suffer from furoxan formation but 
is limited by its incompatibility with certain dipolarophiles. 
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2.8 	1,2,5-oxadiazole 2-oxides (furoxan) chemistry 
One of the inherent drawbacks of nitrile oxide cycloaddition chemistry is the tendency of 
the nitrile oxides to dimerise to furoxans. Using the Mukaiyama conditions minimises 
dimerisation, but this method is not applicable to all dipolarophiles. Even when 
concentrations of nitrite oxide are kept to a minimum, as in the case when pyranosyl 
hydroximoyl chlorides are used as precursor, significant amounts of furoxan may still be 
formed. However, on closer inspection, this "unwanted" by-product may have synthetic 
utility. For example, the furoxan, like the isoxazoline ring is open to chemical manipulation, 
which could lead to novel carbon bridged disaccharides. 
Furoxans have been known since the 1850's and much attention has been paid to structure 
determination, development of preparative methods and examining their reactions. 
25 
There are three main preparative routes to furoxans (15): via oxidative cyclisation of 1,2-
dioximes (172),141  the dehydration of a-nitroketoximes'42  (173) with e.g. chlorosulfonic acid 
and, for symmetrically substituted furoxans, the dimerisation of nitrile oxides 
25  (3) (Scheme 
71). As the dimerisation of nitrile oxides is known to work well and, with suitable 


















Results and Discussion 
Furoxans show a wide range of biological activity, including potential as nitric oxide 
donors. 143  A variety of NO-related bioactivities, including cytotoxicity, mutagenicity, 
immunosupression, central muscle relaxant properties, anticonvulsive effects, monoamino 
oxidase inhibition, and direct vasidilator and blood pressure lowering activities have been 
observed. Examples of active compounds are (174)'
44 
 and (175).'  





Several mechanisms for the release of NO have been postulated. 
145  A common theme 
involves nucleophilic attack at the 3- and/or 4- position of the ring, either by thiols or a 



















Results and Discussion 
There is also interest in the transformations that the furoxan ring can undergo. Although 
generally stable to electrophiles and oxidising conditions, nucleophilic substitution reactions 
have been reported .25  Moreover, the ring can undergo a retrocycloaddition at high 
temperatures, often greater than 200 °C, to afford nitrite oxides (3)25 Hydrogenation of 
furoxans over a metal catalyst usually leads to I ,2-dioximes (172) as does treatment with 
sodium borohydride.'46  However, under more forcing conditions, e.g. Raney nickel as 
catalyst at elevated temperature or reduction with LiAIH4, cleavage of the C-C bond can also 
occur giving amines.' 
46 Deoxygenation with reagents such as PCI5147 and P(OEt)3148 affords 













2.8.1 Synthesis of 3,4-dipyranosyl-1,2,5-oxadiazole 2-oxides 
The dirnerisation of pyranosylnitrile oxides was chosen for the synthesis of dipyranosyl 
furoxans. The nitrite oxides were generated in the absence of dipolarophile from three 
precursors: pyranosylnitromethanes, pyranosyl aldoxiines and pyranosyl hydroximoyl 
chlorides, as described previously (section 2.3). 
Dehydration of pyranosylnitromethanes using a modified version of the Mukaiyama 
approach9  was used to synthesise dipyranosyl furoxans (177) - (180). The results are 
summarised in Table 5. 
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5 Z°N 
R'><: 
Furoxan Yield / % C-3, C-4 m/z (M-60) 
R= (ppm) 
92 112.0, 153.1 571 (n/a) 
 
0\ 
81 112.7, 153.7 603 (543) 
AcO" 	 "'OAc 
OAc 
 
79 112.5, 153.8 631 (571) 
AcO 	 "OAc 
OAc 
 
BnO '  




Table 5: Summary of results for furoxans (177) - (180) 
93 
Results and Discussion 
3,4Di(2,3:4,6_di0-isopropyl-/3-D-maflflOPY1'an05Yl) furoxan (177) was obtained as white 
solid in 92% yield. The product was identified by 'H and '3C NMR spectroscopy. The 13C 
NMR spectrum is of particular value in identifying the furoxan ring as there are diagnostic 
quaternary peaks at Ca. 110 and 150 ppm corresponding to C-3 and C-4.25  For compound 
(177) these peaks appeared at 112.0 and 153.1 ppm. The signals due to the pyranose ring 
protons between 61.5 and 75.8 'double up', consistent with the presence of two similar 
pyranose rings. This is also apparent in the methyl signals of the acetal protection. The 1,3-
dioxane rings have peaks at 18.7, 1 8.7, 28.7 and 28.9 ppm due to the isopropylidene methyl 
groups as well as peaks at 99.9 and 100.0 ppm for the acetal carbons. There are 
corresponding peaks at 26.4, 27.3, 28.3 and 28.4 ppm and 110.4 and 110.5 ppm for the 
acetal carbons of the 1,3-dioxane rings. 
The 'H NMR spectrum is complicated due to the presence of two similar pyranose rings 
whose proton signals overlap at every position except the 1' and 1" site where the two 
doublets corresponding to each anomeric proton are separated by 0.16 ppm. The small 
coupling constants seen for J, 2' and J," 2" of 2.5 Hz are consistent with the expected axial-
equatorial relationship for these protons. Thus, the 3-configuration of the 
nitromethylcompound (130) is retained in the furoxan product. To allow full analysis of the 
spectrum different solvents were tried but CDCI3  gave the best resolution. Full assignment 
was achieved using 600 MHz COSY and 1D-TOCSY spectra. The ID-TOCSY enables 
investigation of the two different ring systems (Figures 13, 14 and 15) enabling resolution of 
the overlapping signals. As with the parent pyranosylnitromethane, the presence of the 1,3-
dioxalane and 1 ,3-dioxane rings fused onto the pyranose ring causes some distortion from 
the regular 4C, conformation as is shown by deviations in the coupling constants as 
compared to the tetra-0-acetyl case. A characteristic peak in the IR spectra of the compound 
was seen at 1606 cm' due to the C=N vibration. 
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A common feature of the mass spectrum of furoxans is a prominent fragment peak at M-
60,25 which is attributed to the collapse of the heterocycle to an alkyne with the expulsion of 
N202  (Scheme 74). This peak is in evidence for most of the dipyranosyl furoxans with the 
exception of (174) where other fragmentation paths dominate. The M-16 peak due to the 









To establish the most efficient route to dipyranosyl furoxans, generation of 3,4,5,6-tetra-0-
acetyl-/-D-mannopyranosyl furoxan (164) from the mannopyranosyl oxime (138) and 
mannopyranosyl hydroximoyl chloride (143) with subsequent dimerisation was attempted 
using the conditions described previously involving sodium hypochlorite oxidation and 
base-catalysed dehydrohalogenation respectively (Scheme 75). 
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Scheme 75 
Using aldoxime (138) as precursor yielded furoxan (164) in 32% yield. Due to the low yield 
of the reaction it was apparent that this route had no advantage over the Mukaiyarna 
approach, described earlier. With the hydroximoyl chloride (143) as precursor, furoxan 
(164) was obtained in 99% yield. 
The 13C spectrum shows the diagnostic peaks at 110.5 and 152.7 ppm due to C-3 and C-4 of 
the furoxan ring as well as the expected resonances attributable to the two 
peracetylpyranosyl rings. The 1 H spectrum is again complicated by the overlapping signals 
of the two pyranose rings. However, the I '-H and I' '-H protons are well resolved (M 0.24 
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ppm) and allowed J, 2 and J," 2" values of 1.0 Hz to be determined which are consistent 
with the axial-equatorial configuration for these protons. The mass spectrum shows the 
characteristic M+1 parent ion peak at 747 amu as well as the diagnostic M-60 breakdown 
peak at 687 anni. The JR has two distinguishing vibrations at 1743 cm-1 due to C0 of the 
acetate protection and at 1606 cm' due to the C=N of the furoxan ring. 
The structure of furoxan (164) was confirmed by X-ray crystallography. (Figure 16). A 
noteworthy feature of the crystal structure is disorder in the furoxan moiety, with the N-
oxide substituent being located at the 2- and 5-positions in a ratio of 85:15. Disorder of this 
type '49' 150  has been reported previously for diphenyl- and tetramethylene-furoxans and some 
norbornane-fused furoxans.'5' Selected bond lengths, bond angles and torsion angles for the 
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Results and Discussion 
Bond lengths I A Bond Angles / ° Torsion angles / 
0(1 )-N(2) 1.465(7) 0(l)-N(2)-C(3) 105.1(5) 0(l)-N(2)-C(3)-C(4) 	0.16 
N(2)-C(3) 1.319(8) N(2)-C(3)-C(4) 108.3(5) N(2)-C(3)-C(4)-N(5) 	0.29 
C(3)-C(4) 1.418(9) C(3)-C(4)-N(5) 110.6(5) C(3)-C(4)-N(5)-O(I) 	-0.68 
C(4)-N(5) 1.309(7) C(4)-N(5)-O(I) 107.3(5) C(4)-N(5)-0( I )-N(2) 	0.76 
N(5)-0(1) 1.355(8) N(5)-0(1)-N(2) 108.7(4) N(5)-0(1)-N(2)-C(3) 	-0.57 
N(2)-0(2) 1.180(7) 0(l)-N(2)-0(2) 111 .2(5) 0(1 )-N(2)-C(3)-C( 1') 	177.51 
C(3)-N(2)-0(2) 139.7(6) O(2)-N(2)-C(3)-C( 1') -1-19 
0(1 )-N(5)-C(4)-C( 1'') -179.63 
Table 6: Selected bond angles, lengths and torsion angles for (164) 
The atoms of the furoxan unit 0(1), N(2)1  C(3), C(4), N(S), 0(2) are near planar (maximum 
deviation 0.004 A), as are the atoms of C(1 '), C(3), C(4), C(1 ") linking the oxadiazole to 
the two pyranoid substituents. The bond lengths are typical of furoxans25 and indicate it-
electron delocalisation over all six atoms with the exocyclic oxygen attached to N(2) 
causing significant distortion of the oxadiazole ring. Of particular note is the long 0(1)-N(2) 
and short N(2)-0(2) bonds. C(3)-C(4) is also shortened corresponding to partial double bond 
character and N(2)-C(3) is longer than C(4)-N(5), consistent with contributions of (181) - 
(184) to the resonance hybrid. The bond angles of the CN02 unit are also typical of 3,4-
disubstituted furoxans, with 0(2)-N(2)-C(3) significantly larger than 0(2)-N(2)-0(l) [139.7 
0  c/i 15.2°]. 
NN 











PhO2S )FA O(CH2)2N(CH3)2 
-o 
185 186 
Results and Discussion 
2.8.2 Summary and future work 
The generation of pyranosyl nitrite oxides and their dirnerisation to the furoxans by both 
dehydration of pyranosyl nitromethanes and dehydrohalogenation of pyranosyl hydroxirnoyl 
chlorides occur in good to excellent yields. The use of pyranosyl aldoximes as precursors 
was less efficient. As the route involving pyranosyl nitromethanes requires two less steps it 
is the method of choice, although the pyranosyl hydroximoyl chloride approach takes less 
time. 
A desirable feature for furoxans as NO generators is water solubility, as this enables their 
study under physiological conditions. This has been reported for furoxans with side chains 
containing amine groups (e.g. 185).'
44 
 It is envisaged that water-soluble furoxans could also 
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2.9 	Ring opening reactions of furoxans. 
The relatively easy access to dipyranosyl furoxans prompted us to investigate their 
chemistry. The chemistry of furoxans is varied and there are a number of reviews in the 
literature. 25  An interesting reaction is the reduction of furoxans to I ,2-dioximes (172) often 
termed glyoximes. These compounds have been reported to give access to a number of 
derivatives (Scheme 76), for example they can be converted to the furazan (176) by 
treatment with reagents such acetic anhydride 
152  and silica gel, 153  or undergo a Beckmann 
rearrangement to give 1,2,4-oxadiazole (187).'
54  Conversion of glyoximes to diarnines (188), 
using such reagents as sodium borohydride'55  and to 1,2-diketone (189), utilising reagents 
such as NaB103156  have also been documented. Another interesting property of dioximes is 
there ability to complex metals (190). For example, the concentration of nickel may be 
determined by reaction with dimethylglyoxime. 
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With this in mind attempts were made to synthesise dipyranosylglyoxirnes. Two furoxans 
were chosen for study. Firstly, 	 furoxan (178) 
as this could be synthesised most readily from the parent aldose. Secondly, 3,4-di(2,3:4,6-di-
0-isopropyl-/3-D-mannopyranosyl) furoxan (177) due to its stability towards nucleophiles. A 
search of the literature showed that there are two main methods for the reduction of 
furoxans to glyoximes: catalytic hydrogenation and reduction with complex hydrides, e.g. 
sodium borohydride.'46 
The first approach considered was hydrogenation using Pd/C as catalyst (Scheme 77). 
Treatment of furoxan (178) with hydrogen in the presence of the catalyst gave two products: 
a white solid (53%) and an unidentified baseline material. The solid was identified by 1 H 
and 13C NMR spectroscopy along with mass spectrometry as the dipyranosylglyoxime (191) 




The three possible isomers (Z,Z), (E,Z) and (EE) are shown below. The appearance of three 
peaks in the region assigned to the C=NO signal, between 145 and 150 ppm, is evidence for 
the presence of more than on isomer. It is likely that one isomer is a either the E/E or Z/Z 
isomer, which contain a rotational symmetry axis and thus should only have one CNOH 
peak in the '3C NMR spectrum, whilst the other is the E/Z arrangement giving two peaks for 
the CNOH. It is possible that the baseline material could be an amine formed by over-
reduction of the oxime, although there is no evidence for this. 
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Results and Discussion 
In hope of obtaining the glyoxime as a single isomer, Raney nickel was used as catalyst. 
Hydrogenation of furoxan (178) using the Raney nickel catalyst gave a red oil, whose TLC 
showed two products, one baseline material and one less polar spot. These were separated 
by chromatography to give a white solid (77%) and a red oil. The white solid was identified 
as a single isomer of dioxime (191). The compound was characterised by '3C and 'H NMR 
spectroscopy. The presence of only one isomer was evident in the '3C NMR spectrum, 
which contains two quaternary peaks at 146.0 and 148.6 ppm that are characteristic of 
dioxime signals. 117  The presence of two C=NOH peaks indicates an E/Z arrangement as this 
has no rotational axis of symmetry. The 'H NMR spectrum, like that of the parent furoxan, 
is complicated by overlapping of signals due to the two similar pyranose rings. There are 
two broad singlets at 9.73 and 9.92 ppm which are due to the NOH peaks, whilst the rest of 
the signals correspond to the pyranose ring protons and the protecting groups. Full 
assignment was obtained using 600 MHz NMR (Figure 17). An interesting feature is the 
large separation, 0.74 ppm, between the anomeric proton signals. 
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Figure 17 
The second method of furoxan ring opening involved treatment with sodium borohydride 
(Scheme 78). It was envisaged that this would not be compatible with acetate protection, so 
its use was investigated on 3,4-di(2,3 :4,6diO-isopropyl-)3.DmannopyranoSYl) furoxan 
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(177). A solution of the furoxan in ethanol and sodium borohydride was heated to reflux for 
24 hours and from the reaction mixture an oil was obtained. Although the 1 H NMR spectrum 
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Scheme 78 
2.9.1 Reactions of dipyranosyiglyoximes 
2.9.1.1 Chelation to metals. 
Asymmetric synthesis is one of the most challenging aspects of synthetic chemistry. There 
are a number of adopted strategies including the use of chiral catalysts, for example 
Sharpless epoxidation.'58  By introducing chirality into the catalyst system an influence on 
the stereochemistry of the catalysed reaction can be inferred. Examples of dioxinie 
complexes were known in the literature 159  and so attempts to chelate the dipyranosyl 
dioximes with a metal, in this case nickel, were undertaken. 
Treatment of 3,4_di(2,3,4-tri-O-acetyl-16-D-xylopyranOsYl) glyoxime (191) with nickel(I1) 
chloride was accompanied by a colour change from green to orange. From the reaction 
mixture was isolated an orange solid, which was assigned structure (192). The complex 
(192) was characterised by 'H and '3C NMR spectroscopy. Compared with the glyoxime the 
spectra were simplified by the axis of rotational symmetry. Thus, all pyranose units are 
equivalent and only one set of signals appear in the spectra. In the 'H spectrum only one 
doublet due to the anomeric position was apparent whilst in the '3C spectrum a peak at 144.7 
ppm, due to the C=NO was evident. This appears at slightly lower chemical shift than in the 








Results and Discussion 
This complexation of dipyranosylglyoxime (191) with nickel may explain the presence of 
the red oil during hydrogenation of furoxan (178) with Raney nickel. Spectroscopy data 
indicates that the red oil has the same structure as complex (192). It is concluded that the 
dioxime formed is reacting with nickel(II) impurities in the Raney nickel. Similar 
observations have previously been reported by Mukaiyama.9  Whilst attempting the 
hydrogenation of dimethylfuroxan, using Raney nickel as catalyst, a red by-product was 
obtained which was identified as the nickel complex (193). 
H3c ? cH3  
H3C 	 CH3 
0-----H-0 
193 
Unfortunately, as yet no crystal structure for the dioxime complex (192) has been obtained. 
However, a molecular model using the CACHE programme 160 has been created showing that 
complex adopts a slightly distorted square planar conformation (Figure 18). The model 
indicates that the metal centre should be accessible to substrates. 
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Figure 18 
The complex (194) has been reported by Noyori'60 as a catalyst for the asymmetric reduction 
of ketones. It is envisaged that the dipyranosyiglyoximes such as (191) may replace the 
diamine ligand and, due to potential hydrogen bonding, show useful selectivity. The molecular 
model for this potential glyoxime complex (195) is shown in Figure 19 and again indicates 
that the metal centre should be accessible to substrates. 
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Results and Discussion 
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Figure 19 
2.9.1.2 Ring forming reactions 
Another feature of dioxime chemistry is the possibility of dehydration to furazan. Various 
reagents have been reported including acetic anhydride. 112  Treatment of 3,44(2,3,446-0-
acetyi-G.D-xy1opyranosy1)-glyoxime (191) with acetic anhydride and DMAP gave an oil 
which was purified by chromatography top give a white solid whose structure was confirmed 
by 'H and '3C NMR spectroscopy to be of furazan (196) (Scheme 79). As the furazan also 
has a rotational symmetry axis the NMR spectra are simplified. In the 'H NMR there are the 
expected resonances for the peracetylated pyranose ring, with only one anomeric doublet, 
whilst in the '3C NMR there is a quaternary signal at 150.9 ppm for C(3) and C(4) of the 
furazan ring. 
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Scheme 79 
In order to confirm dioxime formation, attempts were made to convert glyoxime (191) to 
furoxan (178). The method chosen was a modified version of that of Boyer et al 
162  using 
sodium hypochiorite as oxidant. The reaction yielded (178) in a 67% yield. The compound 
was characterised by 'H and '3C NMR by comparison with an authentic sample. 
2.9.2 Summary and future work 
Attempts to generate dipyranosyl glyoximes have proved successful and the synthetic utility 
of these compounds have been highlighted by conversion to furazan and complexation to 
nickel. The possibility of using the glyoxime in coordination chemistry is currently being 
investigated with the hope of synthesising asymmetric catalysts. The dioxime could also be 
converted to the diamine and the diketone as described previously and again used as chiral 
ligands. 
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2.10 	Functionalisations of pyranosylisoxazolines 
Having gained access to a variety of pyranosylisoxazolines, the next step in the nitrite oxide 
cycloaddition route is modification of the 4-position of the isoxazoline ring. This is one of 
the most attractive features of the nitrite oxide I isoxazoline approach as it greatly increases 
the variety of 3-hydroxyketones and other products available (see section 1.2). The 
substitution is brought about by treatment with strong base followed by reaction with an 
electrophile (Scheme 80). 














Jager et a153  and several other groups have carried out a number of such substitutions leading 
to e.g. deuteration,53 carboxylation,53 silylation53  and hydroxylation 
46  of the isoxazoline ring. 
Of particular interest is the stereoselectivity of the reaction, whether the cis or trans product 
is obtained. This is often governed by the substituent at the 5-position. 
Deprotonation at the 4-position of the isoxazoline ring can also provide an alternative route 
to c3-unsaturated ketones (197) (Scheme 81). If the resulting anion (198) is allowed to 
warm to room temperature, rearrangement can take place leading to the a,13-unsaturated 
oxime (199), which can be converted to the c-enone (197) by treatment with e.g. titanium 
trichloride163 and phosphorous pentachloride.'64 
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Scheme 81 
The pyranosyl isoxazoline (155) bearing a base-stable protecting group was considered to be 








Results and Discussion 
2.10.1 Attempted substitution reaction on 5(spirocyc1ohexyl)-3-(2,3:4,6-di-O- 
(155) 
Addition of a solution of (155) in THF to butyllithium (or LDA) in TI-IF at -78°C afforded a 
yellow solution, indicating anion formation. The solution was allowed to stir at -78°C for 2 
hours and then D20 was added. After warming to room temperature, excess butyllithium 
was quenched using aqueous ammonium chloride solution. Following the usual work up a 
white solid was obtained. The NMR of the compound indicated consumption of starting 
material but showed no sign of deuterium incorporation. There was evidence in the 3C and 
11-1 spectra for the loss of one of the isopropylidene protecting groups ('3C loss of peaks at 
26.1 ppm, 28.2 ppm [C(CH7)2] and 109.8 ppm [C(CH3)2 , 1 H: loss of peaks at 1.23 and 1.49 
ppm). Other features of the '3C spectrum included the appearance of a C-H peak at 106.7 
ppm and a quaternary carbon at 145.8 ppm. The expected signals corresponding to the sugar 
protons H- I' and H-2' for compound (201), were not apparent. The most significant features 
in the proton spectrum were the appearance of a broad singlet at 2.4 ppm characteristic of an 
OH signal and a doublet at 5.07 ppm. In the mass spectrum there was a parent ion peak at 
324 amu. The above evidence suggested the formation of the glycal (200) (Scheme 83). 
BuLi / THF -78°C 
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Results and Discussion 
The formation of the glycal (200) rather than the substituted isoxazoline (201) explains 
several features of the NMR spectra, for example the loss of the signals for one 
isopropylidene group and the appearance of an OH peak in the 'H spectrum. The structure of 
(200) accounts for the presence of the new quaternary carbon at 145.8 ppm corresponding to 
the anomeric position and a C-H at high chemical shift, 106.7 ppm, due to the olefinic 
carbon C(2). The conjugation of the isoxazoline C=N with the alkene unit explains the 
considerable shift in the signal assigned to the C=N (156.6 ppm to 151.6 ppm). The 





Introduction of unsaturation has a major impact on the shape of the pyranose ring, as 
evidenced by both the crystal structure data and the 3J coupling constants for the ring 
protons. The crystal structure shows the shortening of the C( 1 )-C(2) bond from 1.526 A in 
the pyranosyl aldoxime (138) to 1.329 A indicating double bond character (Table 7). The 
bond angles of the ring protons show considerable flattening of the ring especially around 
0(1)-C(1)-C(2) and C(1)-C(2)-C(3). This flattening is further highlighted in the 'H NIv[R 
where the coupling for .123 is 2.4 Hz compared to a 5.2 Hz coupling seen in the parent 
isoxazoline (155). 
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0(1 )-C(1)-C(2) 110.3(4) 0(1)-C(1)-C(2) 123.80(14) 
C( I )-C(2)-C(3) 110.5(4) C( 1 )-C(2)-C(3) 123.90(15) 
C(2)-C(3)-C(4) 108.6(4) C(2)-C(3)-C(4) 107.67(13) 
C(3)-C(4)-C(5) 109.5(4) C(3)-C(4)-C(5) 109.06(13) 
C(4)-C(5)-0(1) 109.5(4) C(4)-C(5)-0(l) 110.05(13) 
Table 7: Pyranose ring bond angles (°) for (138) and (200) 
Glycal formation has been reported for a number of pyranosyl systems containing anion 
stabilising substituents at the anorneric position and good leaving groups at C(2) of the 
pyranose ring. Two examples are shown below (Scheme 84).165 166 
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Results and Discussion 
Formation of the anomeric anion is possible for the pyranosylisoxazoline (155) due to the 
conjugatory stabilising effect of the isoxazoline ring. Once formed, the fate of the anion is 
determined greatly by the nature of the substituent in the 2-position and also the stability of 
the carbanion (Scheme 85).b 67 The pyanosyl anion could act as a nucleophile and react with 
an electrophule. However, if the substituent in the n-position next to the anomeric centre is a 
good leaving group and the carbanion is relatively stable, then an elimination reaction can 
occur resulting in the formation of a glycal. Thus, glycal formation is seen when (155) is 
treated with base due to the stabilising nature of the isoxazoline ring and the relatively good 
leaving group. The final product is obtained by hydrolysis of the resulting hemiketal. 
L0 zL 
BASE 




There are two possible mechanisms for the elimination. The antiperiplanar nature of the 
anomeric proton and leaving group at the 2-position of the sugar ring mean that an E2 
mechanism is possible (Figure 21), whilst the possibility of stabilising the anion by 
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conjugation into the isoxazoline ring also makes an E1cB mechanism feasible (Figure 22). 
The mechanism of the reaction will be discussed in more detail later. 
Figure 21 
B "  
Figure 22 
To investigate the scope of this reaction cycloadducts (156) and (157) were treated under 
similar conditions as for (155), and the products identified by 1 H and '3C NMR 
spectroscopy. The results are summarised below (Scheme 86). The products were obtained 







202 R=Ph, 85% 
203 R = (CH2)5CH3, 54% 
 




Results and Discussion 
Isoxazole (159) was reacted under similar conditions in order to ascertain whether 3-
pyranosylisoxazoles behaved in the same manner as 3-pyranosylisoxazolines (Scheme 87). 
Following the usual work up the glycal isoxazole (204) was obtained in 89% yield and 
identified by 3C  and 'H NMR spectroscopy, which again showed the characteristic carbon 
signals for the olefinic C-H for C-2' at 104.4 ppm, as well as a peak at 97.1 due to C-4 of the 
isoxazole ring and a quaternary signal at 144.1 ppm for the anomeric carbon. The 'H 
spectrum had a doublet at 5.55 ppm due to the olefinic hydrogen at C-2 as well as a singlet 
at 6.53 for the proton of the isoxazole. 






Further support of the assigned structure was obtained by acetylation and methylation of the 
free hydroxyl group at the 3' position of the glycal (Scheme 88). Using standard acetylation 
conditions 	5-(spirocyclohexyl)-3-(4,6-di-O-isoproPYl idene-3 -O-acetyl-2-deoxy-D- 
mannopyranosyl)-2-isoxazoline (205) was obtained in 82 % yield. Its 'H NMR was similar 
to that of the parent compound (200) except for an extra peak at 2.14 ppm due to the CH3 of 
the acetate group and a displacement of 3'-H from 4.50 ppm to 5.45 ppm. The 13C spectrum 




OH 200 205 R = Ac 
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Scheme 88 
Methylation of glycal (200) gave further support for the structure of the glycal. Methylation 
was achieved using potassium hydroxide and methyl iodide as described in section 2.10.2.1 
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below. The product (206) which was obtained in a 42% yield, showed a new signal at 3.50 
ppm in the 'H NMR attributable to the methoxy group. 
2.10.2 Investigation of the effect of stereochemistry and leaving group on the 
elimination reaction 
As described previously, there are two possible mechanisms for the elimination reaction, 
namely the E2 and E1cB. A prerequisite for an E2 elimination is an anti-periplanar 
relationship between the abstracted proton and leaving group. To establish which 
mechanism was taking place the elimination reaction was attempted on a 
pyranosylisoxazoline that did not possess this antiperiplanar relationship. A possible 
candidate would be an isoxazoline (207) derived from 3,4:5,7-di-O-isopropyli dell e-3-D-
glucopyranosylnitromethane (208) (Scheme 89). Although this compound is described in the 
literature, 128  attempts to prepare it by acetonation of 3Dglucopyranosylnitromethane were 
unsuccessful. 	An 	alternative 	candidate, 	5 -(spirocyclohexyl)-3 -(tri-O-methyl--D- 












2.10.2.1 	Formation of 5(spirocyclohexyl)-3-(tri-O-methyl-P-D-xylOPYraflOSYD- 
2-isoxazoline (209) 
The first step in the synthesis of the tri-O-methyl isoxazoline (209) involved deacetylation 
of the triacetyl analogue (160) (Scheme 90). A number of conditions for deacetylation have 
been reported, including treatment with catalytic potassium cyanide 16' and sodium 
methoxide. The method selected for the present work involved the use of ammonia. 
169  The 
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procedure simply involved treatment of the acetylated isoxazoline in methanol with 
ammonia, and removal of the solvent in vacuo to afford the isoxazoline (210), which was 
identified by NMR spectroscopy and mass spectrometry. 
O-Methylation was achieved by treatment of isoxazoline (210) in DMSO with potassium 
hydroxide and methyl iodide. Following aqueous work up the protected isoxazoline (209) 













2.10.2.2 	Attempted glycal formation on 5-(spirocyc1ohexyI)-3-(tri-O-methYl-1- 
D-xylopyranosyl)-2-isoxazoline (209) 
To investigate the mechanism of the elimination reaction, isoxazoline (209) was exposed to 
the usual elimination conditions (Scheme 91). An oil was obtained, which was purified by 
chromatography to give the glycal isoxazoline (211) in 40% yield, as well as some unreacted 
starting material (209) (28%). 
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The reaction proved to be much slower than the previous examples. This could be due to a 
poorer leaving group and / or the change in stereochemistry at C(2). The lack of an 
antiperiplanar relationship between the leaving group and the anorneric proton suggests an 
EIcB mechanism rather than an E2. Similar effects have been reported for related 
Systems.  167 
The 	corresponding 	reaction 	of 5-(spirocyclohexyl)-3 -(2,3 :4,6-tetra-O-benzy-J3-D- 
glucopyranosyl)-2-isoxazoline (150) with butyllith ium under the normal reaction conditions 
afforded only unreacted starting material (Scheme 92). This is a somewhat surprising result, 
as OBn is expected to be a better leaving group than OMe. A possible explanation is the 
steric demand of the benzyl ether, which may prevent access to the anorneric proton by the 
base. The use of a less bulky base such as methyllithium may overcome this steric barrier. 
N—O 	 N—O 
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150 
Scheme 92 
2.10.3 Stability of the pyranosyl carbanion 
The strength of base required to achieve anion formation is an indicator of the stability of 
the anomeric carbanion, the weaker the base the more stable the anion. Up to this point, the 
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reactions had been carried out using the very strong bases, butyllithiurn and LDA, which 
both have PKaH values greater than 35. It was decided to investigate further the stabilising 
effect of the isoxazoline ring by testing the strength of base required to give glycal 
formation. 
For C-pyranosyl aldehydes 
166 (212) the stabilising effect of the formyl group is such that 
pyridine (pKaH = 5.2) is a strong enough base (Scheme 93) whilst, for the C-pyranosyl 
nitrile'7° (213) the reduction in stabilisation is shown by the requirement of a stronger base, 
DBU (pKai-i 	12). This is also the case for the rare situation where a heterocyle, a 
tetrazole 170 (214), is attached to the anomeric position. If chlorine is used as the stabilising 
moiety (215) the lack of conjugatory stabilisation is highlighted by the requirement of 
methyl lithium to achieve anion formation. 
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To test if the isoxazoline group provided similar stabilisation as the tetrazole, 5- 
(spirocyclohexyl)-3 	 (153) 	in 
dichloromethane was treated with DBU. Following work up a solid was obtained which was 
identified as starting material. There was no indication of glycal formation, thus indicating 
that the stabilising effect of the isoxazoline is less than that of the tetrazole. 
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However, the formation of glycal (211) during the attempted preparation of the tri-O-methyl 
isoxazoline (209) indicated that potassium hydroxide was a sufficiently strong base to give 
glycal formation. Whilst attempting methylation of isoxazoline (210) the reaction was left 
for a prolonged time yielding glycal (211) instead of the expected product (209) (Scheme 
94). This observation led to the treatment of isoxazoline (155) with potassium hydroxide in 
DMSO. Following an overnight stir and an aqueous work tip glycal (200) was obtained in 59 
% yield (see Scheme 83). The pKaH  of potassium hydroxide is 14. It is concluded that the 
pKa  of the anomeric proton must be in the range --12 to -14 pKa as elimination occurs in the 
presence of potassium hydroxide but not DBU. 
KOH / Mel 
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Scheme 94 
From the results described above it can be concluded that treatment of 
pyranosylisoxazolines with base does not deprotonation in the isoxazoline ring, but rather 
causes an elimination reaction to afford glycal isoxazolines. Although an unexpected 
reaction, these glycals could be of synthetic interest (see following section). 
2.11 	Manipulation of the glycal isoxazolines 
121 
Results and Discussion 
The formation of unsaturation in the pyranose ring provides a reactive site that can be 
chemically modified. Glycals are often utilised as building blocks in synthesis. Indeed, many 
routes to C-glycosides involve the use of glycals. Glycals readily undergo reactions such as 
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Scheme 95 
Preliminary investigations of the addition of a range of electrophiles to the glycal were 
undertaken. A major consideration when attempting these reactions was whether the 
isoxazoline ring would be stable to the reaction conditions. 
Hydrogenation of the glycal double bond was the first reaction attempted. To minimise 
potential cleavage of the isoxazoline ring, 5% Pd/C was used as catalyst as it was envisaged 
that hydrogenation of the olefinic bond would occur more rapidly than isoxazoline ring 
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opening. Glycal isoxazoline (200) in dry methanol was placed under an atmosphere of 
hydrogen in the presence of Pd/C and left to stir for 16 hrs (Scheme 96). Separation of the 
catalyst by filtration followed by removal of solvent in vacuo gave an oil containing two 
products, one a baseline material. From the mixture isoxazoline (216) was isolated in 62% 
yield by column chromatography. The baseline material was not characterised but gave a 
positive test with ninhydrin spray suggesting the formation of the y-aminoalcohol due to ring 
opening of the isoxazoline. Characterisation of (216) was achieved using NMR 
spectroscopy. The 'H NMR showed the disappearance of the doublet at 5.06 ppm due to the 
olefinic C-H and appearance of two new doublet of doublets of doublets signals at 1 .75 and 
2.23 ppm due to the new CH2  group at the 2-position of the pyranose ring, the low chemical 
shift being indicative of the lack of an oxygen-based substituent. There was also a new 
signal at 4.37 ppm (doublet of doublets) due to the new proton at the anomeric position. The 
J,,, coupling of 11.9 Hz suggests a diaxial arrangement and thus a 3-configuration at the 
anorneric position. In the 13C NMR the loss of a C-H peak at 106.7 ppm and a quaternary at 
145.8 ppm indicate the absence of the double bond. This is confirmed by the appearance of a 
new CH signal at around 70 ppm and a CH2  signal at 24.9 ppm due to the C-2' position. The 
low chemical shift of this peak again emphasises the lack of an oxygen-based substituent. 
Another interesting feature is the change in position of the C=N peak of the isoxazoline ring 
from 151.6 ppm to 157.2 ppm. This is consistent of the loss of conjugation with the imine 
group of the isoxazoline ring as previously described. 
Pd/C, H2 	 0 




The hydrogenation reaction was also successful for glycal (211) (Scheme 97). Subjecting 
(211) to the same hydrogenation conditions as described above gave (217) (56%), which 
was identified by NMR spectroscopy and mass spectrometry. A baseline material was also 
isolated which again gave a positive test with ninhydrin, suggesting y-aminoalcohol 
formation 
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Other electrophilic additions investigated include dihydroxylation using osmium tetroxide 
and hydroboration. However, initial attempts at these reactions failed and time constraints 
prevented further investigation. 
The preliminary results described above suggest that a range of electrophilic additions 
should be possible thus providing access to a variety of functionalised pyranosyl 
isoxazolines. 
124 
Results and Discussion 
2.12 	Attempted synthesis of glycal nitrile oxide precursors 
The discovery that under basic conditions pyranosylisoxazolines can undergo elimination 
reactions to afford glycal isoxazolines prompted an investigation into the possible synthesis 
of glycal nitrile oxide precursors, such as the a,13-unsaturated aldoxirne (218). The initial 
approach considered involved treatment of pyranosylaldoximes such as (138) with DBU as 
base (Scheme 98). However, elimination products were not detected using this method so an 
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Scheme 98 
It was considered that a possible precursor to the a,13  unsaturated oxirne could be the glycal 
aldehyde (219) (Scheme 99). Synthesis of glycal aldehydes such as (219) from the 
corresponding saturated aldehyde (220) have been reported in the literature. 
166  The 
formation of the a,13  unsaturated aldehyde is made possible by strong conjugatory stabilising 
properties of the formyl group. Indeed, glycal aldehydes are often formed as by-products in 
the synthesis of C-forrnyl aldehydes.'°' 
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CN-O 
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220 	 219 
Scheme 99 
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The route selected was based on work of Moffat et al 
130  and Lehmann et al 66 (Scheme 100). 
The first step was the synthesis the 2,3,4-tri-O-acetyl-xylopyranosylnitrile (221).The method 
adopted was based on observations by Koll et a1174  that treatment of pyranosylnitromethanes 
with phosphorous trichloride caused conversion to the nitrite. The pyranosylnitromethane 
chosen for study was 2,3,4tri-O-acetyl-xylopyranosy1nitromethane (128) due to the ease of 
synthesis. Treatment of (128) in pyridine with phosphorous trichloride gave a brown 
solution and, following an acidic work up, 2,3,4-tri-O-acetyl-xylopyranosylnitrile (221) was 
obtained as a white solid in 85% yield. The compound was characterised by 'H and '3C 
NMR spectroscopy by comparison with the literature values. 
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Scheme 100 
One-pot conversion of pyranosylnitriles into pyranosyl aldehydes has been reported by 
Schmidt et al 175  using Raney nickel catalysed hydrogenation of the nitrile, followed by 
hydrolysis of the resultant imine. However, this approach proved unsuccessful and an 
alternative approach was therefore considered. The forrnyl-C-glycoside was synthesised in 
two steps. Firstly a masked form of the aldehyde, the imidazolidine (222), was prepared 
using the method described by Lehmann et al. 
166 2,3,4-Tri-O-acetyl-xylopyranosylnitrile 
(221) was treated with Raney nickel in aqueous conditions in the presence of N,N'-
diphenylethylenediamine and sodium hypophosphite. Imidazolidine (222) was separated 
from excess reagents and by-products by dry flash chromatography in 79% yield as a white 
solid. Characterisation was achieved using 'H and '3C NMR with signals at —3.6 ppm in the 
'H spectrum corresponding to the two CH2  groups of the imidazolidine ring and between 6.8 
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and 7.4 ppm due to the aromatic protons. The coupling between the anomeric proton (H-2) 
and the CH (H-I) of the imidazolidine ring is so small that the signal due to imidazolidine 
the ring proton appears as a singlet. The 13C spectrum show peaks at 46.4 and 17.1 ppm due 
to the CH2  groups of the imidazolidine ring and signals between 112.7 and 146.4 ppm due to 
the aromatic carbons. Unmasking of the aldehyde was achieved by treatment irnidazolidine 
with p-toluenesulfonic acid in acetone. The product (223) was obtained as a oil in a 
60% yield. Characteristic peaks for the aldehydic proton were seen at 9.50 ppm in the 'H 
spectrum and 196.0 ppm in the '3C NMR. 
The elimination of acetic acid was achieved under mild basic conditions by stirring aldehyde 
in pyridine and acetic acid for 5 days. The glycal aldehyde (224) was obtained as an 
clear oil with a purple hue in 76% yield. The formation of the product was indicated in the 
'H NMR by the loss of one acetyl signal and a change in the position of the aldehydic signal 
to lower chemical shift due to the introduction of conjugation. The '3C NMR showed a C-H 
signal at 113.0 ppm due to the C-3 olefinic hydrogen and a quaternary peak at 153.2 due to 
the anomeric carbons. The IR spectrum showed a peak at 1709 cm' characteristic of an c,J3-
unsaturated aldehyde and an absorption at 1643 cm' for of a CC group in conjugation with 
an aldehyde. 
2.12.1 	Attempted oximation of 4,5triOacetyl-2,6-anhydro-3-deoxy-a1dehYdO- 
D-threo-hept-2-enose (224) 
Precedence for conversion of a,J3-unsaturated aldehydes to the corresponding oximes had 
been set by Torssell et al. 176  In their work they describe the conversion of certain acyclic 
a,13-unsaturated aldehydes to the oximes, followed by conversion to the nitrile oxide using 
NCS and subsequent cylcoaddition to yield isoxazolines. The procedure used for oximation 
involved treatment of the aldehyde with hydroxylamine hydrochloride and sodium 
hydrogencarbonate in a two-phase system. However, attempts to apply this methodology to 
the pyranose system (224) gave complicated mixtures of products which proved impossible 
to separate. Thus far, other methods of oximation have not been investigated so the 
synthesis of the sugar-derived a,13-unsaturated oximes has not been achieved. 
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2.13 Ring opening reactions 
The final step of the nitrile oxide / isoxazoline approach involves unmasking of the latent 
functionalities to give either the 3-hydroxyketone or y-aminoalcohol by ring opening of the 
isoxazoline. The product depends on the conditions used. In non-aqueous conditions the y-
aminoalcohol is obtained but, if the reaction is carried out in the presence of water, the 3-
hydroxyketone is formed. 
There are a number of methods in the literature for opening the 2-isoxazoline ring (225) 
(Section 1.2.3 ). The most common approach involves catalytic hydrogenation using 
palladium on charcoal or Raney nickel .47 The weak N-O bond is broken preferentially to the 
carbon heteroatom multiple bond leading to the 3-hydroxyimine intermediate (226) (Scheme 
101). in the absence of water the intermediate undergoes further reduction to give the 'y-
















For the formation of the y-aminoalcohol an alternative mechanism involving initial 
reduction of the C=N bond has been proposed .47 This is likely to be the case when ring 
opening to the y-aminoalcohol using hydride reduction with LiA1I-L1. However, when using 
catalytic hydrogenation the formation of the 3-hydroxyimine intermediate is more likely. 
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Under the acid conditions often used the imine is generally not observed but in two cases 













An in depth investigation into optimum conditions for ring opening has been carried out by 
Curran et al. 14  The usual reaction conditions for the formation of the 3-hydroxyketone 
involve catalytic hydrogenation in an aqueous methanol solution under acidic conditions. 
The acid increases the rate of imine hydrolysis. This has a two-fold effect. Firstly, it 
increases the yield of 3-hydroxyketone by reducing the time the imine spends in reductive 
conditions, thus minirnising -y-aminoalcohol formations. Secondly, rapid hydrolysis reduces 
the chance of epirnerisation that can occur. A variety of acids have been employed including 
acetic acid, 179  conc. HC150, aluminium50  and boron trichlorides'8°  and acetate and phosphate 
buffers. '8' These have been somewhat superseded by the use of boric acid" 4 as it is very 
effective at minimising epimerisation, possibly due to formation of a cyclic borate ester 
(231). 
231 
The application of these hydrogenolysis conditions within the group in the past has proved 
although it is sometimes capricious The ring opening of 160 using H2-Pd/C and 
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Hydrogenation of (160) (Scheme 102) with Pd/C gave an oil that was shown by TLC to 
contain three products, which were separated by dry flash chromatography. The least polar 
spot was identified as unreacted starting material (160), whilst the baseline material proved 
impossible to characterise, although it gave a positive test with ninhydrin stain indicating 
that it may be the y-aminoalcohol. The other spot was isolated in 14% yield and identified 
by 'H NMR and '3C NMR spectroscopy as the f3-hydroxyketone (232). The '3C NMR shows 
formation of (232) by the appearance of a quaternary peak at 207.3 ppm characteristic of a 
carbonyl group whilst the C=N peak at —1 50 ppm of the isoxazoline is no longer apparent. 
In other respects the 'H NMR was broadly similar to that of the parent isoxazoline. The 
mass spectrum contained a weak parent ion peak at 401 amu, but with a much stronger peak 
at 383 amu. This M-18 peak suggests elimination of water during ionisation in the 
spectrometer most likely leading to the formation of an a-enone. 
Hydrogenation of (155) with Raney nickel gave an oil which was purified by 
chromatography to give a baseline material and a less polar oil which was identified by 'H 
and '3C NMR to be the partially deprotected 3-hydroxyketone in (62%) (233) (Scheme 103). 
The '3C NMR again showed the characteristic carbonyl peak at 209.9. The absence of peaks 
at around 26, 28 and 110 ppm indicate the loss of the 1,3-dioxolane ring of the acetal 
protection. Again the 'H spectrum was broadly similar to the parent isoxazoline except for 
the loss of one of the isopropylidene signals at around 1.5 ppm. High levels of fragmentation 
were seen in the mass spectrum preventing detection of a parent ion peak. 
N—O 	 0 OH 
00 
---~Co 
55 / 233 OH 
Scheme 103 
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2.14 	1,3-Addition reactions 
Arguably the most common reactions of nitrile oxides (3) are cycloadditions to unsaturated 
systems to form 5-membered heterocycles, for example reaction with alkenes to give 2-
isoxazolines (234) (Scheme 104). Indeed, much of the work reported in this thesis involves 
this type of reaction. Dirnerisation of nitrile oxides to furoxans (15) is also common. 
However, nitrile oxides can undergo other reactions such as 1,3-addition with nucleophiles 
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Scheme 104 
Addition reactions have been reported for a variety of nucleophiles (Nufl) including 
alcohols, thiols and amines .3  The possible application of such 1,3-addition reactions in 
carbohydrate chemistry has been highlighted by work by Rollin et al31  who have reported the 
formation of thiohydroxirnate-linked pseudodisaccharides by reaction of a 1-thio-D-glucose 
with various sugar-derived nitrile oxides. For example, the D-galactose-derived oxime (235) 
and D-xylose-derived oxime (236) were used as precursors to the corresponding nitrile 
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Scheme 105 
These thiohydroximate-linked pseudodisaccharides are of interest themselves, but could also 
be precursors to glucosinolates, which are naturally occurring thiosugars found in the 








R = more that 100 varius aglycons 
The work described by Rollin et a13 ' was carried out on either acyclic sugar nitrile oxides or 
pyranose systems with the nitrile oxide at the non-reducing terminus of the sugar. Thus, the 
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glycoside analogues, appeared ideal candidates for investigation. Three nucleophiles, 4-
tolylmethanethiol, thiophenol and aniline were used as model nucleophiles and addition 
reaction carried out with 2,3 	 nitrite oxide (115) 
OAc 
Scheme 106 
The general procedure involved the slow addition of triethylamine in dry ether to a solution 
of hydroximoyl chloride (144) and the thiol in dry ether over 24 hours. The product was 
isolated by aqueous work up and column chromatography. 
For the reaction of hydroximoyl chloride (144) and 4-tolylmethanethiol a white solid (79%) 
was obtained, which was shown by 1 H and '3C NMR to be adduct (241) as a single isomer. 
The main feature of the 'H NMR was a broad singlet at 8.96 ppm due to the C=NOH group 
with appropriate signals for the protons of the CH3 group on the aromatic ring (2.35 ppm), 
the benzyl CH2  group (4.20 ppm) and the aromatic ring (7.10 - 7.34 ppm). The 13C spectrum 
showed the usual signals corresponding to the peracetyl pyranose ring along with aromatic 
peaks, peaks at 21.0 and 34.3 ppm due to the methyl and CH2 groups and a diagnostic peak 
at 148.7 ppm for the CNOH. 
133 
Results and Discussion 
The product (242) of the reaction hydroximoyl chloride (144) with thiophenol was obtained 
in a 85% yield, with characterisation being achieved by NMR spectroscopy and mass 
spectrometry. 
Formation of adducts (241) and (242) led to an investigation into alternative nucleophiles. 
Amines were selected as possible candidates with aniline chosen for study. To prevent high 
levels of nitrile oxide concentration and thus dimerisation to furoxan both aniline and 
triethylamine were added via syringe. The reaction of (144) with aniline produced an oil 
which was purified by dry flash chromatography to afford furoxan (162) (44%) and the 
adduct (243) (26 %). The latter product was characterised by 'I-I and '3C NMR which 
showed the presence of only one isomer. The C=NOH peak in the 'H spectrum at 8.39 ppm 
was significantly broader than seen previously. The '3C NMR contained the diagnostic peak 
at 146.5 ppm due to the CNOH. 
2.14.1 Summary and future work 
The initial investigation of 1,3-addition reactions has shown that there is potential for future 
work in the area. The successful reaction using aniline suggests the possible application of 
amino acids in the reaction. Alternatively, amino acids such as cysteine could be reacted 
through the sulfur atom. There is also the prospect of increasing the range of nucleophiles to 
include alcohols and phenols. Perhaps more importantly is the potential use of carbon-based 
nucleophiles such as Grignard reagents. Theses might allow access to non-hydrolysable 
pseudo-disaccharides. Similar compounds (e.g. (244)) have been synthesised by Rollin et 
al' 82  using different methodology and have shown inhibition towards myrosinase. The use of 
these carbon-based nucleophiles may require alternative protection strategies. 3,4,5,7-Tetra-
0-benzyl-3-D-glucopyranosyl hydroximoyl chloride discussed in section 2.3.2 could be an 
ideal candidate. 
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Conclusions and future work 
The work presented in this thesis shows the synthetic utility of pyranosylnitrile oxides as 
precursors to pyranosyl isoxazolines and isoxazoles. Two novel routes to pyranosyl nitrile 
oxides have been developed involving oxidation of pyranosyl aldoximes and 
dehydrohalogenation of the corresponding hydroximoyl chlorides. These new routes 
complement the existing approach based on pyranosylnitrornethanes (Scheme 107). 
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Generation of the pyranosyl nitrile oxides in the absence of a dipolarophile affords 
3,4-dipyranosylfuroxans in high yield. These nitrile oxide dimers, which were 
previously regarded as unwanted by-products, are of interest in there own right. They 
may have potential therapeutic applications as nitric oxide donors, and they have also 
been identified as precursors to carbon-linked disaccharides with functionalised bridges. 
Reduction leads to dipyranosyl glyoximes, which are of particular interest as novel chiral 
ligands for metal complexes. They are also precursors to heterocycles such as furazans and 
may provide access to dipyranosyl I ,2-diamines and 1,2-diketones. 
Substituted oximes have been formed by the 1,3-addition reactions of pyranosyl nitrile 
oxides, generated from the hydroximoyl chloride, with sulphur based- and nitrogen based-
nucleophiles. Similar compounds have been reported to show inhibition of myrosinase.182 
The range of applicable nucleophiles needs to be investigated further. 
Under basic conditions the pyranosyl isoxazoline have been shown to undergo elimination 
reactions to afford glycal isoxazolines. These compounds are susceptible to electrophilic 
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addition reactions at the glycal double bond and thus should provide access to a variety of 
analogues. 
Initial investigations suggest that reductive ring opening of the isoxazolines afford l-
hydroxyketones and 7-amino alcohols, although optimum conditions for the ring opening 
reactions have yet to be determined. 
A possible area for future study is the transfer of this methodology to the solid phase. It is 
envisaged that the pyranoysinitromethyl compound would be tethered to an appropriate 
linker through the hydroxyl group at the 6-position (Scheme 108). A major advantage of 
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and '3C NMR were recorded on Bruker ARX250 and Bruker avarice 360 instruments by 
Mr J. R. A. Miller and Mr W. Kerr. High field 'H NMR was carried out on a Varian inova 
600 instrument by Dr I. Sadler. Two dimensional spectra were typically recorded on the 
Bruker avarice 360 instrument. Chemical shifts () in all spectra are measured in parts per 
million using tetramethysilane (ö = 0.0) as the reference signal 
Fast Atom Bombardment (FAB) mass spectra and exact mass measurement were recorded 
using a Kratos MS50TC instrument using either glycerol or thioglycerol as a matrix by Mr 
A. Taylor. 
Melting points were measured on a Gallenkamp capillary tube apparatus and are 
uncorrected. Optical rotations were measured on an Optical Activity Polaar 20 polarimeter 
using 5 cm  of filtered solution. IR spectra were obtained as liquid films or nujol mulls on a 
Perkin Elmer Paragon 1000 FT-jR spectrometer and are quoted in wavenumbers (cm-1). 
The X-ray structural analysis of (138), (164) and (200) were carried out by Dr S. Parsons, 
3.1.2 Chromatography 
Analytical thin layer chromatography was carried out using Merck aluminium-backed plates 
with Kiesegel GF254 (02 mm). 
Dry flash chromatography was performed using sintered funnels of various diameters filled 
with Kieselgel GF254 and eluted under a water pump vaccuum. 
Medium pressure liquid chromatography was carried out using two imetre columns packed 
with Kieselgel 60. Elution was performed at a pressure of 40-50 psi. 
Experimental Procedures 
High pressure liquid chromatography was carried out on a Gilson instrument fitted with a 
refractive index detector using a Varian dynamax (250 mm x 21.4 mm) column packed with 
rnicrosorb 100 silica. 
3.1.3 Solvents and reagents 
All reagents and solvents were standard laboratory grade and were used as supplied unless 
otherwise stated. 
Dry ether and toluene were Analar grade dried over sodium wire. 
Dry chloroform was obtained by distillation from calcium chloride and stored over 4A 
molecular sieves. 
Dry pyridine was Analar grade distilled from and stored over potassium hydroxide. 
Dry THF and ethylene glycol diethylether was freshly distilled from calcium hydride. 
Acetic anhydride was purified by fractional distillation and stored over 4A molecular sieves. 
3.2 	Synthesis of nitrile oxide precursors 
3.2.1 Acetylated 2,6-anhydro-1-deoxy-1-nitroalditols 
These compounds were prepared from D-glucose (246) and D-mannose (123) by a modified 
version of the procedure of Köll et all 06  by base catalysed addition of nitromethane to the 
parent monosaccharide. 
3.2.1.1 1-Deoxy-1-nitroalditols 
The title compounds were prepared from the corresponding aldoses by a modified version of 
the Fischer-Sowden reaction 106  using the general procedure below. 
GENERAL PROCEDURE: The monosaccharide (1 equiv.) was dissolved in methanol (50 
cm3) and to this nitromethane (12 equiv.) was added under anhydrous conditions in a 
nitrogen atmosphere. A freshly prepared solution of sodium methoxide in methanol, made by 
dissolving sodium (1.3 equiv.) in dry methanol (175 
CM),  was added drop-wise and the 
reaction mixture was allowed to stir overnight. The solid formed was isolated by filtration, 
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washed with ice cold methanol, and dissolved in ice cold water. The solution was then 
rapidly forced through an amberlite IR 120 (H) ion exchange column.*  Excess nitromethane 
was removed by rotary evaporation at reduced pressure until sufficient water distilled over to 
achieve complete removal of nitromethane. 
3.2.1.2 	2,6-Anhydro-1-deoxy-1-nitroalditols 
These compounds were prepared by acid-catalysed cyclisation of l-deoxy-1-nitroalditols 
using a modified literature procedure. 106 
GENERAL PROCEDURE: The solution of the 1-deoxy-I-nitroalditol was heated at reflux 
overnight, then treated with activated charcoal and heated at reflux for a further two hours. 
The charcoal was then removed by filtration through a celite pad and the solvent removed in 
vacuo to give an oil. The product was isolated as a white crystalline solid by continuous 
liquid/liquid extraction using ethyl acetate / water (48 hours), followed by concentration of 
the organic layer in vacuo. 
3.2.1.2.1 	Synthesis of 2, 6-anhydro-1-deoxy-1-nitro-D-glycero-D-gulo-heptitol (Ii- 
D-glucopyranosylnitromethane) (245) 
Sample code: KWBOI 	 H 
Molecular formula: C6H13N07 
Molecular weight: 223 
NO2 
D-Glucose (246) (30.57 g, 0.17mol, 1 equiv.) was dissolved in a mixture of methanol (50 
cm3) and nitromethane (90 cm3, 2 mrnole, 12 equiv.) and reacted with sodium methoxide 
(5.2 g, 0.22 mmole, 1.3 equiv. sodium in 175 cm  dry methanol). Following the procedure 
described above, compound (245) was isolated (6.6 g, 17%); mp 173-175°C (lit. 
106  175-
176°C); [a'8D +20.0 (c = 1.0, H20); S  (360 MHz, D20)3.23-3.46 (4H, m, 3-H, 4-H, 5-H, 
6-H), 3.58 (1H, dd, 7a-H), 3.75 (IH, dd, 7b-H), 3.99 (1H, ddd, 2-H), 4.58 (IH, dd, la-H), 
4.85 (IH, dd, lb-H); J(x-y)/Hz la-lb 13.5, la-2 2.6, lb-2 8.7, 2-3 10.0, 3-4 tid, 4-5 nd, 5-6 
* The column was prepared by washing through with water until any colouration disappeared. The 
amberlite was then acidified by addition of 1M HC1. Water was then passed through until the pH 
returned to pH 4. 
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iid, 6-7a 1.9, 6-7b 5.1, 7a-7b 12.4; 6C (90 MHz, CDC13) 60.6 (C-7), 79.4, 70.5, 76.0, 77.1, 
79.6, (C-2, C-3, C-4, C-5, C-6), 76.6 (C-i); m/z (FAB) Found: M+H, 224.07734. C7H14N07 
requires M+H 224.07703. 
3.2.1.2.2 	Synthesis of 2,6-anhydro-1-deoxy-1-nitro-D-g/ycero-D-galacto-heptitol 
(f3-D-mannopyranosylnitromethane) (125) 
Sample code: KWB03 
Molecular formula C7H13N07 
Molecular weight: 223 
HO NO2 
OM  125 
OH 
D-Mannose (123) (13.0 g, 72.2 mmole, 1 equiv.) was dissolved in methanol and 
nitromethane (50 cm3, 0.72 mole 10 equiv.) and reacted with a methanolic sodium methoxide 
solution (2.21 g, 96.1 mmole, 1.33 equiv. sodium in 80 cm3 dry methanol). Following the 
procedure outlined above the product (125) was obtained as a white crystalline solid (4.99 g, 
31%); mp 151-152°C (lit. 106  151-1520C); [a]u' 8 = -33 (c = 1, 1-120); öc (63 MHz, D20) 61.0 
(C-7), 66.8, 69.3, 73.6, 74.7, 80.0 (C-2, C-3, C-4, C-5, C-6), 76.5 (C- 1); m/z (FAB) Found: 
M+H, 224.077 16. C71-113N07 requires M+H 224.07703. 
3.2.1.3 Acetylated 2,6-anhydro-1-deoxy-1-nitroalditols 
The acetylation of 2,6-anhydro-1-deoxy-i-nitroalditols was carried out by the method of 
Köll et al. 106 
GENERAL PROCEDURE: The 2,6-anhydro-1-deoxy-1-nitroalditol (1 equiv.) was dissolved 
in dry acetic anhydride (100 equiv.) under anhydrous conditions in a nitrogen atmosphere 
and cooled to 0°C (ice bath). To this a catalytic amount of trifluormethanesulfonic acid (0.1 
cm 3)  was added and the reaction mixture allowed to stir overnight. The solution was then 
poured into ice cold water, extracted with chloroform (3 x 50 cm3) and the organic portion 
dried (MgSO4). Removal of solvent in vacuo yielded the product as a white solid, which was 
further purified by recrystallisation from the appropriate solvent. 
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3.2.1.3.1 	Synthesis of 3, 4, 5, 7-tetra-O-acetyl-2,6-anhydro-1-deoxy-1-nitro-D- 
glycero-D-gulo-heptitol (3,4,5,7-tetra-0-acetyi--D-
glucopyranosylnitromethane) (127) 
Sample code: KWB02 
Molecular formula: C15H21N011 
Molecular weight: 391 
NO2 
OAc 
Using the procedure outlined above, 3-D-g!ucopyranosylnitrornethane (245) (500 mg, 2.24 
mmole, I equiv.) was dissolved in dry acetic anhydride (20 cm3, 0.21 mole, 100 equiv.) and 
trifluormethanesulfonic acid (0.1 cm3) added. The product (127) was recrystallised from 
ethanol to give a white solid (0.70 g, 80%); mp 143-145°C (lit.'06 144 -145°C); MD 18 = 
+15.0 (c = 0.4, CHCI3); Fl  (250 MHz, CDC13) 1.95, 1.97, 2.00, 2.01 (121-1, 4 x s, 4 x 
COCH3), 3.70 (IH, ddd, 6-I-I), 3.99 (1H, dd, 7a-H), 4.21 (IH, dd, 7b-H), 4.24 (1 H, dd, 2-H), 
4.36 (IH, dd, la-H), 4.48 (IH, dd, lb-H), 4.88 (11-1, dd, 3-H), 5.01 (11-1, dd, 5-H), 5.21 (1H, 
dd, 4-H); J(x-y)/Hz la- lb 13.7, la-2 2.9, lb-2 8.8, 2-3 10.1, 3-4 9.3, 4-5 9.3, 5-6 10.0, 6-7a 
2.3, 6-7b 4.9, 7a-7b 12.5; & (90 MHz, CDCI3) 20.3, 20.4 (4 x COCH3), 61.4 (C-7), 67.7, 
69.0, 73.3, 74.1, 75.5 (C-2, C-3, C-4, C-5, C-i), 75.7 (C-6), 169.1, 169.5, 169.8, 170.3 (4 x 
COCH3); m/z (FAB) Found: M+H 392.11964 C15H22N01 , requires M+H 392.11929. 
3.2.1.3.2 	Synthesis of 3, 4, 5, 7-tetra-O-acetyl-2,6-anhydro-1-deoxy-1-nitro-D- 
glycero-D-galacto-heptitol (3,4,5,7-tetra-0-acety1--D-
mannopyranosylnitromethane) (122) 
Sample code: KWB07 
Molecular formula: C15H21N011 
Molecular weight: 391 
NO2 
OAc 
Following the general procedure outline above, 3-D-mannopyranosylnitromethane (125) 
(936 mg, 4.20 mmole, 1 equiv.) was dissolved in dry acetic anhydride (40 cm3, 0.414 mole, 
100 equiv.) and trifluormethanesulfonic acid (0.1 cm3) added. The product (122) obtained 
was recrystallised from ethanol to give a white solid (1.44 g, 92%); mp 180-181°C (l 
it.  '06 
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179-180°C); [am'8 = -33 (c = tin CHCI3) flit- 106 [aID18  = -32 (c = I in CHCI3)}; 6H  (360 
MHz, CDCI3) 1.98, 2.04, 2.06, 2.18 (12H, 4 x s, 4 x COCH3), 3.71 (ill, ddd, 6-H), 4.05 (1H, 
dd, 7a-H), 4.27 (1H, dd, 7b-H), 4.39 (1 H, dd, la-H), 4.46-4.54 (2H, m, lb-H, 2-H), 5.09 (1H, 
4-H), 5.24 (1 H, dd, 5-H), 5.43 (1 H, dd, 3-H); J(x-y)/Hz la- lb 13.0, la-2 1.8, lb-2 9.2, 2-3 
0.7, 3-4 3.4, 4-5 10.0, 5-6 10.0, 6-7a 2.3, 6-7b 5.7, 7a-7b 12.4; 6c  (90 MHz, CDC13) 20.9, 
21.0, 21.0, 21.1(4 x COCH3), 62.7 (C-7), 65.9, 68.6, 72.1, 73.8, 76.9 (C-2, C-3, C-4, C-5, C-
6), 75.6 (C-I), 170.0, 170.4, 170.6, 171.0(4 x COCH3); m/z(FAB)Found: M+H 392.11943 
C19H22N0,1 requires 392.11929. 
3.2.1.4 	In situ acetylation of 2,6-anhydro-1-deoxy-1-nitroalditols 
The synthesis of acetylated 2,6-anhydro-1-deoxy-1-nitroalditols without the isolation of the 
2,6-anhydro-1-deoxy-1-nitroalditols was carried out for D-xylose and L-fucose as described 
in the general procedure below. 
GENERAL PROCEDURE: To a stirred suspension of the parent monosaccharide (1 equiv.) 
in nitromethane (10 equiv.) and methanol (50 cm) was added sodium methoxide (1.3 equiv.) 
in methanol, and the mixture stirred for 16 Ii. The resulting solid was isolated by filtration, 
washed with cold methanol, and dissolved in cold water. After passing through an amberlite 
IR (J-[') ion exchange column, the solution was concentrated in vacuo to remove excess 
nitrornethane. The resulting solution was heated under reflux for —16 13, treated with 
activated charcoal, and heated at reflux for a further 2 Ii. After filtration to separate the 
charcoal, the solvent was removed in vacuo to afford an oil, which was treated under 
nitrogen with dry acetic anhydride (100 equiv.) and a catalytic amount of 
trifluoromethanesulfonic acid (0.1 cm3). The mixture was stirred for --'16 11. The resulting 
solution was poured onto ice cold water and the product extracted into chloroform (3 x 20 
cm 3),  the organic portion dried (MgSO4) and the solvent removed in vacuo. The crude syrup 
formed was co-evaporated with toluene (3 x 10 cm3) and the solvent removed in vacuo to 
afford the product. 
3.2.1.4.1 	Synthesis of 3,4,5-tri-O-acetyl-2,6-anhydro-1-deoxy-1-nitro-D-gulo- 
hepitol (3,4,5-tri-O-acetyl--D-xylopyranosy1nitromethane) (128) 
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Sample code: KWB69 
Molecular formula: C121117N09 
Molecular weight: 319 
AcO" 
NO2 
To a stirred suspension of D-xylose (247) (2.00 g, 1.3 mrnole) in nitrornethane (7.2 cm 
3,  13 
mmole, 10 equiv.) and methanol (5 CM),  was added sodium methoxide (380 mg, 1.63 
mmole, 1.25 equiv.) in methanol (10 cm3). Following the general procedure outlined above a 
red oil was obtained which was purified by passing as a solution in ether through a pad of 
silica. Trituration with ethanol and recrystallisation from the same solvent gave the product 
(128) as a white solid (2.90 g, 68%); mp 164— 166°C (lit.106 164— 165 °C); 6H(2SO MHz, 
CDCI3) 2.30, 2.33 (9H, 3 x s, 3 x COCH3), 3.61 (IH, dd, 6a-H),4.40 (IH, dd, 6a-H), 4.44 
(11-I, 2-H), 4.67 (1 H, dd, la-H), 4.76 (1 H, dd, lb-H), 5.15 (1 H, dd, 3-1-1), 5.26 (1 H, dd, 5-H), 
5.52 (lH, t, 4-H); J(x-y)IHz la-lb 13.4, la-2 3.0, lb-2 8.9, 2-3 10.1, 3-4 9.3, 4-5 9.4, 5-6a 
5.7, 5-6b 10.6, 6a-6b 11.3; 6c(63  MHz, CDCI3) 21.0, 21.0, 21.2 (COCH3), 67.1 (C-6), 69.0, 
69.9, 73.5, 75.4 (C-2 to C-5), 76.4 (C-I), 170.2, 170.2, 170.6 (COCH 3). 
3.2.1.4.2 	Synthesis of 3,4,5-tri-O-acetyl-2,6-anhydro-1 ,7-dideoxy-1-nitro-L- 
g/ycero-D-manno-hepitol (3,4,546-0-acetyl--L-
fucopyranosylnitromethane) (129) 
Sample code: KWB71 
Molecular formula: C13H19N09 
Molecular weight: 333 
NO2 
OAc 
To a stirred suspension of L-fucose (248) (600 mg, 3.7 mmole), in nitrornethane (2 cm3, 36.5 
mmole, 10 equiv.) and methanol (2 cm) was added sodium methoxide (0.1 mg, 4.4 mmole, 
1.2 equiv.) in methanol (5 CM)  . Following the general procedure outlined above, the desired 
product (129) was isolated as a white solid (800 mg, 70%); mp 127-128 °C (from ethanol); 
(Found: C, 46.9; H, 5.5; N, 3.9. C13H20N09 requires C, 46.9; H, 5.8; N, 4.2); [a]'8 -35.0 (c 
= 1.0, CHCI3); 8H  (250 MHz, CDC13) 1.14 (3H, d, 7-H), 1.97, 2.06, 2.16 (9H, 3 x s, COCH3), 
3.83 (1H, dq, 6-H), 4.20 (1H, ddd, 2-H), 4.35 (1H, dd, la-H), 4.54 (1H, dd, lb-H), 5.02-5.12 
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(21-1, rn, 3-H,4-H), 5.27 (IH, dd, 5-H); J(x-y)/Hz la-lb 13.3, la-2 2.7, lb-2 9.2,2-3 9.8,4-5 
2.7, 5-6 1.1, 6-7 6.4; 3c  (63 MHz, CDC13) 16.0 (C-7), 20.5, 20.5, 20.6 (COCH3), 66.7, 70.2, 
71.8, 73.0, 74.6 (C-2 - C-6), 76.1 (C-i), 169.9, 170.0, 170.3 (COCH3); ni/z (FAB) Found: 
M+1, 334.11398. C13H20N09 requires M+H 334.11381. 
3.2.2 Acetonation of 2,6-anhydro-1-deoxy-1-nitroalditolS 
The introduction of acetal protection was carried out using the procedure of Köll et al. 
3.2.2.1 	Synthesis of 3,4:5,7 diOisopropylidene-2,6-anhydro-1-deoxY-1-flitrO-D- 
g/ycero-D-ga/acto-heptitol (3,4:5,7-di-0-isopropylidene-f3-D-
mannopyranosylnitromethane) (130) 
Sample code: KWB74 
Molecular formula: C13H21N07 
Molecular weight: 303 
-D-Mannopyranosylnitromethane (125) (100 rng, 0.448 rnmole), dried CaSO4 (0.25 g) and 
powdered toluenesulfonic acid (10 mg, 0.054 rnmole) were suspended in dry DME (5 cm 3) 
and the mixture stirred for 15 minutes under anhydrous conditions in a nitrogen atmosphere. 
To this 2-niethoxypropene (0.5 cm3, 5 mmole) was added and the mixture stirred for a 
further 15 minutes. NaHCO3 (0.1 g) was then added to the red solution and the resulting 
yellow solution filtered. The solvent was removed in vacuo to give an oil which afforded the 
product (130) on purification by dry flash chromatography (ether/hexane) (86 mg, 63%); nip 
159-161°C (from ethanol) (lit.128 148-150°C); 6F1  (250 MHz, CDC13),  1.31, 1.39, 1.47, 1.51 
(12H, 4 x s,4 x CH3), 3.15 (111, ddd, 6-H), 3.68 (21-1, m, 5-H, 7'-H), 3.87 (11-1, dd, 7-H), 4.11 
(11-1, dd, 4-H), 4.21 (11-1, dd, 3-H), 4.54 (21-1, rn, 2-H, 1'-H), 4.68 (111, dd, 1-H); J(x-y)/Hz 1-
1' 14.1, 1-2 9.9, 1'-2 2.9, 2-3, 2.5, 4-3 5.4, 5-4 7.9, 6-5 10.1, 7-6 5.7, 7'-6 10.1,7'-7 10.9; öc 
(63 MHz, CDC13) 18.6, 26.2, 28.1, 28.8 (4 x CU-I3), 61.4 (C-7), 69.3, 72.4, 72.9, 73.6, 75.9 
(C-2 to C-6), 75.8 (C-i), 99.6 (CCH3), 110.3 (CCH3). 
Improved yields were obtained using a modified version of that reported by Köll et al. 
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3.2.2.2 	Synthesis of 3,4:5,7 di-O-isopropylidene-2,6-anhydro-1-deoxy-1-nitro-D- 
glycero-D-galacto heptitol (3,4: 5,7-di-O-isopropylidene-f3-D-
mannopyranosylnitromethane) (130) 
Sample code: KWB257 
Molecular formula: C13H21N07 
Molecular weight: 303 
-D-Mannopyranosylnitrornethane (125) (1.0 g, 4.48 mrnole), Na2SO4 (2.5 g) and powdered 
toluene sulfonic acid (100 mg, 0.536 rnmole) were suspended in dry DME (15 cm3) and the 
mixture stirred for 15 minutes under anhydrous conditions in a nitrogen atmosphere. To this 
2-methoxypropene (2.9 cm3, 30.28 mmole) was added and the mixture stirred for a further 
15 minutes. NaHCO3 (1.0 g) was then added to the red solution and the resulting yellow 
solution filtered. Removal of solvent in vacuo gave an oil which on addition of hexane 
yielded a white solid. Recrystallisation from ethanol gave the desired product (130) as a 
white solid (1 .lg, 8 1%). For analysis see section 3.2.2.1. 
3.2.3 Benzyl ether protection 
3.2.3.1 	Synthesis of 3, 4, 5, 7-tetra-0-benzyl-2,6-anhydro-1-deoxy-1-nitro-D- 
glycero- D-gulo-heptitol (3,4,5,7-tetra-0-benzyl-J-D-
glucopyranosylnitromethane) (13 1) 
The target compound (131) was synthesised from methyl a-D-glucopranoside (132) in a 3 
step synthesis. Conversion of 2,3,4,6-tetra-0-benzyl-D-glucose (134) to 3,4,5,7-tetra-0- 
benzyl-3-D-g1ucopyranosy1nitromethane (131) was achieved using the method of Best et 
al. 129 
3.2.3.1.1 	Synthesis of methyl 2,3,4,6-tetra-0-benzyl-a-D-glucopyranoside (133) 
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Sample code: KWB 168 
Molecular formula: C35H3806 





To a suspension of sodium hydride (60% w/w, 88 mg, 22 mmole) in anhydrous DMF (20 
cm 3)  cooled to 5°C was added a solution of methyl a-D-glucopyranoside (132) (500 mg, 
2.75 mmole) in DMF (20 cm3) over 30 mins. and the mixture stirred for 1 hour and allowed 
to warm to room temperature. After re-cooling to 5°C, benzyl bromide (2.8 g, 16.5 mmole) 
was added in three portions via syringe and the reaction stirred for 20 hours. Excess Sodium 
hydride was quenched carefully with methanol (10 cm 3),  toluene (20 cm3) and water (20 
cm3) added, and the aqueous layer extracted with toulene (2 x 50 cm3). The combined 
organic layers were washed with water (20 cm3), brine (20 cm3), dried (MgSO4) and the 
solvent removed in vacuo. Addition of triethylamine (1 cm 
3)  to the crude oil followed by 
stirring for 1 hour converted excess BiiBr into benzyl triethylammonium bromide which was 
removed by partitioning the mixture between ether (50 cm3) and water (50 cm3). The organic 
portion was washed with brine (20 cm3), dried (MgSO4) and the solvent removed in vacuo. 
The resulting oil was purified by column chromatography (eluting from ether/hexane) to 
give the product (133) as a colourless oil (770 mg, 52%); 6H  (250 MHz, CDCI3) 3.39 (3H, s, 
OCH3), 3.52 (1 H, dd, .J12 3.6, J23 9.6, 2-H), 3.62-3.79 (4H, rn, 4-H, 5-H, 6a-H, 6b-H), 4.00 
(I H, t, J23 9.5, J 4 8.8), 4.46-5.02 (8H, in, ArCH2), 4.64 (1 H, d, 1-H), 7.13 —7.40 (20H, m, 
ArH); öc (63 MHz, CDCI3) 55.0 (UGH3), 68.3 (C-6), 73.2, 73.3, 74.9, 75.6 (ArCH2), 69.9, 
77.5, 82.0 (C2 - C5),98.1 (CI), 127.5, 127.8, 127.8, 128.0, 128.2 (ArH), 137.8, 138.0, 138.1, 
138.2 (ArC). 
3.2.3.1.2 	Synthesis of 2,3,4,6-tetra-0-benzyl-D-glucose (134) 
Sample code: KWB215 
Molecular formula: C34H3606 





To a solution of methyl 2,3,4,6-tetra-0-benzyl-a-D-glucopyranoside (133) (3.07 g, 5.7 
mmole) in glacial acetic acid (40 cm 3)  was added 2M aqueous sulfuric acid (20 cm3, 39.5 
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mmole) and the mixture stirred at 90°C for 18 hours. After cooling to room temperature, the 
acetic acid was removed in vacuo, the resulting oil diluted with DCM (50 cm3) and the 
organic layer washed with saturated aq. NaHCO3 (25 cm3), brine (25 ern 3) and dried 
(MgSO4). The solvent was removed in vacuo to give a white solid which was recrystallised 
from methanol to afford the title compound (134) as a white crystalline solid (1020 mg, 
33%); 6H  (250 MHz, CDC13)  1.81 (1 H, br s, OH), 3.42-4.13(1211, m, a2-H to a6-H, j32-H 
to 136-H), 4.50-5.03 (17H, m, aArCH2, 13 ArCH2 131-H), 5.29 (111, d, J12 3.1, al-H), 6.80-
7.70 (40H, m, (xAr, 13Ar); 6c (63 MHz, CDC13) 69.0 (ctC6), 69.3 (13C6), 73.9, 75.2, 75.5, 
76.2 (aArCH2) 70.6, 78.2, 80.4, 82.2 (aC2 - aC5), 91.7 (aCI), 97.7 (PC]), 128.1 - 129.0 
(ArH), 138.2— 139.1 (ArC). 
3.2.3.1.3 	Synthesis of 3,4,5,7-tetra-O-benzyl-2,6-anhydro-1-deoxy-1-nitro-D- 
glycero-D-gulo-hepitol (3,4,5,7-tetra-0-benzyl-13-D-
glucopyranosylnitromethane) (13 1) 
Sample code: KWB 176 
Molecular formula: C35H37N07 
Molecular weight: 583 
BnO NO2  
Bno\\\\"" r""/// O B n 
131 
OBn 
Using the procedure of Best et al 129  nitromethane (6 cm3) and diaminoethane (0.034 cm3, 0.5 
mmole) were added to a solution of tetra-O-benzyl-D-glucopyranose (134) (270 mg, 0.5 
mmole) in DMSO (4 cm3) and the mixture stirred at 80°C for 5 days. A further equivalent of 
diaminoethane was added and the mixture heated for another 4 days. The reaction mixture 
was extracted with chloroform (3 x 50 cm3), the organic layer washed with water (2 x 50 
cm3), brine (2 x 50 cm3) and then dried (Mg504). Removal of solvent in vacuo gave an oil 
which was purified by dry flash chromatography (eluting from ether/hexane) to yield the 
product (131) as an oil (210 mg, 72%) which partially solidified on standing; mp 80-81°C 
(lit 82-83°C); ö (250 MHz, CDC13) 3.41 (1H, dd, J23 9.8 -h,4 8.6 3-H), 3.52 (111, m, 6-H), 
3.69 - 3.85 (4H, rn, 4-H, 5-H, 7a-H, 7b-H), 4.04 (ill, ddd, .11a2  8.6, Jb,2  2.8, J23 9.8, 2-H), 
4.30 —4.67 (1 OH, m, la-H, lb-H, ArCH2), 7.16 - 7.44 (2011, m, ArH); 8C (63 MHz, CDC13) 
67.9 (C7), 71.2, 73.2, 74.7, 74.8 (ArCH2), 76.4 (Cl), 75.4, 76.9, 77.2, 78.9 (C3 - C6), 86.7 
(C2), 127.5, 127.6, 128.0, 128.2, 128.3, 128.5 (ArH), 137.1, 137.7, 137.9 (ArC). 
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3.2.4 Synthesis of pyranosyl oximes 
The D-glucose, D-mannose and L-fucose based oximes (139), (140), (138), (141) and (142), 
respectively were generated by reduction of the corresponding protected nitromethanes using 
a modified procedure of Bartra et al. 
GENERAL PROCEDURE: Triethylamine (5 equiv.) and thiophenol (4.5 equiv.) were added 
to a solution of tin(I1) chloride (1.5 equiv.) in dry TI-IF (6 cm') under nitrogen at 0°C. To the 
resulting solution was added a solution of protected nitromethyl compound (1 equiv.) and the 
mixture stirred for 16 hours. After removal of the solvent in vacuo, the resulting semi-
crystalline residue was washed with hexane to remove excess thiophenol and the product 
separated by dry-flash chromatography (silica, hexane/ether gradient elution) to afford the 
target compound. 
3.2.4.1 	Synthesis of 3, 4, 5, 7-tetra-O-acetyl-2,6-anhydro-1-deoxy-1- 
hyd roxyimino-D-glycero-D-gu/o-heptitol (3,4,5,7-tetra-0-acetyl--D-
glucopyranosylformaldoxime) (139) 
Sample code: KWB05 
Molecular formula: C151-121N010 






3,4,5,7Tetra-0acetyl-3-D-glucopyranosylnitromethane (127) (500 mg, 1.28 mmole, 1 
equiv.) was added to a cooled (ice-bath) solution of tin(TI) chloride (363 mg, 1.92 mmole, 
1.5 equiv.), triethylamine (0.9 cm3, 6.4 mmole, 5 equiv.) and thiophenol (0.61 cm3, 5.76 
mmole, 4.5 equiv.) as outlined in the general procedure above. The product (139) was 
isolated by dry flash chromatography, eluting with ether/hexane (416 rug, 87%). (139) was 
further purified (to remove final traces of thiophenol) by recrystallation from a 60:40 
ether/hexane mix. The oxime was obtained as a mixture of E/Z isomers in a 4:1 ratio; rnp 
139-141CC (lit.134 155-157 °C); vmax/cm' (Nujol), 3498 (OH); 8H (260 MHz, CDC13) 1.95, 
1.97, 2.00, 2.01 (12H, 4 x s, 4 x COCH3), 3.72 (1H, ddd, 6-H), 4.09 (1H, dd, 7a-H), 4.04 
(1H, dd, 2-H), 4.22 (1H, dd, 7b-H), 5.07 (114, dd, 3-H), 5.08 (IH, dd, 5-H), 5.24 (IH, dd, 4-
H), 7.30 (1H, d, 1-H), 8.40 (IH, br s, OH); J(x-y)/Hz 1-2 6.8, 2-3 9.8, 3-4 9.1, 4-5 9.6, 5-6 
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9.6, 6-7a 2.2, 6-7b 4.7, 7a-7b 12.5; ö (90 MHz, CDC13) 20.5, 20.5, 20.6 (4 x COCH3), 61.8 
(C-7), 68.0, 69.4, 73.4, 75.6, 75.7 (C-2, C-3, C-4, C-S, C-6), 146.6 (C-i), 169.4, 169.6, 
170.2, 170.7 (4 x COCH3); m/z (FAB) Found: M+H 376.12452 C15H22N010 requires 
376.12437. 
3.2.4.2 	Synthesis of 3, 4, 5, 7-tetra-O-acetyl-2,6-anhydro-1-deoxy-1- 
hydroxyimino-D-g/ycero-D-galacto-heptitol (3,4,5,7-tetra-0-acetyl--D-
mannopyranosylformaldoxime) (13 8) 
Sample code KWB09 
Molecular formula: C15H21N010 





3,4,5,7-Tetra-0-acetyl-f3-D-rnannopyranosylnitromethafle (122) (513 mg, 1.31 mmole, 1.0 
equiv.) was added to a cooled solution of tin(II) chloride (371 mg, 2 mmole, 1.5 equiv.), 
triethylamine (0.9 cm3, 6.5 mmole, 5 equiv.) and thiophenol (0.61 cm3, 5.95 mmole, 4.5 
equiv.) in THF (6 cm3) according to the procedure outlined above. The product was isolated 
by dry flash chromatography, eluting with ether/hexane to yield (138) (410 mg, 84%), 
prepared as a 2.3:1 mixture of E/Z isomers; mp 154-156 C (from hexane/ether) (lit. 
134  152-
154 °C); E-isomer: oH (360 MHz, CDC13)  1.96, 2.03, 2.07, 2.13 (12H, s, COCH3), 3.68 (1 H, 
ddd, 6-H), 4.24 (ill, dd, 7a-H), 4.13 (1H, dd, 7b-H), 4.33 (1H, dd, 2-H), 5.08 (1H, dd, 4-H), 
5.22 (1H, dd, 5-H), 5.49 (1H, dd, 3-H), 7.30 (1H, d, 1-H), 8.53 (1H, br s, NOH); J(x-y)/1-Iz 1-
2 5.5, 2-3 1.1, 3-4 3.3, 4-5 10.1, 5-6 9.8, 6-7a 2.2, 6-7b 5.6, 7a-7b 12.4; 0c  (63 MHz, CDC13) 
20.5, 20.5, 20.6 (4 x COCI-13), 62.5 (C-7), 65.5, 69.3, 71.7, 74.5, 76.2 (C-2 - C-6), 146.1 (C-
i), 169.6, 170.1, 170.2, 170.8 (COCH3). Selected data for Z-isomer: O  (360 MHz, CDC13) 
1.95, 2.03, 2.08, 2.11 (12H, s, COCH3), 3.72 (1H, ddd, 6-H), 4.24 (1H, dd, 7a-H), 4.13 (1H, 
dd, 7b-H), 4.85 (1H, d, 2-H), 5.12 (IH, dd, 4-H), 5.22 (1H, dd, 5-H), 5.81 (iH, dd, 3-H), 
6.69 (1H, d, 1-H), 7.79 (1H, br s, NOH); J(x-y)/Hz 1-2 4.1, 2-3 1.1, 3-4 3.4, 4-5 10.1, 5-6 
9.9, 6-7a 2.2, 6-7b 5.5, 7a-7b 12.4; rn/z (FAB) Found: M+H 376.12328 C15H22N010 requires 




3.2.4.3 	Synthesis of 3,4,5-tri-O-acetyl-2,6-anhydro-1,7-dideoxy-1- 
hydroxyimino-L-glycero-D-manno-hepitol (3,4,5-tri-O-acety1--L-
fucopyranosylformaldoxime) (142) 
Sample code: KWB72 
Molecular formula: C13141908 




Triethylamine (0.2 cm3, 1.5 rnmol) and thiophenol (0.14 cm3, 1.35 mmol) were added to a 
solution of tin(1I) chloride (100 mg, 0.45 mrnol) in dry THF (6 
CM),  followed by tri-0-
acetyl-J3-L-fucopyranosylnitromethane (129) (100 mg, 0.3 mrnol), as described in the 
procedure above. The product was isolated by dry-flash chromatography (silica, 
hexane/ether gradient elution), to afford compound (142) (82.6 rng, 90%), as a 7:1 mixture 
of E/Z isomers; mp 37-39 °C; E-isomer: [aI D' 8 -22 (c = 1.0, CHCI3); S,, (250 MHz, CDCI3) 
1.17 (3H, d, 7-H), 1.97, 2.00, 2.17, (911,3 x s, COCH3), 3.98 (11-1, dd, 2-H), 5.07 (1H, dd, 4-
H), 5.13-5.27, (2H, in, 3-H & 5-H), 7.33 (111, d, i-H), 8.54 (IH br s, NOH); J(x-y)/Hz 1-2 
6.9, 2-3 9.7, 3-4 10.2, 4-5 3.3, 5-6 1.0, 6-7 6.4; 8c (63 MHz, CDC13) 16.2 (C-7), 20.5, 20.6 
(COd 3), 66.8, 70.4, 71.7, 72.9, 75.9 (C-2 - C-6), 147.2 (C-i), 169.9, 170.1, 170.6 
(COCH3); m/z (FAB): Found M+1, 318.11880, C131-130N08 requires 318.11889. The isomer 
ratio was determined by comparison of the 1-H peaks at 7.33 and 6.75 ppm. 
3.2.4.4 	Synthesis of 3,4:5,7 di-O-isopropylidene-2,6-anhydro-1-deoxy- 1- 
hydroxyimino-D-glycero-D-galaclo-heptitol (3,4: 5,7-di-O-
isopropyIidene--D-mannopyranosy1formaldoxime) (141) 
Sample code: KWB 108 
Molecular formula:C13H21N06 
Molecular weight: 287 
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To a mixture of tin(II) chloride (112 mg, 0.50 mmole), thiophenol (1.49 mmole, 0.15 cm) 
and triethylamine (1.65 rnrno!e, 0.23 cm) was added 2,3:4,6-di-0-isopropylidene-13-D-
mannopyranosylnitromethane (130) (100 mg, 0.33 mmole) and the reaction carried out as 
described in the general procedure above to give the product (141) (260 mg, 80%) prepared 
as a 1.6:1 mixture of E/Z isomers; rnp 147-148 °C (from hexane/ether); E-isomer: oH (250 
MHz, CDCI3) 1.32, 1.41, 1.40, 1.54 (12H, 4 x s, CH3), 3.12-3.24 (IH, rn, 6-H), 3.70-3.80 
(2H, m, 5-H, 7b-H), 3.92 (IH, dd, 7a-H), 4.08 (IH, dd, 4-H), 4.22 (IH, dd, 3-H), 4.40 (1H, 
dd, 2-H), 7.52 (IH, d, 1-H), 8.49 (IH, br s, NOH); J(x-y)/Hz 1-2 6.6, 2-3 2.7, 3-4 5.3, 4-5 
7.9, 5-6 nd, 6-7a 5.6, 6-7b 10.0, 7a-7b 10.9; 0c  (63 MHz, CDCI3) 18.6, 26.2, 28.2, 28.8 (4 x 
CH3), 61.6 (C-7), 69.6, 72.4, 74.3, 75.2, 75.8 (C-2 - C-6), 99.7, 110.1 (CMe2), 147.6 (C-I). 
Z-isomer: Oj (250 MHz, CDCI3) 1.32, 1.41, 1.40, 1.53 (12H, s, 4 x CI1), 3.12-3.24 (IH, in, 
6-H), 3.70-3.80 (2H, m, 5-H, 7b-H), 3.91 (111, dd, 7a-fl), 4.08 (1H, dd, 4-H), 4.57 (IH, dd, 
3-H), 5.02 (1H, dd, 2-H), 6.84 (IH, d, 1-H), 8.84 (IH, br s, NOH); J(x-y)/Hz 1-2 4.7, 2-3 
2.7, 3-4 5.3, 4-5 7.9, 5-6 nd, 6-7a 5.6, 6-7b nd, 7a-7b 10.9; oc (63 MHz, CDCI3), 18.6, 26. 1, 
28.2, 28.8 (4 x CH3), 61.6 (C-7), 69.3, 70.6, 72.6, 73.2, 75.5 (C-2 - C-6), 99.7, 109.9 
(CMe2), 148.3 (C- 1); ni/z(FAB): Found: M+1, 288.14549, C13H22N06 requires 288.14471. 
3.2.4.5 	Synthesis of 3,4,5,7-tetra-O-benzyl-2,6-anhydro-1-deoxy-1- 
hydroxyimino-D-glycero-D-gu/o-hepitol (3,4,5,7-tetra-0-benzyI--D-
glucopyranosylformaldoxime) (140) 
Sample code: KWB230 
Molecular formula: C35H37N06 





To a mixture of tin(II) chloride (220 mg, 1.16 mmole), thiophenol (3.50 mmole, 0.35 
CM), 
and 	triethylamine (3.88 mmole, 0.54 cm 
3)  was added 2,3,4,6-tetra-0-benzy1-3-D- 
glucopyranosylnitromethane (131) (447 mg, 1.16 mmole), and the reaction carried out as 
described in the procedure above to yield the product (140) (284 mg, 65%) prepared as a 
4.2:1 mixture of E/Z isomers; mp 127-128°C (from hexane/ether); 0H  (250 MHz, CDCI3) 
3.53-4.06 (7H, m, 1-H - 7H), 4.55-5.05 (8H, rn, PhCH2), 6.85 (0.2H, d, J 2 7.0 Hz, 1-H Z-
isomer), 7.18-7.45 (20.8H, m, PhH & 1-H E-isomer), 8.42 (0.8H, br s, NOH E-isomer), 8.74 
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(0.2H, br s, NOH Z-isomer); 8c  (63 MHz, CDCI3) 68.8 (C-7), 73.7, 75.1, 75.3, 75.9 (PhCH2), 
77.0, 77.9, 79.0, 80.0, 86.7 (C-2 - C-6), 128.3, 128.4, 128.8, 128.9 (20 x PhCH), 138.0, 
138.3, 138.4, 138.9 (PhC), 148.9 (C-I E-isomer), 149.2 (C-I Z-isomer); m/z (FAB): Found: 
M+ 1, 568.26725, C35H37N06 requires 568.26991. 
3.2.5 Synthesis of hydroximoyl chlorides 
GENERAL PROCEDURE: Dry chlorine gas was bubbled through a solution of the 
pyranosylformaldoxime (Ca 1 mmol), in dry dichloromethane (15 cm3), at -78 °C until the 
colour changed from blue to green. On warming to room temperature the colour faded and 
the solvent was removed in vacuo to afford an oil. The product was dissolved in ca 1 cm  of 
dichloromethane and allowed to crystallise. 
3.2.5.1 	Synthesis of 3,4,5,7-tetra-O-acetyl-2,6-anhydro-1-deoxy-1-chloro-1- 
hydroxyimino-D-glycero-D-gulo- 	heptitol (144) 
ri 
Sample code: KWB06 
Molecular formula: C15H20NO10 
Molecular weight: 409.5 
OAc 
Following 	the 	procedure 	outlined 	above 	3,4,5,7-tetra-0-acetyl-13-D- 
glucopyranosylformaldoxime (139) (485 mg, 1.29 mmole) was converted to the 
hydroximoyl chloride (144) as a white solid (500 mg, 95%); mp 157-159 °C (from CH202); 
urnaxlcm' (Nujol), 3311 (OH), 1747 (C=O); LaIn18 -5.0 (c = 1.0, CHC13); 6H  (250 MHz, 
CDCI3) 1.97, 2.00, 2.03, 2.07 (12H, 4 x s, 4 x COCH3), 3.80 (111, dd, 6-H), 4.14 (1H, dd, 7a-
H), 4.23 (1 H, dd, 7b-H), 4.31 (1H, d, 2-H), 5.14, 5.26, 5.36 (314, 3 x dd, 3-H, 4-H, 5-H), 8.93 
(I H, br s, NOH); J(x-y)/Hz 2-3 9.6, 3-4 nd, 4-5 nd, 5-6 9.8, 6-7a 2.4, 6-7b 4.6, 7a-7b 12.5; öc 
(63 MHz, CDCI3) 20.4, 20.5, 20.5, 20.6 (4 x COCH3), 61.8 (C-7), 67.8, 68.8, 73.7, 75.7, 78.3 
(C-2 - C-6), 136.2 (C-i), 169.2, 169.5, 170.5, 170.8 (4 x COCH3); m/z (FAB) Found: M+1, 




3.2.5.2 	Synthesis of 3,4,5,7-tetra-O-acetyt-2,6-anhydro-1-deoxy-1-chlOrO-1- 
hydroxyimino-D-glycero-D-galacto- heptitol (143) 
r.i 
Sample code: KWB50 
Molecular formula: C15H20N010 
Molecular weight: 409.5 
 
OAc 
Following 	the 	procedure 	outlined 	above, 	3 ,4,5,7-tetra-O-acetyl-3-D- 
mannopyranosylformaldoxime (138) (330 mg, 0.88 rnmole) was converted into the 
hydroximoyl chloride (143) (313 mg, 90%), which was in the form of a white powder; mp 
102-103 °C; [ajn'8 111.8 (c = 0.7, CHC13); uinax/cni' (Nujol), 3503 (OH), 1744 (C=O); 6H 
(250 MHz, CDCI3) 1.98, 2.04, 2.09, 2.12 (1211, 4 x s, 4 x COCH3), 3.73, (11-I, ddd, 6-H), 
4.23 (11-1, dd, 7a-H), 4.29 (1H, dd, 7b-H), 5.06-5.33 (3H, m, 2-H, 4-H, 5-H), 5.73 (1H, t, 3-
H), 8.80 (1H, broad s, NOH); J(x-y)/Hz 2-3 1.9, 3-4 3.3, 4-5 nd, 5-6 9.8, 6-7a 2.5, 6-7b 5.6, 
7a-7b 12.3; öc (90 MHz, CDCI3), 20.38, 20.44, 20.55 (4 x COCH3), 62.4 (C-7), 65.5, 67.7, 
71.6, 76.5, 77.1 (C-2 - C-6), 134.6 (C-I), 169.4, 169.5, 169.9, 170.2 (4 x COCH3); ni/z 
(FAB) Found: M+1, 410.08545 C15H21N01035C1 requires 410.08540; Found: M+1, 
412.06859. C15H21N01037C1 requires 412.08245. 
3.2.5.3 	Synthesis of 3,4,5,7-tetra-O-benzyl-2,6-anhydro-1-deoxy-1-chlOrO-1- 
hydroxyimino-D-glycero-D-gu/o-hepitoi (145) 
Sample code: KWB232 
Molecular forrnula:C35H36C1N06 
Molecular weight: 601.5 
NOR 
Following 	the 	procedure 	outlined 	above 	3,4,5,7-tetra-0-benzoyl-13-D- 
glucopyranosylformaldoxime (140) (146 mg, 0.257 rnmole) was converted into the 
hydroxirnoyl chloride (145) as an oil (122 mg, 82%); 8H (250 MHz, CDCI3) 3.50-4.12 (7H, 
m, 1-H - 7H), 4.50-4.81 (8H, m, PhCH2), 7.04 - 7.25 (21H, rn, PhH & 1-H), 9.15 (1H, br s, 
OH); 6c  (63 MHz, CDCI3) 68.8 (C-7). 73.9, 75.4, 75.6, 76.2 (ArCH2), 78.2, 79.5, 80.2 (C-3 
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to C-6), 86.6 (C-2), 128.2, 128.4, 128.5, 128.7, 128.9, 130.3 (Ar H), 129.5 (C-i), 138.0, 
138.2, 138.3, 138.8 (Arc); ,n/z (FAB) Found: M+1, 602.23120 C35H37N0635C1 requires 
602.23094; Found: MH+1,  604.22334 C35H37N0637C1 requires 604.22799 
3.3 	Nitrile Oxide Cycloadditions: Generation of pyranosylnitrile oxides by 
dehydration of pyranosylnitromethanes 
The nitrile oxides were generated from the corresponding protected pyransoylnitromethanes 
using a modified version of the Mukaiyama procedure, with tolylene diisocyanate (TDI), as 
the dehydrating agent rather than phenyl isocyante.9 The general conditions utilised 
throughout were as outlined below. 
GENERAL PROCEDURE: To a solution of the pyranosyJnitromethane (0.5 mmole, 1 equiv.) 
in dry toluene (20 cm') under an inert atmosphere (N2), was added the alkene/alkyne (3 - 5 
equiv.), followed by triethylamine (0.1 - 0.2 cm3) and TDI (3 equiv.) and the mixture heated 
under reflux for seven days. During this time a polymeric orange solid formed. After cooling 
to 0 °C I ,2-diaminoethane (3 equiv.) was added dropwise with stirring. After one hour the 
mixture was filtered through a celite pad to remove the polymeric urea. The pad was washed 
with toluene (1 x 50 cm3) and chloroform (2 x 50 cm3) and the combined organic layers 
evaporated to afford the product which was purified by chromatography and/or 
recrystallisation. 
3.3.1 Reactions of glucopyranosylnitrile oxides 
3.3.1.1 	Cycloaddition of 3,4,5,7-tetra-0-acetyl-f3-D-glucopyranosylformonitrile 
oxide (115) with methylenecyclohexane via the Mukaiyama approach 
Sample code:KWB08 
Molecular formula:C22H31N06 
Molecular weight: 469 
Following 	the 	procedure 	outlined 	above 	3,4,5,7-tetra-0-acetyl--D- 
glucopyranosylnitromethane (127) (200 mg, 0.5 mmole, 1 equiv.) in dry toluene (20 cm3) 
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was reacted with methylenecyclohexane (0.3 cm3, 2.53 mmole, 5 equiv.), triethylarnine (cat 
0.1 cm3) and TD] (0.22 cm3, 1.5 mmole, 3 equiv.). Due to the lower boiling point of the 
alkene, the reaction was heated to 90°C. 5-(Spirocyclohexyl)-3-(2,3,4,6_tetra-O-acetyl-13-D-
glucopyranosyl)-2-isoxazoline (147) was isolated by dry flash chromatography eluting from 
ether/hexane as a white solid (190 mg, 79%), which was recrystallised from ethanol; rnp 
135-137°C. [aID'8 —42.0 (c = 1.0, CHCI3); 6H  (250 MHz, CDCI3) 1.22-1.67 (10H, broad m, 
6a-H to lObH), 1.99, 2.02, 2.06 (12H, 4 X S, 4 X COCH3), 2.68 (1 H, d, J4a4b  17.1, 4a-H), 
2.78 (lH, d,J4b4a 17.1, 4b-H), 3.73 (lH, ddd, 5'-H), 4.08 (1H, dd, 6a'-H), 4.21 (lH, dd, 6b'-
H), 4.29 (lH, d, 1'-H), 5.04 (2H, t, 2'-H and 4'-H), 5.27 (lH, t, 3-H); J(x-y)/Hz 1'-2' 10.0, 2'-
3 94, 3'-4' 9.4, 4-5' 10.0, 5'-6b' 5.1, 5'-6a' 2.2, 6a'-6b' 12.4; 6C (90 MHz, CDCI3) 20.42, 
20.46, 20.49, 20.63 (4 x COCH3), 23.13, 23.26, 24.78, 36.12, 36.42 (C-6 to C-b), 42.19, (C-
4), 61.95 (C-6'), 68.18, 68.61, 73.25, 740.25, 75.80 (C-I 'to C-5'), 87.46 (C-5), 154.12 (C-3), 
169.43, 169.65, 169.93, 170.50 (4 x COCH3); ni/z (FAB) Found: M+H, 470.20227 
C22H32N0,0 requires M+H 470.20262. 
3.3.1.2 	Cycloaddition of 3,4,5,7-tetra-0-acetyl-3-D-glucopyranosyJformonitrile 
oxide (115), with 3-O-acetyl-5,6-dideoxy-1 ,2-O-isopropylidene-a-D-xy/o-
hex-5-enofuranose (149) 
Sample code: KWB16 
Molecular formula: C26H35N015  
Molecular weight: 601 
Following 	the 	procedure 	outlined 	above 	3,4,5,7-tetra-0-acetyl-13-D- 
glucopyranosylnitromethane (127) (200 mg, 0.5 mmole, 1 equiv.) in dry toluene (20 cm3), 
was reacted with 3 -O-acetyl-5 ,6-dideoxy- 1,2-0-i sopropylidene-a-D-xy/o-hex-5-enofuranose 
(149) (supplied by A. R. March) (470 mg, 2 mmole, 4 equiv.), triethylamine (cat 0.1 cm) 
and TDI (0.22 cm 3, 1.5 mmole, 3 equiv.). The product (148) was isolated from unreacted 
alkene (174 mg) by dry flash chromatography eluting from ether/hexane, as a mixture of 
isomers in a 3:1 ratio (231 mg, 75%). The major isomer was isolated by recrystallisation 
from ethanol; mp 182-184°C; [al l)"  —114.0 (c = 2.65, CHC13); 511 (360 MHz, CDC13) 1.22, 
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1.42 (6H, 2 x s, C(CH3)2), 1.93, 1.93, 1.95, 2.00, 2.03 (15H, 5 x s, 5 x COCH3), 3.08-3.10 
(2H, in, 6a-6b), 3.70 (11-1, ddd, 12-H), 4.03 (1H, dd, 13a-H), 4.17 (1H, dd, 13b-H), 4.28 (1 H, 
dd, 4-H), 4.44 (1H, d, 8-H), 4.67 (111, dd, 5-H), 4.97 (IH, dd, 9-H), 5.01 (1H, dd, li-H), 
5.16 (1H, dd, 3-H), 5.23 (1H, dd, 10-H), 5.82 (1H, d, 1-H); J(x-y)/l-Iz 1-2 3.2, 2-3 0.0, 3-4 
3.2, 4-5 9.5, 5-6a nd, 5-6b nd, 6a-6b nd, 8-9 10.0, 9-10 9.5, 10-11 9.5, 11-12 10.1, 12-13a 
5.1, 12-13b 2.2, 13a-13b 12.4; 5c (63 MHz, CDC13) 20.3, 20.4, 20.5 (5 x COCH3), 35.7 (C-
6), 61.8 (C-13), 68.1 (C- 11), 68.7, (C-9), 73.0 (C- 10), 73.5 (C-8), 75.7 (C-3), 75.8 (C- 12), 
76.9 (C-5), 78.7 (C-4), 84.2 (C-2), 104.7 (C-i), 112.1 (C(CH 3),), 155.5 (C-7), 169.1, 169.2, 
169.7, 170.3 (5 x COCH3); m/z (FAB) Found: M+H, 602.20850. C26H36N015 requires 
M+H 602.20863. 
3.3.1.3 Cycloaddition of 3,4,5,7-tetra-0-benzy1--D-g1ucopyranosylformonitrile oxide 
(116) with methylenecyclohexane 
Sample code: KWB202 
Molecular formula: C42H47N06 
Molecular weight 661 
OBn 
Following the general procedure outlined above, 3,4,5,7-tetra-0-benzyl-3-D-
glucopyranosylnitromethane (131) (100 mg, 0.17 mmole) in dry toluene (20 cm 3)  was 
reacted with methylenecyclohexane (0.51 mmole, 3 equiv.), triethylamine (0.1 cm3) and TDI 
(0.6 mmole, 3.5 equiv.). After purification by passing as a solution in DCM through a silica 
pad 5-(spirocyclohexyl)-3 -(2,3 ,4,6-tetra-O-benzyl-3-D-glucopyranosyl)-2-isoxazoline (150) 
was obtained as an oil which solidified on standing (90 mg, 80%); mp = 85 - 87°C; LaIn'8 - 
11.5 (c = 1.82, CHC13); o (250 MHz, CDC13) 1.20-1.76 (10H, m, 6-H to 10-H), 2.71 (2 H, 
dd, 4a-H, 4b-H), 3.45 - 3.88 (6H, m, 2'-H to 6W-H), 4.21 (1H, d, J, 2 9.6, 11-H), 4.57 - 4.99 
(8H, m, 4 x ArCH2), 7.18 -7.35 (20H, m, Ar-H); 8c (63 MHz, CDC13) 23.2, 23.3, 24.9, 36.2, 
36.4 (C-6 to C-b), 43.9 (C-4), 68.6 (C-6'), 73.2, 74.5, 75.0, 75.5 (ArCH2), 75.0, 77.8, 79.0, 
79.2, (C-l' to C-5'), 86.6 (C-5),127.5, 127.7, 127.8, 128.0, 128.2, 128.3 (aromatic C-H), 
137.7, 137.8, 138.3 (aromatic quat), 155.5 (C-3), m/z (FAB) Found: M+H, 662.34826 
C42H48N06 requires M+H 662.348 16. 
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3.3.1.4 Cycloaddition of 3,4,5,7-tetra-0-benzy1--D-glucopyranosy1formonitrile oxide 
(116) with styrene 
Sample code: KWB225 
Molecular formula:C43H43N06 
Molecular weight: 669 
Following the general procedure outlined above, 3,4,5 ,7-tetra-O-benzyl-j3-D-
glucopyranosylnitromethane (131) (204 mg, 0.35 mmole), in dry toluene (30 
CM),  was 
reacted with styrene (1.75 mmole, 5 equiv.), triethylamine (0.2 cm3), and TDI (1.23 mmole, 
3.5 eqiuv.). After purification by passing as a solution in DCM through a silica pad 5(R) and 
5(S)-phenyl-3 -(2,3 ,4,6-tetra-O-benzyl-3-D-glucopyranosyl)-2-isoxazol me 	(151) 	were 
obtained as an oil which solidified on standing (201 mg, 80%) in a 51:49 ratio as determined 
by '3C NMR; rnp 84 - 86°C; S (250 MHz, CDCI3) major isomer 2.83 (1 H, in, 4a-H), 3.40 - 
3.70(7H, in, 4b-H, 2'-H to 6b'-H), 4.22 (1 H, d,J12 l0.0 Hz, 1'-H), 4.37-4.85 (8fl, m, 4 x 
ArCH2) 7.08-7.26 (25H, in, Ph, 4 xArCH2); (63 MHz, CDC13) 66.3 (C-6'), 69.1, 73.8, 74.9, 
75.6, 76.2 (ArCH2), 75.1, 78.4, 78.7, 79.7, 82.4 (C-I' to C-5'), 87.5 (C-5),126.1, 128.1, 
128.3, 128.9, 129.1 (aromatic C-H), 138.4, 138.5, 138.3, 141.8 (aromatic quat), 156.2 (C-3); 
rn/z Found: M+H, 670.3 1741 C42H48N06 requires M+H 670.3 1686. 
3.3.2 Reactions of mannopyranosylnitrile oxides 
3.3.2.1 	Cycloaddition of 3,4,5,7-tetra-0-acety1--D- 
mannopyranosylformonitrile oxide (117), with styrene utilising the 
Mukaiyama approach. 
Sample code: KWB25 
Molecular formula: C23H27N010 




Following the general procedure outlined above, 3,4,5,7tetra-0-3-D-mannopyranosyl 
nitromethane (122) (0.5 mmole, I equiv.) in dry toluene was reacted with styrene (0.30 
mmole, 5 equiv.), triethylamine (cat 0.1 cm3) and TDI (1.5 mmole, 3 equiv.). Removal of 
solvent gave (5R)- and (5S)-5-phenyl-3-(2,3,4,6 tetra-0-acetyl-J13-D-rnannopyranosyl)-2-
isoxazoline (146), as a mixture of inseparable isomers (236 mg, 97%) in a ratio of 56:44; 614 
(250 MHz, CDC13) 2.02, 2.03, 2.04, 2.05 (12H, 4xs, 4x COCH3 ), 2.96 (1 H, m, 4a-H), 3.44 
(I H, m, 4b-H), 3.7 1, (1 H, ddd, 5'-H), 4.14 (1H, dd, 6a'-H), 4.25 (1H, dd, 6b'-H), 4.67, (1H, 
d, 1'-H), 5.13, (1 H, dd, 3'-H), 5.26 (1H, dd, 4'-H), 5.56 (1 H, dd, 2-H), 5.51-5.76 (1 H, m, 5-
1-1), 7.28 (5H, m, aromatic); J(x-y)/Hz 1'-2' 1.3, 2'-3' 3.3, 3'-4' 10.1, 4'-5' 8.9, 5'-6a' 2.2, 
5'-6b' 5.8, 6a'-6b' 12.4; 6c  (63 MHz, CDC13) 20.3, 20.4, 20.5, 20.6 (4xCOCH), 43.2 (C4), 
62.4 (C6'), 65.4, 69.9, 71.4, 73.0, 76.6 (C1'to CS'), 81.2 (CS), 125.0, 125.5, 128.5, 128.1, 
128.6 (aromatic C-H), 140.8 (aromatic quat), 154.9, (0), 169.5, 169.8, 169.9, 170.4 (4x 
COCH3); m/z (FAB) Found: 478.317108 C23H28N1010 requires M+H 478.17132. 
3.3.2.2 Cycloaddition of 3,4,5,7-tetra-0-acetyl-f3-D-mannopyranosylformOflitrile oxide 
(117) with oct-1-ene 
N—O 
Sample code: KWB38 AcO 
Molecular formula: C23H33N010 	
ro 	OAc 	152 
Molecular weight: 483 	
AcO 
OAc 
Following the general procedure outlined above, 3,4,5,7-tetra-0-3-D-mannopyranosyl 
nitromethane (122) (100 mg, 0.256 mmole, 1 equiv.) in dry toluene (10 cm 3)  was reacted 
with oct-i-erie (0.05 cm 3,  0.3 mmole, 1.2 equiv.), triethylarnine (0.1 cm3) and TDI (0.11 cm3, 
0.76 mmole, 3 equiv.). (5R)- and (55)-hexyl-3-(2,3,4,6- tetra-0-acetyl-3-D-
mannopyranosyl)-2-isoxazoline (152) was isolated as a clear colourless oil (86 mg, 72%) by 
passing the oil dissolved in a ether through a silica pad in a ratio of 51:49 determined by 13C 
NMR; 51-1  (250 MHz, CDC13) major isomer; 0.86 (3H, in, 11-H), 1.24 (1 OH, m, 6-H to 10-H), 
1.94, 2.01, 2.05, 2.05 (12H, 4xs, 4x COCH3 ), 2.57 (1H, in, 4a-H), 3.00 (1H, m, 4b-H), 3.70, 
(IH, ddd, 5'-H), 4.11 (1H, dd, 6a'-H), 4.24 (1H, dd, 6b-H), 4.53 (1H, d, 1'-H), 5.07, (1H, dd, 
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3'-H), 5.23, (IH, dd, 4'-H), 5.56 (1H, dd, T-H); J(x-y)/Hz 1'-2' 1.2, 2'-3' 3.3, 3'-4' 10.0, 4'-
5' 9.3, 5'-6a' 2.4, 5'-6b' 5.9, 6a-6b' 12.2; 6c  (90 MHz, CDCI3) 13.8, (C-I 1), 20.4, 20.5, 20.6 
(4 x COCH3), 22.3, 25.1, 28.8, 31.4, 34.8 (C-6 to C-b), 39.7 (C-4),62.5 (C-6'), 65.5, 69.1, 
71.6, 73.3, 76.5 (C-l' to C-5'), 80.8 (C-5), 154.6, (C-3), 169.5, 169.8, 169.8, 170.4 (4 x 
COCH3); m/z (FAB) Found M+H: 484.21788 C23H34N010 requires M+H 484.21827. 
3.3.2.3 	Cycloaddition of 3,4,5,7-tetra-0-acety1-13-D- 
mannopyranosylformonitrile oxide (117) with methylenecyclohexane 
Sample code: KWB42 
Molecular formula: C22H31N010 
Molecular weight: 469 
8 
OAc 
Following the general procedure outlined above, 3,4,5 ,7-tetra-O-3-D-mannopyranosyl 
nitromethane (122) (500 mg, 1.30 mmole, 1 equiv.) in dry toluene (40 cm') was reacted with 
methylenecyclohexane (0.46 cm3, 3.8 mmole, 3 equiv.), triethylamine (0.3 c1113) and TDI 
(0.55 cm3, 3.8 mmole, 3 equiv.). Removal of solvent in vacuo gave a solid which on 
recrytallisation from ethanol gave 5-(spirocyclohexyl)-3 -(2,3,4,6- tetra-0-acetyl-13-D-
rnannopyranosyl)-2-isoxazoline (153) as a white crystalline solid (528 mg, 88%); mp 113-
115°C; [aID'8 = -30.0 (c = liii CHCI3); 6H  (250 MHz, CDC13) 1.22-1.71 (1OH, br, m, 6a-H 
tolO-H), 1.97, 2.04, 2.08, 2.12 (12H, 4 X 5, 4 X COCH3), 2.64 (1H, d, J4.-b  17.4, 4a-H), 2.73 
(11-1, d, J4a4b  17.4, 4b-H), 3.70 (IH, ddd, 5'H), 4.10 (1H, dd, 6b,-H), 4.26 (1H, dd, 6a'-H), 
4.30 (IH, d, 1'-H), 5.09 (IH, 2 x dd, 2'-H, 4'-H), 5.24 (114, dd, 3'-H); J(x-y)/FIz 1'-2' 1.2, 
2'-3' 3.3, 3'-4' 10.0, 4'-5' 9.8, 5'-6a' 2.5, 5'-6b' 5.8, 6a'-6b' 12.3; 6c  (63 MHz, CDCI3), 
21.0, 21.1, 21.2, 21.2(4 x COCH3), 23.7, 23.7, 25.3, 36.5, 36.6 (C6 to CIO), 45.4 (C-4), 63.2 
(C-6'), 66.2, 70.0, 72.2, 74.2, 77.1 (C-l'to C-5'), 87.3 (C-5), 154.9 (C-3), 170.1, 170.1, 




3.3.2.4 	Cycloaddition 3,4,5,7tetra-0-acetyl--D-mannopyranOSYlfOrmOflitrile 
oxide (117) with oct-1-yne. 
Sample code: KWB47 
Molecular formula: C27H33N010 
Molecular weight: 483 
Following the general procedure outlined above, 3,4,5,7-tetra-0-f3-D-mannopyranosyl 
nitromethane (122) (0.26 mmole, 1 equiv.) in dry toluene (20 cm 
3)  was reacted with oct-lyne 
(1.3 mrnole, 5 equiv.), triethylamine (0.1 cm3) and TDI (1.0 mmole, 4 equiv.). Removal of 
solvent in vacuo yielded 5-hexyl-3 -(2,3 ,4,6-tetra-O-acetyI-3-D-mannopyranosyl)i soxazole 
(154) as an oil (120 mg, 88%); 6H  (250 MHz, CDCI3) 0.83 (3H, t, 11-H), 1.25-2.66 (10H, m, 
6-H to 10-H), 1.93, 2.01, 2.02, 2.04 (12H, 4 x s, 4 x COCH3), 3.78 (1H, ddd, 5'-H), 4.13 (1H, 
dd, 6a'-H), 4.26 (1H, dd, 6b'-H), 4.86, (IH, d, 1'-H), 5.16 (IH, dd, 3-H), 5.28 (1H, dd, 4'-H), 
5.60 (IH, dd, 2'-H), 5.97 (1H, s, 4-H);J(x-y)/Hz 1'-2' 1.3, 2'-3' 3.3, 3'-4' 10. 1, 4'-5' 9.7, 5'-
6a' 2.4, 5'-6b' 5.7, 6a'-6b' 12.3; öc (90 MHz, CDC13), 13.8, (C-I 1), 20.4, 20.4, 20.5, 20.6 (4 
x COCH3), 22.2, 26.4, 27.1, 28.4, 31.1 (C-6 to C- 10), 62.6 (C-6'), 65.6, 69.4, 71.6, 72.4, 76.5 
(C-I' to C-5'), 99.5 (C-4), 159.9, (C-3), 174.0, (C-5), 169.5, 169.8, 170.5 (4 x COCH3); m/z 
(FAB) Found: M+H, 484.23302 C27H34N07 requires M+H 484.233 53. 
3.3.2.5 	Cycloaddition of 2,3 :4,6-di-O-isopropylidene-f3-D- 
mannopyranosylnitrile oxide (118) with methylenecyclohexane 
Sample code: KWB94 
Molecular f6rmula:C20H32N106 
Molecular weight: 381 




generation of pyranosyl nitrile oxides via Mukaiyarna conditions, 2,3:4,6-di-0-
isopropy1idene-3-D-mannopyranosylnitromethane (130) (200 mg, 0.66 mmole, 1 equiv.) in 
sodium-dried toluene (20 cm) was reacted with TDI (1.98 mmole, 0.3 cm3, 3 equiv.), 
triethylamine (0.1 cm 3,  cat) and methylenecyclohexane (2.64 mmole, 0.31 cm3, 4 equiv.). 
Purification through a short silica pad eluting with ether yielded 5-(spirocyclohexyl)-3-
(2,3 ;4,7_di-O-isopropyIidene-8-D-mannopyranoSyl)-2-iSoxaZol me (155) as a white 
crystalline solid (210 mg, 84%); mp 160-161°C; oH (250 MHz, CDC13) 1.23- 1.83 (IOH, in, 
6-H to 10-H), 1.28, 1.39, 1.49, 1.50 (12H, 4 x s,4 x CCH3), 2.80 (2H, 2 x d, 4a-H, 4b-H), 
3.17 (1 H, ddd, 5'-H), 3.70 (2H, in, 6b'-H. 4'-H), 3.89 (1H, dd, 6a'-H), 4.07 (1H, dd, 3'-H), 
4.24 (1 H, dd, 2'-H), 4.67 (1 H, d, 1-H); J(x-y)/I-Iz 1'-2' 2.7, 2'-3' 5.2, 3'-4' 7.9, 4'-5' 10. 1, 
5'-6a' 5.7, 5'-6b' 10.0, 6a-6b' 10.9; 0c  (63 MHz, CDCI3), 18.6, 26.1, 28.2, 28.8 (4 x CCH3), 
23.2, 23.3, 35.8, 35.9, 36.3 (C-6 to C-b), 44.7 (C-4), 61.6 (C-6'), 69.8, 72.5, 73.0, 75.9, 76.2 
(C-I' to C-5'), 86.8 (C-5), 99.5, 109.8 (CCH3), 156.6 (C-3); m/z (FAB) Found: M+H, 
382.22290 C20H32N06 requires M+H 382.22296. 
3.3.2.6 Cycloaddition of 2,3 :4,6-di-O-isopropylidene-f3-D-mannopyranosylflitrile oxide 
(11 8) with styrene 
Sample code: KWB 111 
Molecular formula: C21H27N06 
Molecular weight: 389 
Following the general procedure outlined above, 2,3:4,6-di-0-isopropylidene-3-D-
mannopyranosylnitromethane (130) (200 mg, 0.66 mmole), in dry toluene (40 cm3), was 
reacted with styrene (0.4 cm3, 3.3 mmole, 5 equiv.), triethyamine (0.2 cm3), and TDI (0.28 
cm 3,  1.98 mmole, 3 equiv.). 5(R) and 5(S)-phenyl-3-(2,3:4,6-di-O-isopropylidene-13-D-
rnannopyranosy!)-2-isoxazoline (156) were isolated by dry flash chromatography eluting 
from ether hexane to give the product as an oil (202 mg, 79%) in a 53:47 ratio, determined 
by 1 H NMR; S  (360 MHz, CDC13) (major isomer) 1.45, 1.53, 1.54, 1.58 (12H, 4 x s, 4 x 
CCH3), 3.12 (IH, dd, 4a-H), 3.26 (1H, in, 5'-H), 3.61 - 3.80 (3H, in, 4'-H, 4b-H, 6b'-H), 
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3.96 (1H, dd, 6a'-H), 4.15 (IH, dd, 3'-H), 4.33 (1H, dd, 2'-H), 4.84 (IH, d, 1'-H), 5.58 (1H, 
dd, 5-H), 7.29— 7.428 (5H, m, Ar H); J(x-y)/Hz 1'-2' 2.7, 2'-3' 5.3, 3'-4' 7.9, 4'-5' lid, 5'-
6a' 5.6, 5'-6b' iid, 6a-6b' 10.9, 4a-4b 17.7, 4a-5 8.0, 4b-5 11. 1;8c (63 MHz, CDCI3)18.6, 
26.0, 28.1, 28.7 (4 x CCH3), 42.6 (C-4), 61.5 (C-6'), 69.7, 72.4, 72.7, 75.8, 76.2 (C-l' to C-
5'), 82.0 (C-5), 99.5, 109.8 (2 x CCH 3), 126.0, 128.0, 128.3 (aromatic C-H), 140.5 (C-6), 
156.6 (C-3); minor isomer: 611  (360 MHz, CDC13) 1.39, 1.46, 1.55, 1.60 (12H, 4 x s, 4 x 
CCH3), 3.13 (IH, dd, 4a-H), 3.26 (1H, m, 5'-H), 3.64 (1H, dd, 4b'-H), 3.75 (2H, rn 6b'-H, 
4'-H), 3.95 (IH, dd, 6a'-H), 4.17 (IH, dd, 3'-H), 4.36 (IH, dd, 2'-H), 4.83 (1H, d, 1'-H), 
5.66 (1H, dd, 5-H), 7.29— 7.428 (5H, m, Ar H);. J(x-y)/l-Iz i'-2' 2.7, 2'-3' 5.7, 3'-4' 7.9, 4'-
5' 10.1, 5'-6a' 5.6, 5'-6b' 10.1, 6a'-6b' 10.9, 4a-4b 17.6, 4a-5 8.3, 4b-5 11.2; m/z (FAB) 
Found: M+H, 390.19163 C21H28N06 requires M+H 390.19166. 
3.3.2.7 	Cycloaddition 	of 	2,3: 4,6-di-O-isopropylidene-13-D- 
mannopyranosylnitrile oxide (118) 	with oct-1-ene 
Sample code: KWB 125 
Molecular formula: C24H35N06 
Molecular weight: 397 
Using the general procedure outlined above, 2,3 :4,6-di-O-isopropylidene-f3-D-
mannopyranosylnitromethane (131) (100 mg, 0.33 rnrnole), in dry toluene (20 cm 
3), was 
reacted with oct-1-ene (0.26 cm3, 1.65 mmole, 5 equiv.), triethylamine (0.1 cm3), and TDI 
(0. 14cm3, 1.0 rnmole, 3 equiv.), to give 5(R) and 5(S)-hexyl-3-(2,3;4,6-di-O-isopropyiidene-
/3-D-mannopyranosyl)-2-isoxazoline (157) as a colourless oil (70 mg, 53%) in a 57:43 ratio; 
6H (250 MHz, CDCI3) 0.82— 1.64 (13H, m, 6-H to 11-H), 1.30, 1.40, 1.50, 1.51 (12H, 4 x s, 
4 x CCH3), 2.74 (1H, m, 4a-H), 3.02 - 3.25 (2H, m, 4b-H, 5'-H), 3.63-3.76 (2H, rn, 4'-H, 
6b'-H), 3.89 (1H, m, 6a'-H), 4.09 (1H, m, 3'-H), 4.22 (1H, m, 2'-H), 4.56 (1H, d, 1'-H), 4.70 
(IH, rn, 5-H). ); .J(x-y)/Hz i'-2' 2.6, 2'-3' 5.3, 3'-4' 8.0, 4'-5' 10.0, 5'-6a' 5.6, 5'-6b' 10.0, 
6&-6b' 10.9; 6c (63 MHz, CDCI3) major isomer 13.9 (C-1 1), 18.6, 26.2, 28.2, 28.8 (4 x 
CCH3), 22.4, 25.2, 28.1, 31.5, 34.6 (C-6 to C-b), 39.9 (C-4), 61.6 (C-6'), 69.9, 72.4, 73.6, 
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75.9, 76.2 (C-I' to C-5'), 99.6, 109.9 (CCH3),156.9 (C-3); rn/z (FAB) Found: M+H, 
398.25426 C21H35N06  requires M+H 398.25426. 
3.3.2.8 	Cycloaddition 	of 	2,3 :4,6-di-O-isopropylidene-13-D- 
mannopyranosylnitrile oxide (118) 	with oct-1-yne 
Sample code: KWB 162 
Molecular formula: C21H33N06 
Molecular weight: 395 
Following the general procedure outlined above, 2,3 :4,6-di-O-isopropyl idene-13-D-
mannopyranosylnitromethane (130) (106 mg, 0.35 mmole), in dry toluene (20 
CM),  was 
reacted with oct-1-yne (0.26 cm3, 1.75 mmole, 5 equiv.), triethylamine (0.1 cm3), and TDI 
(0.15 	cm3, 	1 .05 	mmole, 	3equiv.). 	5-Hexyl-(2,3 ;4,6-di-O-isopropylidene-,8-D- 
rnannopyranosyl)isoxazole (158) was isolated by dry flash chromatography eluting from 
ether/hexane as an oil (ill mg, 80%); [am'8 —22.0 (c = 1.40, CHC13); 8H  (250 MHz, CDCI3) 
0.82 (3H, t, CH3), 1.19— 1.66 (IOH, m, 6-H to 1OH), 1.25, 1.38, 1.48, 1.50 (12H, 4 x s, 4 x 
CCH3), 3.26 (1H, m, 5'-H), 3.75 (2H, m, 6a'-H, 6b'-H), 3.88 (1H, dd, 4'-H), 4.10 (1 H, dd, 
3'-H), 4.31 (in, dd, 2'-H), 4.92 (IH, d, 1'-H), 6.09 (1 H, s, 4-H); J(x-y)/Hz 1'-2' 2.3, 2'-3' 
5.2, 3'-4' 7.9, 4'-5' 9.9,5'-6a' 5.7, 5'-6b' 10.1, 6a'-6b' nd; 6c (63 MHz, CDC13) 13.9 (C-I 1), 
18.7, 26.2, 28.3, 28.9 (4 x CCH3) 22.3, 26.6, 27.2, 28.6, 31.2 (C-6 to C-b), 61.7 (C-6'), 
70.4, 72.1, 72.6, 75.4, 75.9 (C-I' to C-5'), 99.6, 110.0 (C(CH3)2), 100.6 (C-4), 160.7 (C-3), 
173.6 (C-5); m/z (FAB) Found: M+H, 3 96.23 922 C21H34N06 requires M+H 396.23861. 
3.3.2.9 	Cycloaddition of 2,3 :4,6-di-O-isopropylidene-f3-D- 
mannopyranosylnitrile oxide (118) 	with phenylacetylene 
Sample code: KWB323 
Molecular formula: C21H25N06 
Molecular weight: 387 
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Following the general procedure outlined above, 2,3 :4,6-d iOisopropylidene-13-D-
mannopyranosylnitromethane (130) (250 mg, 0.825 mmole) in dry toluene (30 cm), was 
reacted with phenylacetylene (0.45 cm3, 4.13 mmole, 5 equiv.), triethylarnine (0.2 cm3), and 
TDI (0.41 cm3, 2.89 mmole, 3.5 equiv.). 5phenyl-3-(2,3;4,6-di-O-iSOprOpYlidefle-8-D 
mannopyranosyl)isoxazole (159) was isolated by dry flash chromatography eluting from 
ether/hexane (140 mg, 43%); mp = 137-138°C; [(D18  = -25.0 (c = 0.32 in CHCI3); 31-1 (250 
MHz, CDCI3) 1.25, 1.48, 1.49, 1.51 (12H, 4 x s, 4 x CCH3), 3.29 (1H, in, 5'-T-I), 3.77 - 3.91 
(3H, in, 6b'-H, 6a'-H, 4'-H), 4.13 (1H, dd, 3'-H), 4.37 (IH, dd, 2'-H), 5.00 (IH, d, 1'-1-I), 
6.63 (1H, s, 41-H), 7.19 to 7.74 (5H, in, Ar H); J(x-y)/Hz 1'-2' 2.5, 2'-3' 5.2, 3'-4' 7.7, 4'-5' 
10.2, 5'-6a' 5.8, 5'-6b' 10.1, 6a-6b' 10.7; 6c  (63 MHz, CDCI3), 18.7, 26.2, 28.3, 28.9 (4 x 
Cd-I3), 61.7 (C-6'), 70.5, 72.6, 72.1, 75.4, 75.9 (C-l' to C-5'), 99.7, 110.1(CCH3), 99.5 (C-
4), 125.7, 128.8, 130.1 (Ar CH), 127.2 (Ar H), 161.5 (C-3), 169.7 (C-5); rn/z (FAB) Found: 
M+H, 388.175 19 C21H26N06  requires M+I-1 388.17601, 
3.3.3 Reactions of xylopyranosylnitrile oxides 
3.3.3.1 	Cycloaddition of 3,4,5-tri-O-acetyl--D-xyIopyranoSylflitriIe oxide (116) 
with methylenecyclohexane 
Sample code: KWB 133 
Molecular formula: C19H27N08 
Molecular weight: 397 
Using the usual conditions for the generation of pyranosyl nitrile oxides via Mukaiyarna 
conditions 3,4,5-tri-O-acetyl-j3-D-xylopyranosylnitromethane (128) (250 mg, 0.78 mmole, 
iequiv.) in dry toluene (20 cm) was heated with TDI (2.35 mmole, 0.33 cm3, 3 equiv.), 
triethylamine (0.1 cm3, cat) and methylene cyclohexane (2.35 mmole, 0.3 cm3, 3 equiv.). The 
usual work up yielded a yellow oil which was purified by passing through a short silica pad 
(ether) to give, on removal of solvent in vacuo, 5-(spirocyclohexy!)-3-(2,3,4-tri-O-acetyl-13- 
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D-xylopyranosyl)-2-isoxazoline as white solid (160) (240 mg, 78%); [a]D18 —82.6 (c = 0.47, 
CHCI3); mp 199-200°C; 6H (250 MHz, CDC13) 1.24 —1.77 (1 OH, m, 6-H to 10-H), 2.01, 2.04, 
2.04 (9H, 3 X S, 3 X COCH3), 2.73 (2H, 2 X d, J4n,4b  17.2 4a-H, 4b-H), 3.36 (IH, t, Saq'-H), 
4.14 (IH, dd, Seq'-H), 4.22 (1-H, d, 1'-H), 4.99 (211, in, 4'-H, 2'-H), 5.28 (IH, dd, 3'-H); 
J(x-y)/Hz P-2' 9.9 2'-3' nd, 3'-4' iid, 4'-5ax' 10.7, 4'-5eq' 5.6, Sax'-Seq' 11.2; 6c (63 MHz, 
CDCI3) 20.96, 21.1 (3 x COCH3), 23.7, 25.3, 36.6, 36.9 (C-6 to C-b), 42.8 (C-4) 67.1 (C-
5'), 69.3, 69.4, 73.2, 75.5 (C-l' to C-4'), 87.8 (C-5), 154.8 (C-3), 170.2, 170.3, 170.3 (3 x 
COCH3); m/z (FAB) Found: M+H, 398.18061 C19H28N08 requires M'-+H 398.18149. 
3.3.3.2 	Cycloaddition of 3,4,5-tri-O-acetyl-3-D-xylopyranosylnitrile oxide (116) 
with styrene 
Sample code: KWB219 
Molecular formula: C20H23N08 
Molecular weight: 405 
Following the general procedure 
OAc 
outlined 	above, 	3 ,4,5-tri-O-acetyl-13-D- 
xylopyranosylnitromethane (128) (990 mg, 3.1 rnmole) in dry toluene (50 cm) was reacted 
with styrene (1.78 cm 3,  15.5 mmole, 5 equiv.), triethylamine (0.3 cm3) and TDI (1.34 cm 
1, 
9.3 mmole, 3 equiv.) to give 5(R)- and 5(S)-(spirocyclohexyl)-3-(2,3,4-tri-O-acetyl-/3-D-
xylopyranosyl)-2-isoxazoline (161) as a white solid (700mg, 60%) in a 55:45 ratio 
determined by '3C NMR; ö (250 MHz, CDCI3) major isomer: 1.96, 1.98, 1.98 (9H, 3 x s, 3 
x COCH3), 2.96 (1H, dd, 4a-H), 3.30 (1H, dd, 5a'-H), 3.43 (111, rn, 4b-H), 4.07 (111, dd, 5b'-
H), 4.26 (1H, d, 1'-H), 4.89 - 5.02 (211, m, 2'-H, 4'-H), 5.25 (1H, dd, 3'-H), 5.48 (1H, t, 5-
H), 7.22-7.32(5H, m, ArH);J(x-y)/Hz 1'-2' 9.9, 2'-3' 9.5, 3'-4' 9.5, 4'-5ax' 11.0, 4'-5eq' 
5.7, Sax'-Seq' 11.2. 4a-4b 17.3, 4a-5 8.6 4b-5 11.0; 6c (63 MHz, CDCI3): 20.2, 20.3, 20.7 (3 
x COCH3), 40.4 (C-4), 66.3 (C-6'), 68.5, 68.8, 72.2, 74.0, 82.0 (C-l' to C-5'), 125.6, 127.9, 
128.3 (aromatic C-H), 140.0 (aromatic quat), 154.9 (C-3), 169.5, 169.6, 169.7 (3 xCOCH3); 
m/z (FAB) Found: M+H, 406.15019 C20H24N08 requires M+1-1 406.15019. 
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3.4 	Nitrite oxide cycloadditions: Generation of pyranosylnitrile oxides from 
pyranosyl aldoximes 
The nitrite oxides were generated by oxidation of their corresponding oxirnes in situ using a 
modified version of the procedure of Lee et al.19 The general conditions used were as 
follows: 
GENERAL PROCEDURE: Aqueous sodium hypochlorite (5%, 16.2 mrnole, 60 equiv.) was 
added drop-wise to a stirred solution of the pyranosylforrnaldoxime (0.26 mrnole, I equiv.) 
in H20/CH2C12 (1:1, 20 cm) with the alkene (5 equiv.). After vigorous stirring overnight the 
organic layer was separated and the aqueous layer extracted with chloroform (3 x 50 cm 
3). 
The combined organic layers were dried (MgSO4), and the solvent removed in vacuo to yield 
the product, which was recrystallised from the appropriate solvent 
3.4.1 Reactions of glucopyranosytnitrile oxides 
3.4.1.1 	Cyctoaddition of 3,4,5,7-tetra-0-acetyl-3-D-glucopyranosylformonitritC 
oxide (115), with methylenecyclohexane via the hypochiorite method. 
Sample code:KWBI2 
Molecular formula:C22H3 1N06 
Molecular weight: 469 
3,4,5,7-tetra-0- acetyl-3-D-glucopyranosy1aldoxime (139) (100 mg, 0.26 rnmole, 1 equiv.) 
and methylenecyclohexane (0.13 cm3, 1.06 mmole, 4 equiv.) were reacted according to the 
general procedure above. The product (147), was isolated by dry flash chromatography (77 
mg, 62%), as was the furoxan (162) (60 mg, 30% yield). For analysis see section 3.3.1.1 
3.4.2 Reactions of mannopyranosylnitrile oxides 
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3.4.2.1 	Cycloaddition 	 of 
	
3,4,5,7-tetra-0-acetyl-13-D- 
mannopyranosylformonitrile oxide(1 17) with styrene via the 
hypochlorite method. 
Sample code: KWB24 
Molecular formula: C23H27N010 
Molecular weight: 477 
3,4,5,7-tetra-0- acetyl-3-D-mannopyranosylnitromethane (138) (100 rng, 0.27 mmole, 1 
equiv.), and styrene (0.12 cm3, 1.05 mmole, 4 equiv.) were reacted using the reaction 
conditions outlined above. (5R)- and (5S)-phenyl-3-(2,3,4,6 tetra-0-acetyl-/3-D-
mannopyranosyl)-2-isoxazoline (146) was isolated by dry flash chromatography (94 rng, 
85%), along with recovered starting material (138) (13 mg, 0.04mrnole), and a trace of 
furoxan (164). For analysis see section 33.2.1. 
3.4.2.2 	Cycloaddition of 2,3 :4,6-di-O-isopropyIidene-3-D- 
mannopyranosylnitrile oxide with methylenecyclohexane 
Sample code: KWB85 
Molecular f6rmula:C20H32N106 
Molecular weight: 381 
8 
2,3 :4,6-Di-O-isopropylidene-f3-D-rnannopyranosylnitromethane (130) (60 mg, 0.21 mmole) 
and methylencyclohexane (0.1 cm3, 0.84 mmole, 4 equiv.) were reacted using the reaction 
conditions 	outlined 	above. 	5 -(Spirocyclohexyl)-3 -(2,3 ;4 ,6-di-O-i sopropyIidene-8-D- 
rnannopyranosyl)-2-isoxazoline (155) was isolated by dry flash chromatography eluting from 




3.5 	Nitrite oxide cycloadditions: Dehydrohaolgenation of pyranosyl hydroximoyl 
chloride route 
The nitrile oxide was generated in situ from the hydroximoyl chloride by 
dehydrochlorination using triethylamine. The general conditions used are outlined below. 
GENERAL PROCEDURE.To a solution of the pyransoyl hydroximoyl chloride (0.22 
mmole, 1 equiv.) and alkene/alkyne (1.1 mmole, 5 equiv.) in dry ether (10 cm 3), 
triethylamine (0.25 rnmole, 1.1 equiv.) in dry ether (20 
CM),  was added drop-wise via 
syringe pump over a 24 hour period and the solution left to stir for a further 10 hours. The 
mixture was then poured into water, the organic layer separated and the aqueous layer 
extracted with chloroform (3 x 50 cm3). The combined organic layers were dried (MgSO4), 
and the solvent removed in vacuo. The product was isolated from by-products by dry flash 
chromatography eluting from ether/hexane and/or recrystallisation. 
3.5.1 	Cycloaddition 	reaction 	of 	3,4,5,7-tetra-0-13-D- 
mannopyranosylformonitrile (117) oxide with DMAD 
Sample code: KWB30 
Molecular formula: C211-125N014 
Molecular weight: MW 515 
CO2Me 
OAc 
Triethylamine (0.04 cm 3,  0.3 mmole) in dry ether (20 cm 
3),  was added to DMAD (140 mg, 
0.98 mmole, 4 equiv.) and the hydroximoyl chloride (143) (100 mg, 0.245 mmole, 1 equiv.) 
in dry ether (20 cm3), as described in the general procedure above. Dimethyl 3-(2,3,4,6-tetra-
O-acetyl-/3-D-rnannopyranosyl)isoxazole-4,5-dicarboxylate (163) was separated from by-
products by dry flash chromatography using ether/hexane elutant. The product was 
recovered as an oil (89 mg, 70%). Furoxan (164) was obtained (14 mg, 15.4%); [a]D'8 —35.7 
(c = 0.84, CHCI3); oH (360 MHz, CDCI3) 1.97, 2.03, 2.04, 2.05 (12H, 4 x s, 4 x COCH3), 
3.82, (1H, ddd, 5'-H), 3.8 8, 3.95 (6, 2 x s, 2 x COCH3), 4.14 (1H, dd, 6a'-H), 4.24 (1H, dd, 
6b'-H), 5.15, (IH, d, l'-H), 5.20, (1H, dd, 3'-H), 5.28, (1H, dd, 4'-H), 5.78 (1H, dd, 2'-H); 
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J(x-y)/Hz P-2' 1.0, 2'-3' 3.3, 3'-4' 10.0, 4'-5' 9.8, 5'-6a' 2.4, 5'-6b' 5.9, 6a'-6b' 12.4; 5c  (90 
MHz, CDCI3) 20.4, 20.5, 20.5, 20.6, (4 x CO2CI-13), 52.8, 53.4, (2xCH3), 62.5 (C-6'), 65.7, 
67.8, 71.5, 72.1, 77.0 (C-l'to C-5'), 156.1 (C-3), 158.3 (C-5, C-4), 160.0, 160.2 (2 x 
CO2CH3), 169.4, 169.8, 169.9, 170.5 (4 x COCH3); m/z (FAB) Found: M+H, 516.13626. 
C21 H26N014 requires M+H 516.13533. 
3.5.2 	Cycloaddition reaction of 3,4,5,7-tetra-0--D- 
mannopyranosylformonitrile oxide (117), with ethyl propiolate 
Sample code:KWB23 
Molecular formula:C20H25N012 
Molecular weight: 472 
OAc 
Triethylamine (0.57 cm', 0.4 mmole, 1.1 equiv.), was added to ethyl propiolate (158 mg, 1.8 
mmole, 5 equiv.), and hydroximoyl chloride (143), (150 mg, 0.37 mmole, 1 equiv.), in dry 
ether (15 cm3), according to the general procedure above. 3-(2,3,4,6-Tetra-O-acetyl-/3-D- 
mannopyranosyl)-5-ethylester-isoxazole 	(165a) 	and 	3-(2,3 ,4,6-tetra-O-acetyl-/3-D- 
mannopyranosyl)-4-ethylester-isoxazole (165b) were separated from by-products by dry 
flash chromatography using ether/hexane elutant as a mixture of two isomers in a 7: 1 ratio 
(138 mg, 79%). Furoxan (164) was obtained (30 mg, 10%); oH (250 MHz, CDC13) for major 
adduct 1.38 (3H, I x t, CH2CH3), 1.96, 2.04, 2.05, 2.07 (12H, 4 x s, 4 x COCH3), 3.85, (1H, 
ddd, 5'-H), 4.16 (IH, dd, 6a'-H), 4.26 (1H, dd, 6b'-H), 4.40, (2H, 1 x q, CH2CH3), 4.98, (1H, 
d, 1'-H), 5.19, (IH, dd, 3'-H), 5.30, (1H, dd, 4'-H), 5.65 (IH, dd, 2'-H), 6.97, (1H, s, 4-H); 
J(x-y)/Hz 1'-2' 1.3, 2'-3' 3.2, 3'-4' 10. 1, 4'-5' 9.7, 5'-6a' 2.4, 5'-6b' 5.8, 6a-6b' 12.3; oc  (63 
MHz, CDC13), 14.0, (CH2CH3), 20.5, 20.6, 20.6 (4 x COCH3), 62.4 (C6'), 65.4, 69.3, 71.5, 
72.0, 76.8 (C-l'to C-5'), 108.4 (C-4), 156.3, (C-3), 160.6 (C-5), 160.9 (COCH2CH3), 169.5, 
169 
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169.9, 170.5 (4 x COCH3); m/z (FAB) Found: M+H, 472.14599 C20H26N012 requires M+H 
472.14550. 
3.5.3 Cycloaddition of 3,4,5,7tetra-0-p-D-mannopyraflOSyIfOrmOflitriIe oxide (117) 
with styrene 
Sample code: KWB27 
Molecular formula: C23H27N010 
Molecular Weight: 477 
Triethylamine (0.07cm3, 0.05 mmole, 1.4 equiv.), in dry ether (40 
CM),  was reacted with the 
hydroximoyl chloride (143) (133 mg, 0.245 mmole), and styrene (0.2 cm3, 1.24 mmole, 5 
equiv.), in dry ether (15 cm3), according to the general procedure outlined above. Removal of 
the solvent in vacuo gave (5R)- and (5S)-phenyl-3-(2,3,4,6 tetra-0-acetyl-/3-D-
mannopyranosyl)-2-isoxazoline (146), as a mixture of inseparable isomers (152 mg, 98% 
yield) in a ratio of 56:44%. For analysis see section 3.3.2.1 
3.5.4 Cycloaddition of 3,4,5,7tetra0-I3-D-mannopyranosylformOflitri1e oxide (117) 
with oct-1-ene 
N—O 
Sample code: KWB34 
Molecular formula: C23H33N010 
(0
166  Molecular weight: 483 
AcO" OAc 
OAc 
Triethylamine (0.04 cm3, 2.88 mmole, 1.2 equiv.), in dry ether (40 cm') was reacted with 
oct-1-ene (4.8 mmole, 20 equiv.), and the hydroximoyl chloride (143) (0.24 mmole, I 
equiv.) in dry ether (15 CM).  (5R)- and (5S)-5-Hexyl-3-(2,3,4,6- tetra-0-acety1-3-D- 
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mannopyranosy!)-2-isoxazoline (166) were separated from by-products using dry flash 
chromatography, eluting with ether/hexane (96 mg, 86.6%). Furoxan (164) was obtained as a 
by-product (10 rng, 11.%). For analysis see section 3.3.2.2. 
3.5.5 Cycloaddition of 3,4,5,7-tetra-0-3Dmannopyranosylformonitrile oxide (117) 
with cyclohexenone 
N—O 
Sample code: KWB35 
Molecular formula: C21H27N011 
Molecular weight: 469 
OAc 
Triethylamine (0.05 cm3, 0.3 mmole, 1.2 equiv.) in dry ether (40 cm 
3),  was reacted with 
cyclohex-2-enone (0.1cm3, 1 mmole, 4 equiv.) and hydroximoyl chloride (143) (105 mg, 
0.25 mmole. I equiv.) in dry ether (15 cm3), as outlined in the general procedure above. 3-
(2,3 ,4,6-Tetra-O-acetyl-8-D-mannopyranosyl)-3 a,5 ,6,7a-tetrahydro-4H-benzo [d] isoxazol-7-
one (167) was isolated using dry flash chromatography in a (95 mg, 79%). A by-product was 
detected which was believed to be the nitrile; oH (360 MHz, CDCI3) 1.87 (6H, m, 5-H to 7-H 
), 2.00, 2.05, 2.10, 2.14 (12H, 4 x s, 4 x COCH3), 3.75 (1H, d, 3a-H), 3.79, (II-!, ddd, 5'-H), 
4.14 (1H, dd, 6a'-H), 4.27 (111, 6b'-H), 4.75, (111, s, J'-H), 4.87 (111, m, 7a-H), 5.14, (IH, 
dd, 3'-H), 5.29, (1H, dd, 4'-H), 5.66 (1H, dd, 2'-H); J(x-y)/1-Iz 1'-2' 1.0, 2'-3' 3.4, 3'-4' 9.9, 
4'-5' 10.0, 5'-6a' 2.2, 5'-6b' 5.4, 6a'-6b' 12.4; Oc  (90 MHz, CDC13), 21.0, 21.1, 21.1, 21.2 (4 
x COCH3),18.5, 26.4, 40.3 (C-5, C-6, C-7), 59.6 (C-7a), 63.0 (C-6'), 66.4, 68.3, 72.1, 74.4, 
77.5 (C-l'to C-5'), 81.8 (C-3a), 152.9 (C-3), 170.0, 170.4, 171.0, 171.1 (4 x COCH3), 205.7 
(C-8); rn/z (FAB) Found: M+H 470.16757 C21H28N011 requires 470.16624. 
3.5.6 Cycloaddition of 3,4,5,7tetra-0-3-D-mannopyranosylformonitri1e oxide (117) 
with ethyl cyanoformate 
Sample code: KWB 26 
Molecular formula: C19H24N2012 





Triethylamine (0.05 cm 3,  0.44 mmole, 1.2 equiv.), in dry ether (40 
CM),  was reacted with 
ethyl cyanoformate (0.1 8 cm3, 0.185 mmol, 5 equiv.), and the hydroximoyl chloride (143) 
(125 mg, 0.37 mmole, I equiv.) in dry ether (15 cm'), as described in the general procedure 
above. The products were isolated using dry flash chromatography eluting with ether/hexane. 
The 	5-ethylester-3 -(2,3 ,4,6-tetra-O-acetyl-/3-D-mannopyranosyl)- 1 ,2,4-oxadiazole (168), 
was isolated (11 mg, 7%) although trace impurities made full characterisation impossible. 
The dominant product was the furoxan (164) (80 mg 58%) yield. 
3.5.7 Cycloaddition 3,4,5,7-tetra-0--D-mannopyranosylformOflitrile oxide (117) 
with ethyl cyanoformate at elevated temperature. 
Sample code:KWB36 
Molecular formula: C19H24N2012 
Molecular weight: 472 
OAc 
The dipolarophile (0.5 cm', 5.22 mmole, 18 equiv.) and hydroximoyl chloride (143), (120 
mg, 0.29 mmole, 1 equiv.) were dissolved in dry THF and the solution degassed. The system 
was then heated to 70°C. To this solution triethylamine (0.05 cm3, 0.35 mmole, 1.2 equiv.), 
in dry THF was added via syringe pump over a 24hr period. The resulting solution was 
washed with water, the organic layer isolated and the aqueous layer extracted with ether. The 
organic layer was dried (MgSO4), and the solvent removed in vacuo. 5-Ethylester-3-(2,3,4,6-
tetra-O-acetyl-8-D-mannopyranosyl)-1,2,4-oxadiazole (168), was isolated using dry flash 
chromatography eluting with ether/hexane (20 mg, 14.5%). The major product was the 
furoxan (164) (70 mg, 65%); 6H  (360 MHz, CDCI3), 1.43 (3H, 1 x t, CH2CH1 1.99, 2.06, 
2.0 8, 2.10 (12H, 4 x s, 4 x COCH3), 3.87, (1H, ddd, 5'-H), 4.23 (1H, dd, 6a'-H), 4.33 (1H, 
dd, 6b'-H), 4.5 0, (2H, 1 x q, CH2CH3), 5.00, (1H, d, 1'-H), 5.20, (1H, dd, 3'-H), 5.3 6, (1H, 
dd, 4'-H), 5.77 (IH, dd, 2'-H); J(x-y)/I-Iz 1'-2' 1.0, 2'-3' 3.0, 3'-4' 10.1, 4'-5' 10.3, 5'-6a' 
3.0, 5'-6b' 5.5, 6a-6b' 12.5; & (90 MHz, CDCI3), 14.4, (CH2CH3), 21.0 21.1, 21.1, 21.2 (4 x 
COGH3), 63.0, (cH2CH3), 63.0 (C-6'), 64.5, 66.0, 68.5, 72.0, 77.6 (C-l'to C-5'), 154.0, (C-
3), 167.4 (COCH2CH3), 170.0, 170.4, 170.5, 171.1 (4x COCH3); m/z (FAB) Found: M+H, 
473.14105 C19H25N2012 requires M+H 473.14075. 
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3.5.8 Cycloaddition 3,4,5,7-tetra-0-3-D-mannopyranosylformonitrile oxide (117), 
with cyclohexenone at elevated temperature 
Sample code: KWB37 
Molecular formula: C15H20N09 
Molecular weight: 357 





The alkene, (0.2 cm3, vast excess), and hydroximoyl chloride (143) (120 rng, 0.29 mmole, 1 
equiv.), were dissolved in dry THF and the solution degassed. The system was then heated to 
70°C. To this solution triethylamine (0.05 cm 3, 0.35 mmole, 1.2 equiv.) in dry THF was 
added via syringe pump over a 241ir period. The resulting solution was washed with water, 
the organic layer isolated and the aqueous layer extracted with ether. The organic layer was 
dried (Mg504), and the solvent removed in vacuo. The resulting products were isolated by 
dry flash chromatography. The major product was 3,4,5,7-tetra-O-acetyl-2,6-anhydro-D-
glycero-D-galacto-heptonitrile (168) (60 mg, 58%), with the desired product (169) only 
observed in trace amounts by TLC. Furoxan (164) was isolated (28 mg, 25%); 6H  (250 MHz, 
CDCI3), 1.99, 2.04, 2.10, 2.24 (12H, 4xs, 4x COCH3), 3.68, (1H, ddd, 6-H), 4.14 (1H, dd, 
7a-H), 4.24 (1H, dd, 7b-H), 4.56, (IH, d, 2-H), 5.02, (1H, dd, 4-H), 5.24, (1H, dd, 5-H), 5.60 
(I H, dd, 3-H); J(x-y),/Hz, 2-3 1.5, 3-4 3.4, 4-5 10.0, 5-6 9.8, 6-7a 2.5, 6-7b 5.7, 7a-7b 12.6; 
öc (90 MHz, CDCI3), 20.37, 20.42, 20.48, 20.61 (4 x COCH3), 61.95 (C-7), 64.6, 66.6, 67.4, 
70.4, 76.9 (C-2, to C-6), 113.3 (C-i), 169.3, 169.5, 169.8, 170.5 (4 x COCH3). 
3.5.9 Cycloaddition of 3,4,5,7-tetra-0-3-D-mannopyranosylformonitrile oxide (117) 
with phenylacetylene 
Sample code:KWB39 
Molecular formula: C23H25N010 
Molecular weight: 475 
OAc 
Triethylamine (0.04 cm3, 0.294 mmole) in dry ether (10 cm) was reacted with phenyl 
acetylene (0.14 cm3, 1.225 mmole, 5 equiv.) and the hydroximoyl chloride (143) (100 mg, 
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0.245 mmole, I equiv.) as described in the general procedure above. 5-Phenyl-3-(2,3,4,6-
tetra-0-acety!-/3-D-mannopyranosy!)isoxazole (170) was isolated as a white crystalline solid 
using dry flash chromatography, eluting from ether/hexane (43 mg, 37% yield). Furoxan 
(164) was obtained as a by-product (32 mg, 35%); mp 167-168°C; oH (250 MHz, CDCI3) 
1.99, 2.06, 2.07, 2.10 (12H, 4 x s, 4 x COCH3), 3.85, (IH, ddd, 5'-H), 4.20 (1H, dd, 6a'-H), 
4.33 (IH, dd, 6b'-H), 4.96, (1H, d, 1'-H), 5.20, (IH, dd, 3'-H), 5.34, (IH, dd, 4'-H), 5.72 
(1H, dd, 2'-H), 6.56, (IH, s, 4-H), 7.60, (5H, m, aromatic); J(x-y)/Hz 1'-2' 1.3, 2'-3' 3.3, 3'-
4' 9.8, 4'-5' 9.6, 5'-6a' 2.4, 5'-6b' 5.9, 6a'-6b 12.4; 0c  (90 MHz, CDCI3), 20.5, 20.6, 20.6, 
20.7 (4 x COd-I3), 62.7 (C-6'), 65.6, 69.4, 71.7, 72.6, 76.7 (Cl'to CS'), 98.3 (C-4), 125.7, 
128.9, 130.3 (aromatic C-H), 126.9 (aromatic quat), 160.7 (C-3), 169.9 (C-5), 169.6, 169.9, 
170.2, 170.6 (4 x COCH3). m/z (FAB) Found: M+H, 476.15621. C23H26N010 requires 
M+H 476.15567. 
3.5.10 Cycloaddition of 3,4,5,7-tetra-0-0-D-mannopyranosyIformonitrile oxide (117), 
with ally! alcohol. 
Sample code: KWB53 
Molecular fromula: C18H25N011 
Molecluar weight: 431 
Triethylamine (0.03 cm 3,  0.021 mmole), in dry ether (10 cm') was reacted with ally! alcohol 
(0.06 cm3, 0.88 mmole, 5 equiv.) and hydroximoyl chloride (143) (72 mg, 0.176 mmole, 1 
equiv.) in dry ether (15 cm3), TLC of the oil produced showed three products. These were 
isolated by dry flash chromatography yielding, in order of elution, a unknown product 
(10mg), probably unreacted oxime (138), carried through from the chlorination reaction, the 
furoxan (164), (15 mg, 14 %), and finally the 5-methanol-3-(2,3,4,6-tetra-O-acetyl-fl-D-
mannopyranosyl)-2-isoxazoline (171), as a white crystalline solid (20 mg, 30%) in a 50:50 
ratio, determined by 13C NMR; mp 136-138 °C 	(250 MHz, CDCI3), 1.97, 2.05, 2.08, 2.14 
(12H, 4 x s, 4 x COCH3), 3.04 (2H, m, 4a-H, 4b-H), 3.47, (1H, m, 6a-H), 3.76 (2H, m, 5'-H, 
lb-H), 4.16 (1H, dd, 6a'-H), 4.26 (IH, dd, 6W-H), 4.60, (IH, d, l'-H), 4.67 (IH, rn, 5-H), 
5.11, (1H, dd, 3'-H), 5.25 (IH, dd, 4TH), 5.55 (1H, dd, 2-H); J(x-y)/I-Iz 1'-2' 1. 1, 2'-3' 3.3, 
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3'-4' 10.1, 4'-5' 9.8, 5'-6a' 2.6, 5'-6b' 5.7, 6a-6b' 12.4; öc (90 MHz, CDC!3), 21.0, 21.1, 
21.2 (4 x COCH3), 30.1 (C-6), 36.9 (C-4), 63.1 (c-I), 63.9 (c-6), 66.1, 69.3 , 70.5, 72.0, 
73.8 (C-l' to C-5'), 81.0 (c-5), 156.6 (c-3), 170.1, 170.4, 171.1 (4x cod 3). m/z (FAB) 
Found: M*+H,  432.14988. d18H26NO11  requires M+H 432.15059. 
3.6 	Dimerisation of pyranosylnitrile oxides to dipyranosyl-1,2,5-oxadiazole-2-oxides 
(furoxans) 
The furoxans were prepared by dimerisation of the corresponding nitrile oxides, which were 
generated either by dehydration of the pyranosylnitromethane (Method A), or 
dehydrogenation of the pyranosylformaldoxime (Method B), or dehydrochiorination of the 
pyranosyl hydroximoyl chloride (Method Q. 
Method A. To a solution of the pyranosylnitromethane (0.5 mmole, 1 equiv.) in dry toluene 
(20 cm) under nitrogen was added triethylamine (0.1-0.2 cm3) and tolylene diisocyanate (3 
equiv.), and the mixture heated under reflux for seven days. After cooling to 0 °c 1,2-
diaminoethane (3 equiv.) was added drop-wise with stirring. After one hour the mixture was 
filtered through a celite pad to remove the precipitated polymeric urea. The pad was washed 
with toluene and chloroform and the combined organic layers evaporated to afford the 
product, which was purified by chromatography and/or recrystallisation. 
Method B. Aqueous sodium hypochlorite (5%, 16.2 mmole, 60 equiv.) was added drop-wise 
to a stirred solution of the pyranosylformaldoxime (0.26 mmole, 1 equiv.) in H20/CH2Cl2 
(1:1, 20 CM)  . After stirring overnight the organic layer was separated and the aqueous layer 
extracted with chloroform (3 x 50 cm3). The combined organic layers were dried (MgSO4) 
and the solvent removed in vacuo to yield the product, which was recrystallised from the 
appropriate solvent. 
Method C. To a solution of the pyransoyl hydroxirnoyl chloride (0.22 mmole, 1 equiv.) in 
dry ether (10 CM),  triethylamine (0.25 mmole, 1.1 equiv.) was added drop-wise via a syringe 
and the solution left to stir overnight. The mixture was then poured into water, the organic 
layer separated and the aqueous layer extracted with chloroform (3 x 50 
CM)  . The combined 
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organic layers were dried (MgSO4) and the solvent removed in vacuo to yield the product, 
which was purified by recrystallisation. 
3.6.1 Synthesis of 3,4-di(2,3 :4,6-di-O-isopropylidene-3-D-mannopyranosyI)-1 ,2,5-
oxadiazole 2-oxide (177) 
Sample code: KWB80 
Molecular formula: C20H39N2012  
Molecular weight: 570 
Using the procedure outlined in method A, 2,3:4,6-di-0-isopropylidene-3-D-
mannopyranosylnitromethane (130) (220 mg, 0.73 mmole) in dry toluene (20 cm) was 
reacted with triethylamine (0.1 cm3) and TDI (0.31 cm3, 2.19 rnrnole, 3 equiv.) to yield a 
white solid (177) (190 mg, 92%); mp 131-133 °C (from hexane); (Found: C, 54.7; H, 6.8, N, 
4.8. C20H38N2012 requires C, 54.7; H, 6.7, N, 4.9); [aID '8 29.1 (c = 0.23, CHCI3); vinax/cfli'  
(Nujol) 1606 (C=N); 6H  (600 MHz, CDC13) 1.35, 1.37, 1.48, 1.48, 1.57, 1.58, 1.58, 1.64 
(24H, 8 x s, 8 x CCH3), 3.28 (1H, dt, 5"-H), 3.33 (1H, dt, 5'-H), 3.73 (1H, t, 6ax'-H), 3.80 
(IH, dd, 4'-H), 3.90 (1H, t, 6ax"-H), 3.97 (dd, 4"-H), 3.99 (IH, dd, 6eq"-H), 4.01 (1H, dd, 
6eq'-H), 4.18 (IH, dd, 3"-H), 4.21 (111, dd, 3'-fl), 4.53 (IH, t, 2'-H), 4.54 (IH, t, 2"-H), 5.05 
(H, d, 1'-H), 5.21 (1H, d, 1"-H);J(x-y)/Hz 1'-2' 2.6, 2'-3' 5.2, 3'-4' 7.9, 4'-5' 10. 1, 5'-6ax' 
10.7, 5'-6eq' 5.5, 6ax'-6eq' 10.2, 1"-2" 2.4, 2"-3" 5.1, 3"-4" 7.9, 4"-5" 10. 1, 5"-6ax" 10.7, 
5"-6eq" 5.5, 6ax"-6eq" 10.1; 6H  (600 MHz, CD3COCD3) 1.31, 1.32, 1.35, 1.36, 1.52, 1.53, 
1.54, 1.56 (24H, 8 x s, 8 x CCH3), 3.39 (1H, dt, 5"-H), 3.48 (1H, dt, 5'-H), 3.82 (1H, t, 6ax"-
H), 3.85-3.96 (5H, m, 4'-H, 4"-H, 6ax'-H, 6eq'-H, 6eq"-H), 4.19 (1H, dd, 3"-H), 4.28 (1H, 
dd, 3'-H), 4.64 (1H, dd, 2"-H), 4.68 (1H, dd, 2'-H), 5.31 (H, d, 1'-H), 5.46 (1H, d, 1"-H); 
J(x-y)/Hz 1'-2' 2.7, 2'-3' 5.3, 3'-4' 7.9, 4'-5' 10.0, 5'-6ax' 10.0, 5'-eq' 5.7, 6ax"-6eq" rid, 
1"-2" 2.5, 2"-3" 5.2, 3"-4" 7.9, 4"-5" 10.0, 5"-6ax" 10. 1, 5"-6eq" 5.7, 6ax7-eq" 10.7; 3c  (63 
MHz, CDCI3) 18.7, 18.7, 26.4, 27.3, 28.3, 28.4, 28.7, 28.9 (8 x CCH3), 61.5, 61.6, 71. 1, 
71.4, 72.3, 72.5, 72.6, 73.8, 75.4, 75.8 (C-l' - C-5', C-l" - C-5"), 61.5, 61.6 (C-6', C-6"), 
99.9, 100.0, 110.4, 110.5 (4 x CCH3), 112.x (C-3), 153.1 (C-4); m/z (FAB) Found: M+i, 
571.24946. C20H39N2012  requires 571.25030. 
176 
Experimental Procedures 
3.6.2 Synthesis of 3,4-Di(2,3,4-tri-O-acetyl--D-xy1opyranosyl)-1 ,2,5-oxadiazole 2-
oxide (178). 
Sample code: KWB258 
Molecular formula: C24H32N2016 
Molecular weight: 602 
Using the procedure outlined in method A, 2,3,4-tri-O-acetyl-f3-D-xylopyranosyl 
nitromethane (128) (1.0 g, 3.13 mmole) in dry toluene (30 cm) was reacted with 
triethylarnine (0.5 cm3) and TDI (1.56 cm3, 10.97 mmole. 3.5 equiv.) to yield an oil which 
was purified by dry flash chromatography eluting from ether hexane to give a white solid 
(178) (760 mg, 81%); inp 190 °C; [U]D'8 -33 (c = 1.0, CHCI3); v iiax/cm (Nujol) 1759 
(C0), 1600 (C=N); oH (250 MHz, CDCI3) 1.94, 2.03, 2.06, 2.07, 2.07 (18H, 6 x s, 6 x 
COCH3), 3.40-3.52 (2H, m), 4.10-4.22 (1H, m), 4.29-4.38 (111, m), 4.62 (2H, 2 x d, J1 ' 2' 
9.5, j12 9.6, 1'-H, 1"-H), 5.00-5.10 (2H, m), 5.28-5.43 (4H, m); 0c  (63 MHz, CDCI3) 20.0, 
20.3, 20.5 (6 x COCH3), 66.9, 66.9 (C-6', C-6"), 68.3, 69.7, 70.2, 71.6, 72.3, 72.4, 73.9, 76.3 
(C-I' - C-5', C-I" - C-5"), 112.7 (C-3), 153.7 (C-4), 169.3, 169.5, 169.6, 169.8, 169.9 (6 x 
COCH3); ni/z (FAB) 603 (M+1) 543 [(M-N202)+1]; m/z (FAB) Found: M+1, 603.17504. 
C24H33N2016 requires 603.175 18. 
3.6.3 Synthesis of 3,4-Di(2,3,4,6-tetra-O-benzyI-3-D-g1ucopyranosy1)-1 ,2,5-oxadiazole 
2-oxide (180) 
Sample code: KWB289 
Molecular formula: C70H70N2012 
Molecular weight: 1130 
Using the procedure outlined in method A, 2,3,4,6-tetra-0-benzyl-3-D-glucopyranosyl 
nitromethane (131) (105 mg, 0.18 mmole) in dry toluene (15 cm3) was reacted with 
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triethylamine (0.1 cm3) and TDI (0.09 cm 
3,  0.63 mmole, 3.5 equiv.) to yield an oil which 
was purified by dry flash chromatography eluting from ether hexane to give colourless oil 
(180) (56 mg, 55%); [U]D18 —4.9 (c = 0.82, CHC13); v,Jcrn' (CHC13) 1529 (C=N); 61 (250 
MHz, CDC13) 3.30 - 3.91 (12H, rn, 2'-I-I to 6'-H, 2"-H to 6"-H), 4.20 - 4.91 (18H, in, 
ArCI-12, 1'-H, 1"-H), 6.97— 7.32 (40H, in, ArH); 6c  (63 MHz, CDC13) 68.0, 68.6, 73.4, 74.8, 
75.8, 76.0 (ArCH2), 75.2, 75.5, 77.2, 77.6, 77.7, 79.1, 79.3, 79.8, 86.9 (Cl'- CS', Cl" - 
CS"), 114.1 (0), 127.6, 127.7, 127.8, 128.0, 128.3, 128.6 (ArH), 137.1, 137.3, 137.5, 
137.8, 138.0, 138.3 (ArC), 154.9 (C4); m/z (FAB) Found: M+1, 113 1.49975. C70H71N2012 
requires 1131.50070. 
3.6.4 Synthesis of 3,4-Di(2,3,4-tri-O-acetyl-3-L-fucopyranosy1)-1,2,5-oxadiazole 2-
oxide (179). 
Sample code KWB200 
Molecular formula: C26H34N2016 
Molecular weight: 630 
 
OAc 	 OAc 
Using the procedure outlined in method A, 2,3,4-tri-O-acetyl-13-L-
fucopyranosylnitromethane (129) (70 mg, 0.2 mmole) in dry toluene (15 cm) was reacted 
with triethylamine (0.1 cm3) and TDI (0.15 cm 
3,  0.7 mrnole, 3.5 equiv.) to give an oil which 
was purified by preparative HPLC (50:50 ethyl acetate / hexane) to give a white solid (50 
mg, 79%); mp 212-214 °C (from hexane-EtOAc); [aID18 27.8 (c = 0.29, CHCI3); oH (600 
MHz, (CD1)2C0) 1.20 (3H, d, CH3'), 1.25 (311, d, CH3") 1.95, 1.95, 1.96, 1.96, 2.22, 
2.23(18H, 6 x s, 6 x COCH3), 4.21 (1 H, dd, 5'-H), 4.28 (1H, dd, 5"-H), 5.06 (1H, d, 1'-H), 
5.11 (1H, d, 1"-H), 5.29 (1 H, dd, 3'-H), 5.31 (1H, dd, 3"-H), 5.33 (1 H, dd, 3'-H), 5.38 (1H, 
dd, 4'-H), 5.38 (1H, dd, 4"-H), 5.53 (1H, t, 2'-H), 5.67 (1H, t, 2"-H); J(x-y)/Hz 1'-2' 10.1, 
2'-3' 1.0, 3'-4' 3.4, 4'-5' 1.0, 5'-6' 6.4, 1"2" 10.1, 2"-3" 1.0, Y7-451 3.41 41'-511 1.0, 5"-6" 6.4; 
Oc (63 MHz, CDC13) 16.7, 16.8 (2 x CH3), 20.8, 21.0, 21.1, 21.2 (6 x COCH3), 66.4, 67.0, 
70.7, 70.7, 71.1, 72.4, 72.7, 72.9, 74.2, 74.3 (C-I' - C-5', C-l" - C-5"), 112.5 (C-3), 153.8 
(C-4), 169.7, 170.0, 170.5, 170.6, 170.9, 170.9 (6 x COCH3); m/z (FAB) 681 (M+1), 571 
[(M-N202)+1]; m/z(FAB) Found: M+I, 631.19732. C26H35N2016 requires 631.19866. 
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3.6.5 3,4-Di(2,3,4,6-tetra-O-acetyl-P-D-mannopyranoSyD-1 ,2,5-oxadiazole 	2-oxide 
(164). 
Sample code: KWBI 1 
Molecular formula: C10H38N2020 
Molecular weight: 746 
 
OAc 	 OAc 
Using the procedure outlined in method B, 2,3,4,6-tetra-0-acetyl-3-D-rnannopyranosyl 
aldoxirne (138) (92 mg, 0.24 mmole) was treated with sodium hypochiorite (14.72 rnrnole, 
60 equiv.) to yield the product (164) as white needles (28 mg, 32%), mp 213-215 °C (from 
EtOH) (Found: C, 47.9; H, 5.0, N, 3.8. C30H38N2020 requires C, 48.2; H, 5. 1, N, 3.7); [all) 18 - 
14.0 (c = 1.0, CHCI3); vinax/clTl1  (Nujol) 1743 (C0), 1606 (C=N); Si  (250 MHz, CDCI3) 
1.93, 1.93, 1.96, 2.02, 2.03, 2.05, 2.05, 2.06, 2.07, 2.11 (24H, 8 x s, 8 x COCH3), 3.80-3.94 
(2H, m, 5'-H, 5"-H), 4.17-4.36 (4H, rn, 6'a-H, 6'b-H, 6"a-H, 6"b-H), 4.93 (1 H, d, J1 ' 2 0.9, 
1'-H), 5.17 (IH, d, J1" 2" 1.0, 1"-H) 5.10-5.36 (4H, in, 2'-H, 2"-H, 4'-H, 4"-1-l) 5.68-5.74 
(2H, m, 3'-H, 3"-H); öc (63 MHz, CDCI1) 20.3, 20.3, 20.4, 20.4, 20.6, 20.6 (8 x COCJ-13), 
62.1, 62.7 (C-6', C-6"), 64.9, 65.4, 66.0, 67.3, 70.5, 71.0, 71.6, 76.8, 77.1 (C- 1', C-2', C-3', 
C-4', C-5', C-l", C-2", C-3", C-4", C-5"), 110.5 (C-3), 152.7 (C-4), 169.2, 169.3, 169.6, 
169.7, 169.9, 170.2, 170.3 (8 x COCH3); m/z (FAB) 747 (M+1), 687 [(M-N202)+1J; ni/z 
(FAB) Found: M+1, 747.20920. C30H39N2020 requires 747.20962. The structure of 
compound (164) was confirmed by X-ray crystallography. 
3.6.6 	 2-oxide 
(164). 
Sample code: KWB20 
Molecular formula: C30H38N2020 
Molecular weight: 746 
'OAc 
Using the procedure outlined in method C, triethylamine (0.035 cm) in dry ether (1 cm) 
was added to the hydroximoyl chloride (143) (91 mg, 0.22 rnrnole) in dry ether (1 cm) to 
give the product (164) as a white solid (82 mg, 99%). See section 3.5.1 for analysis 
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3.7 	DIOXIME SYNTHESIS 
3.7.1 Ring-opening of furoxan ring under hydrogenation conditions 
The dioxirne (191) was synthesised from furoxan (178) using the conditions described below 
using different catalysts 
3.7.1.1 Conversion of 3,4-di(2,3,4-tri-O-acetyl--D-xylopyranosyl)-1 ,2,5-oxadiazole 2- 
oxide (178) to 	 (191) using 
Pd/C 
Sample code: KWB280 
Molecular formula: C24H32N2016 
Molecular weight 604 
OAc 	 OAc 
The furoxan (178) (280 mg, 0.46 rnmole) was dissolved in methanol (10 cm') and Pd/C (5%, 
100 mg) added. The solution was degassed 3 times and then the reaction mixture was left 
under an atmosphere of hydrogen for 16 hours. The catalyst was removed by filtration and 
the solvent removed in vacuo to give an orange oil. The product, 3,4-di(2,3,4-tri-O-acetyl-13-
D-xylopyranosyl)glyoxime (191), was isolated from baseline material by dry flash 
chromatography, eluting from ether/hexane as a white foam (150 mg, 53%). The product 
(191) appeared to be a mixture of isomers; ö (250 MHz, D3COD) 1.95, 1.96, 2.00 (12H, 3 x 
s, COCH3), 3.40 (2H, m, 5ax'-H, Sax"-H), 4.07 (2H, m, 5eq'-H, Seq"-H), 4.30 (1H, d, 1'-
H), 4.91 (2H, m, 4'-H, 4"-H), 4.95 (1H, d, 1"-H), 5.17 (2H, t, 31-H, 3"-H), 5.35 (2H, t, 21-
H, 2"-H); .J(x-y)/1-lz 1-2 9.9, 2-3 9.0, 3-4 9.8, 4-5ax nd, 4-5eq 5.5, 5ax-5eq 10.9; öc (63 
MHz, D3COD) major isomer 22.1, 22.2 (6 x COCH3), 69.0 (C-5', C-5"), 71.5, 71.5, 72.4, 
77.1, 80.7, 80.8 (C-l' to C-4' and C-l' to C-4"), 148.7, 151.0 (2 x CNOH), 172.6, 172.7, 
173.0, 173.3, 173.4, 173.4 (COCH3); selected data minor isomer 148.1 (CNOH). 
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3.7.1.2 Conversion of 3,4-di(2,3,4-tri-O-acetyl-f3-D-xylopyranosyl)-1,2,5-oxadiaZOle 2-
oxide (178) to 3,4-di(2,3,4-tri-O-acetyl4-D-xylopyranosyl)glyOxime (191) using 
Raney nickel 
Sample code: KWB300 
Molecular formula: C24H32N2016 
Molecular weight 604 	 AcO' 
The furoxan (178) (272 mg, 0.452 mmole) was dissolved in methanol (10 cm3)and Raney 
Nickel (6 spatula tips) added. The solution was degassed 3 times and then the reaction 
mixture was left under an atmosphere of hydrogen for 16 hours. The catalyst was removed 
by filtration and the solvent removed in vacuo to give a red oil. The product (191) was 
isolated by dry flash chromatography as a white solid (211 mg, 77 %) along with a red oil 
(21 mg); mp 132 - 134°C; [a]18D —25.0 (c = 0.24, CHCI3); ö (600 MHz, CDCI3) 1.93, 1.96, 
1.98, 1.98, 2.00, 2.00 (18H, 6 x s, 6 x COCH3), 3.30 (1H, t, Sax'-H), 3.34 (IH, t, Sax"-H), 
4.11 (111, dd, Seq'-H), 4.12 (IH, dd, Seq"-H), 4.23 (1H, d, 1"-H), 4.93 (1H, m, 4'-H), 4.97 
(1H, d, 1'-H), 4.98 (IH, in, 4''-H), 5.17 (1H, t, 3'-H), 5.20 (111, t, 3''-H), 5.28 (IH, t, 2'-H), 
5.40 (111, t, 211-H) 9.43, 9.66 (2H, 2 x br s, 2 x OH); J(x-y)/Hz V-2' 9.9, 2'-3' 9.3, 3'-4' 9.4, 
4'-5ax' 10.5, 4'-5eq' 5.7, 5ax'-5eq' 11.4; 1"-2" 10.0, 2"-3" 9.5, 3"-4" 9.4, 4"-5ax" 10.4, 
4"-5eq" 5.7, 5ax"-5eq" 11.5; ö (63 MHz, CDC13) 20.5 (6 x COCH3), 66.6 (C-5', C-5"), 
68.6, 69.1, 69.6, 71.1, 73.8, 74.1, 77.5 (C-l' to C-4' and C-l' to C-4"), 146.0, 148.6 (2 x 
C=NOH), 169.9, 170.2, 170.4, 170.5 (COCH3); m/z (FAB) Found: M+H, 605.18256 
C24H33N2016 requires M-'-+H 605.18301 
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3.7.1.3 Ring opening of 3,4di(2,3:4,6-di-O-isopropylidene-/3-D-maflnOpYranOSY1)-
1,2,5-oxadiazole 
Sample code: KWB275 
Molecular formula: C26H40N2012 
Molecular weight: 572 
The furoxan (177) (90 mg, 0.158 mmole) was dissolved in methanol (10 cm3) and Pd/C 
added (5%, 60 mg). The solution was degassed 3 times and then the reaction mixture was 
left under an atmosphere of hydrogen for 16 hours. The catalyst was removed by filtration 
and the solvent removed in vacuo to give a yellow oil. TLC showed the presence of baseline 
material which mass spectrum data indicated to be 3,4-di-(2,3:4,6-di-0-isopropylidene-/3-D-
mannopyranosyl)-dioxime (248) (74 mg, 82%); rn/z (FAB) Found: M+H, 573.26727 
C26H41N2012 requires M+H 573 .26565 
3.7.2 Dehydration of dioxime (191) to 3,4-di-(2,3,4-tri-O-acetyl-f3-D-xylopyranosyf)-
1 ,2,5-oxadiazole (196) 
Sample code: KWB327 
Molecular formula: C24H30N2015 
Molecular weight: 586 
The dioxime (191) (80 mg, 0.132 mmole, 1 equiv.) was dissolved in DCM (3 cm') and 
triethylarnine added (0.28 cm3, 0.200 mmole, 1.5 equiv.). Next DMAP (10 mg, cat.) was 
added and the solution cooled (ice-bath) and stirred for 30 minutes. Finally acetic anhydride 
(0.19 cm3, 1.98 mmole, 15 equiv.) was added and the solution left to stir overnight. The 
reaction mixture was then diluted with DCM (20 cm) the organic layer isolated, washed 
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with NaHCO3 (2 x 25 cm3), water (25 cm3) and dried (MgSO4). Removal of solvent in vacuo 
gave an oil which on purification by dry flash chromatography, eluting from ether I hexane 
afforded the product (196) as a white solid (45 mg, 58%); mp 86 - 88 °C; 6H (360 MHz, 
CDC13) 1.86, 1.98, 2.01 (18 H, 3 x s, 3 x COCH3), 3.43 (2H, in, 5ax'-H, Sax"-H), 4.28 (2H, 
dd, Seq'-H, Seq'-I-I), 4.81 (2H, d, P-H, 1"-H), 5.04 (2H, in, 4-H, 4-H), 5.28 (2H, t, 3'-H, 3_ 
H), 5.37 (2H, t, 2'-H, 2!H);  J(x-y)IHz I'-2' 9.7, 2'-3' 9.4, 3'-4' 8.9, 4'-5ax' rid, 4'-5eq' 5.3, 
5ax'-5eq' 11.1; 5c (63 MHz, CDC13) 20.3, 20.6(6 x COd-I3), 66.9 (C-5', C-5"), 68.5, 70.0, 
72.1, 72.7 (C-I' to C-4' and C-I' to C-4"), 150.9 (CN), 169.2, 169.7, 170.1 (3 x COCH3); 
m/z (FAB) Found: M+H, 587.17021 C24H31N2015 requires M+H 587.17244. 
3.7.3 Reoxidation of 3,4-di-(2,3,4-tri-O-acetyl--D-xy1opyranosyl)-1,2,5-oxadiaZOle 
(196) to3,4-di-(2,3,4-tri-O-acetyl-J3-D-xylopyranosyl)furOXan (178) 
Sample code: KWB328 
Molecular formula: C24H30N2016 
Molecular weight: 602 
AcO\\" 
 
OAc 	 OAc 
The dioxime (191) (75 mg, 0.124 mmole) was dissolved in DCM (2 cm3) along with 
triethylamine (cat. 0.1 cm3). The solution was stirred vigorously and sodium hypochlorite (1 
cm3) added drop-wise over 30 mins. After stirring for 24 hours the solution was diluted with 
DCM (25 CM),  washed with water (2 x 25 cm3), dried (MgSO4) and the solvent removed in 




3.7.4 Complexation of 3,4di(2,3,4tri-O-acetyl-13-D-xylopyranosy1)-diOXime (191) 
with NiCl2.6H20 
Sample code: KWB343 
Molecular formula: C48H62N4NiO32 
Molecular weight: 1264 
DAc 
OAc 
The dioxime (191) (100 mg, 0.166 mmole, 1 equiv.) in ethanol (3 cm) was added to a 
solution of NiCl2.61-120 (157 rng, 0.662 mmole, 4 equiv.) in ethanol (3 cm3) and stirred for 
48 hours. A orange solution formed. Removal of solvent in vacuo gave an orange solid 
which was isolated by dissolution in chloroform. Insoluble material was isolated by filtration 
and the solvent removed in vacuo to give a orange solid (192) (58 mg, 55%); mp 133-136 
°C; 5H  (250 MHz, D3COD), 1.86, 1.88, 1.92 (12H, 3 x s, COCH3), 3.33 (1 H, t, Sax-H), 4.02 
(I H, dd, Seq-H), 4.21 (1 H, d, 1-H), 4.86 (1 H, m, 4-H), 5.16 (21-1, rn, 2'-H, 3'-H); J(x-y)IHz 
1-2 9.5, 2-3 9.3, 3-4 9.6, 4-5ax nd, 4-5eq 5.7, Sax-Seq 10.9 8C (63 MHz, D3COD) 18.7, 18.8, 
19.0 (COCH3), 65.7 (C-6', C-6"), 68.2, 68.7, 73.9, 77.0 (C-l' to C-4"), 144.7 (4 x C=NO), 
169.4, 169.6, 170.0 (COCH3) 
3.8 	Deacetylation reactions 
General procedure: The isoxazoline (0.69 mmole) was suspended in methanol (20 cm3) and 
then added to a saturated solution of ammonia in methanol (20 
CM)  . The reaction was left to 
stir for 16 hrs and then the solvent was removed in vacuo to give the product. 
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3.8.1 Deacetylation of 5-(spirocyclohexyl)-3-(2,3,4,6- tetra-0-acetyl-3-D-
man nopyranosyl)-2-isoxazoline (160) 
Sample code: KWB 118 
Molecular formula: C14H23N06 
Molecular weight: 301 
OH 
Using the general procedure outlined above, the isoxazoline (153) (100mg, 0.21 mrnole) was 
treated with methanol saturated with ammonia. The product (249) was isolated by removal 
of solvent in vacuo as a white solid (63 mg, 100%). rnp = 137— 139 °C; 8H  (250MHz, D20), 
1.49— 1.77 (1 OH, in, 6-H to 10-H), 3.00 (2H, d, 4a-H, 4b-H), 3.35 —3.42 (2H, d, 6a-H, 6b-
H), 3.64 (1 H, rn, 5H), 3.79 (1 H, dd, J23 6.3, J3,4 12.0. 3-H), 4.05 - 4.47 (2H, m, 2-H, 4-H), 
4.46 (1H, d, J12 1.0, 1 '-H); 6c  (63 MHz, D20) 22.6, 24.2, 35.3, (C-6 to C-1 0) 44.3 (C-4) 61.2 
(C-6') 66.5, 70.8, 73.9, 74.5, 80.5 (C-l' to C-5') 85.8 (C-5), 157.8 (C-3). ni/z (FAB) Found: 
M+1, 302.16041 C14H24N06 requires 302.16036. 
3.8.2 Deacetylation of 5-(spirocyclohexyl)-3-(2,3,4-tri-O-acetyl-fl-D-xylOpyraflOSYl)-2-
isoxazoline (160) 
Sample code: KWB 193 
Molecular formula: C13H21N05 




Using the general procedure outlined above, the isoxazoline (160) (275 mg, 0.69 mmole) 
was treated with methanol saturated with ammonia. The product (210) was isolated by 
removal of solvent in vacuo as a brown solid (180 mg, 96%); mp 205-206 °C H  (250 MHz, 
CD30D) 1.42 - 1.85 (1011, m, 6-H to 10-H), 2.88 (211, s, 4a-H, 4b-H), 3.29 - 3.49 (3H, m, 
Sax-H, Seq-H, 1-H), 3.60 (1H, m, 4-H), 3.97 - 4.05 (2H, m, 3-H, 2-H); 6C (63 MHz, D20) 
22.4, 22.6, 24.2, 35.3 (C-6 to C-b) 42.3 (C-4) 69.3 (C-5') 69.3, 70.9, 75.7, 77.6, (C-I' to C-




3.9 	Glycal formation reactions 
The formation of glycal by elimination of the 2-substituent was induced by treatment with 
base following the general methods below: 
Method 1: Glycals (200), (202), (203), (204), (205) were formed using the procedure 
outlined below. 
General procedure. THF (5 cm 3)  was cooled to -78°C (dry ice / acetone) and n-BuLi (2.5-5 
equiv.) was then added drop-wise and the mixture left to stir for 30 minutes. The 
isoxazoline/isoxazole (1 equiv.) in dry THF (1 cm3) was then added drop-wise over a 10 
minute period and the mixture stirred for a further 2hrs. The reaction was then allowed to 
warm to room temperature and quenched with saturated NH4CI solution. DCM (50 cm') was 
added and the organic layer isolated, the aqueous layer extracted (3 x 50 cm3), the organic 
layers combined and dried (MgSO4). The solvent was removed in vacuo and product purified 
by dry flash chromotography and / or recrystallisation. 
3.9.1.1 Treatment 	of 	5-(spirocyclohexyl)-3-(2,3 :4,6-di-O-ispropyl-Ji-D- 
mannopyranosyl)-2-isoxazoline (155) with BuLl 
Sample code: KWB 103 
Molecular formula: C17H25N05 
Molecular weight 323 
Following 	method 	I 	above, 	5-(spirocyclohexyl)-3 -(2,3 :4,6-di-O-ispropyl-3-D- 
rnannopyranosyl)-2-isoxazoline (155) (150 mg, 0.40 mmole) in THF (5 cm3) was treated 
with butyllithium (0.65 cm3, 1.0 mmole) to give the 5-(spirocyclohexyl)-3-(4,6-O-
isopropylidene-2-deoxy- 1 ,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxazoline (200) (120 
mg, 92%) as a white solid (ether/hexane); mp = 69-71 °C; [aJD18 3.0 (c = 1.0, CHCI3); Sii 
(250 MHz, CDCI3) 1.23-1.75 (1 OH, m, 6a-H, lOb-H), 1.43, 1.53 (6H, 2 x s, C(CH3)2), 2.42 
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(I H, br. s, OH), 2.76 (2H, d, 4a-H, 4b-H), 3.82 —3.92 (2H, rn, 6a'-H. 6b'-H), 3.96 (1 H, rn, 
4'-H), 4.08 (111, ddd, 5'-H), 4.45 (1H, in, 3'-H), 5.07 (II-!, d, 2'-H); J(x-y)tHz 2'-3' 2.4, 3'-
4' 7.9, 4'-5' 5.1, 5'-6a' nd, 5'-6b' 4.5, 6a'-6b' 11.0; 6c(63Hz, CDCI3) 18.9, 28.8 (C(CH3)2), 
23.2, 23.2, 24.8, 36.1, 36.1 (C6 to C- 10) 43.7 (C-4), 61.3 (C-6'), 67.5, 69.5, 72.6 (C-3', C-4', 
C-5'), 88.0 (C-5), 99.8 (C(CH3)2)3), 106.7 (C-2'), 145.8 (C-l'), 151.6 (C-3); m/z (FAB) 
Found: M+i, 324.18088 C17H26N05 requires 324.18110. The structure of (200) was 
confirmed by X-ray crystallography (see Appendix 3). 
3.9.1.2 Treatment of 5-phenyl-3-(2,3 :4,6-di-O-ispropy1idine--D-mannopyranosyI)-2-
isoxazoline (202) with base 
Sample code: KWB 126 
Molecular formula: C18H21N05 
Molecular formula: 331 
OH 
Following method 1 above, 5-phenyl-3-(2,3:4,6-di-O-ispropyl--D-mannopyranosyl)-2-
isoxazoline (156) (100 mg, 0.26 mmole) in TI-IF (5 cm 3)  was treated with BuLi (0.4 cm 3, 
0.64 mmole, 2.5 equiv.) to give the products, 5(R) and 5(S)-phenyl-3-(4,6-O-isopropylidene-
2-deoxy-1,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxazoline (202), as a white foam (73 
mg, 85%) in a 55:45 ratio; 6H  (250 MHz, CDc13) 1.44, 1.48 (614, 2 x s, (C(CH3)2), 3.04 (1H, 
dd, 4a-H), 3.51(1H, dd, 4b-H), 3.85-4.04 (311, rn, 4'-H, 6a'-H, 6b'-H), 4.10 (111, m, 5'-H), 
4.44 (1H, dd, 3'-H), 5.12 (1H, d, 2'-H), 5.65 (1 H, dd, 5-H); J(x-y)IHz 2'-3' 2.4, 3'-4' 7.5, 4'-
5' 5.1, 5'-6a' nd, 5'-6b' 4.7, 6a'-6b' 10.8, 4a-4b 16.6, 4a-5 8.1, 4b-5 11.2; 8C (63Hz, cDc13) 
18.9, 28.8 (C(C113)2), 42.1 (C-4), 61.3 (c-6'), 67.3, 69.7, 72.6 (C-3' to C-5') 82.8 (C-5), 99.9 
(C(CH3)2), 108.0 (C-2'), 125.6, 128.6 (aromatic C-H), 140.1 (aromatic quat), 145.0 (C-l'), 
151.8 (c-3); m/z (FAB) Found: M+i, 332.14951 C18H22N05 requires 332.14980. 
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3.9.1.3 Treatment of 5-hexyl-3-(2,3 :4,6-di-O-ispropylidine-f3-D-mannopyrafloSYl)-2-
isoxazoline 
I1= 
Sample code: KWB 183 
Molecular formula: C18H29N05 




Following method I above, 5 -hexyl-3 -(2,3 :4,6-di-O-ispropyl idine--D-mannopyranosyl)-2- 
isoxazoline (157) (130 mg, 0.33 rnmole) was treated with BuLi (1 cm3, 1.63 mmole, 5 
equiv.) to give an oil which was purified by dry flash chromatography to give 5(R)-and 5(5)-
hexyl-3 -(4,6-O-isopropyl idene-2-deoxy- 1 ,2-didehydro-D-arabino-hexo-pyranosyl)-2- 
isoxazoline (203) as an oil (50 mg, 45%); 61 (250 MHz, CDCI3) 1.79 (3H, m, Il -H), 1 .19 - 
1.68 (1011, in, 6-H to 10-H),1.43, 1.53 (6H, 2 x s, C(CH3)2), 2.51 (IH, br s, OH), 2.68 (1H, 
dd, 4a-H), 3.11 (111, m, 4b-H), 3.83 —3.97 (3H, m, 6a'-H, 6b'-H, 4'-H), 4.08 (1H, m, 5'-H), 
4.45 (1 H, m, 3'-H), 4.64 (1H, in, 5-H), 5.10 (11-i, d, 2-H); J(x-y)/Hz 2'-3' 2.3, 3'-4' 7.9, 4'-
5' 8.2, 5'-6a' 10.5, 5'-6b' 5.0, 6a'-6b' 10.9, 4a-4b 16.3, 4a-5 7.8, 4b-5 10.6; öc (63Hz, 
CDCI3) 13.9 (C-I 1)18.9, 28.8 (C(CH3)2), 22.4, 25.0, 28.9, 31.5, 34.9 (C-6 to C-b) 38.8 (C-
4), 61.3 (C-6'), 67.5, 69.6, 72.6 (C-3' to C-5') 81.9 (C-5), 99.8 (C(CH3)2), 107.3 (C-2')145.9 
(C-l'), 151.8 (C-3); m/z (FAB) Found: M+H, 340.21236 C18H30N05 requires M+H 
340.21240. 
3.9.1.4 Treatment of 5-phenyl-3-(2,3 :4,6-di-O-ispropy1--D-mannopyranosyl)isoxazole 
(159) with base 
Sample code: KWB334 
Molecular formula: C18H19N05 
Molecular weight: 329 
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Following 	method 	1 	above, 	5-phenyl-3 -(2,3 :4,6-di-O-i spropyl idine-j3-D- 
mannopyranosyl)isoxazole (60 mg, 0.16 mmole) in THF (5 cm 
3)  was treated with BuLi (0.3 
cm3, 3 equiv.) to give an oil which was purified by dry flash chromatography to give 5-
phenyl-3 -(4,6-O-isopropylidene-2-deoxy- I ,2-didehydro-D-arabino-hexo-pyranosyl)- 
isoxazole as a foam (47 mg, 89%); [a]D" 18.8 (c = 0.48, CHCI3); ö, (250 MHz, CDCI3): 
1.41, 1.51 (6H, 2 x s, C(CH3)2), 2.36 (1H, br s, OH), 3.87— 3.98 (3H, in , 6a'-H, 6b'-H, 4'-
H), 4.06 (1 H, in, 5'-H), 4.46 (1 H, in, 3'-H), 5.55 (11-1, d, 2'-H), 6.53 (1H, s, 4-H), 7.72 - 7.37 
(5H, in, aromatic); J(x-y)IHz 2'-3' 2.4, 3'-4' nd, 4'-5' nd, 5'-6a' 10.2, 5'-6b' 5.2, 6a'-6b' nd; 
6(63Hz, CDCI3) 19.0, 28.8 (C(CH3)2, 61.4 (C-6'), 67.4, 69.8, 72.8 (C-3' to C5') 97.1 (C-4) 
99.9 (C(CH3)2), 104.9 (C-2'), 125.7, 128.9, 130.3 (Ar H), 126.9 (Ar C), 144.1 (C-I'), 158.6 
(C-3); m/z (FAB) Found: M+H, 330.13420 C,8H20NO5 requires M+H 330.13415. 
3.9.1.5 Treatment of 5(spirocyclohexyl)-3-(2,3,4-tri-O-methyl-1-D-xylOpyraflOySl)-2-
isoxazoline (160) with base 
Sample code: KWB 174 
Molecular formula: C,5H23N04 
Molecular weight: 281 
We 
Following method I above, 5-(spirocyclohexyl)-3 -(2,3 ,4-tri-O-methyl-3-D-xylopyranoysl)-
2-isoxazoline (160) (70 mg, 0.22 mmole) in THF (5 cm 3)  was treated with BuLi (0.7 cm3, 
1.12 mmole, 5 equiv.) to give an oil which was purified by dry flash chromatography to give 
the 	5 -(spirocyclohexyl)-3 -(3 ,4-di-O-methyl-2-deoxy- I ,2-didehydro-D-threo-pento- 
pyranosyl)-2-isoxazoline (211) (18 mg, 40%) and unreacted starting material (160) (20 mg, 
0.063 mmole); [a]DI 8  —103.0 (c = 0.54, CHC13); 8H  (360 MHz, CDCI3) 1.24-1.76 (10H, in, 
H-6a to H-lOb), 2.83 (2H, d, 4a-H, 4b-H), 3.47, 3.50 (6H, 2 x s, 2 x OMe), 3.51 (1H, ddd, 
4'-H), 3.74 (IH, in, 3'-H), 4.02 (1H, dd, 5eq'-H), 4.33 (1H, ddd, Sax-H) 5.32 (1H, dd, 2-H); 
J(x-y)/Hz 2'-3' 4.8, 3'-4' nd, 4'-5aq' 5.5, 4'-5eq' 1.9, Saq'-Seq' 11.9; öc (63 MHz, CDCI3) 
23.3, 24.8, 36.2 (C-6 to C-b), 43.6 (C-4) 50.1, 56.9 (OMe), 63.3 (C-5'), 71.6, 74.0 (C-3', C-
4') 87.8 (C-5), 101.3 (C-2'), 147.4 (C-l'), 152.3 (C-3); m/z (FAB) Found: M+H, 282.17020 
C15H24N04 requires M+H 282.17053. 
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Method 2: Glycal (200) was formed as described below 
3.9.2 Treatment of 5-(spirocyclohexyl)-3-(2,3 :4,6-di-O-ispropyl--D-
mannopyranosyl)-2-isoxazoline (15 5) with LDA 
Sample code: KWB246 
Molecular formula: C17H25N05 
Molecular weight 323 
OH 
Using the same procedure as outlined in method 1, but replacing BuLi with LDA as base, 5-
(spirocyclohexyl)-3-(2,3 :4,6-diOispropyl-3-D-mannopyranosyl)-2-isoxazoline (155) (177 
mg, 0.465 rnrnole) in THF (10 cm) was treated with LDA (0.65 cm3, 1.16 mmole, 2.5 
equiv.) to give 5-(spirocyclohexyl)-3 -(4,6-O-isopropylidene-2-deoxy- 1 ,2-didehydro-D-
arabino-hexo-pyranosyl)-2-isoxazoline (200) (104 mg, 69%) as a white solid (ether/hexane); 
For analysis see section 3.9.1. 
Method 3: Glycal (211) was formed as described below 
3.9.3 One pot protection and elimination from 5-(spirocyclohexyl)-3-(-D-
xylopyranosyl)-2-isoxazoline (210) 
Sample code: KWB305 
Molecular formula: C15H23N04 
Molecular weight: 281 
5 -(spirocyclohexy1)-3-(3-D-xy1opyranosy1)-2-isoxazol me (210) (72 mg, 0.26 mrnole) was 
added to a pre-stirred suspension of powdered KOH (0.25 g, 4.25 mmole, 16 equiv.) in 
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DMSO (3 cm3) and stirred for 10 minutes. Mel (0.14 cm3, 2,13 mmole, 8 equiv.) was then 
added and the reaction mixture stirred for 72 hours. The reaction mixture was extracted with 
DCM ( 3 x 50 CM),  the organic layer washed with brine (2 x 50 cm 
3),  water (2 x 50 cm), 
dried (MgSO4) and the solvent removed in vacuo. After purification by dry flash 
chromatography eluting from ether/hexane, 5-(spirocyclohexyl)-3-(3 ,4-d i-O-methyl-2-
deoxy- I ,2-didehydro-D-threo-pento-pyranosyl)-2-isoxazol me (211) was isolated as a 
colourless oil (60 mg, 80%). See section 3.9.1.5 for analysis. 
Method 4 Glycal (200) was formed as described below 
3.9.4 Treatment of 5-(spirocyclohexyl)-3-(2,3 :4,6-di-O-ispropyl-f-D-
mannopyranosyl)-2-isoxazoline (15 5) with KOH 
Sample code: KWB313 
Molecular formula: C17H25N05 
Molecular weight 323 
The isoxazoline (155) (200 mg, 0.53 mmole) was added to a pre-stirred suspension of 
powdered KOH (119 mg, 2.12 mmole, 4 equiv.) in DMSO (5 cm3) and the reaction mixture 
stirred for 24 hrs. The reaction mixture was extracted with DCM (3 x 50 cm 3),  the organic 
layer washed with brine (2 x 50 cm3), water (2 x 50 cm3), dried (MgSO4) and the solvent 
removed in vacuo. 5-(Spirocyclohexyl)-3 -(4,6-0-i sopropylidene-2-deoxy- 1 ,2-didehydro-D-
arabino-hexo-pyranosyl)-2-isoxazoline (200) was isolated by dry flash chromatography 
eluting from ether/hexane (100 mg, 59%). For analysis see section 3.9.1.1. 
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3.10 Glycal manipulations 
3.10.1 Reduction of the glycal double bong under hydrogenation conditions 
Reduction of glycals (200) and (211) to give the unsaturated products (216) and (217) was 
achieved using hydrogenation according to the procedure outlined below: 
General procedure: The glycal (0.4 mmole) was dissolved in a 1:1 ethyl acetate / ethanol 
mix (8 cm3) and 5% Pd/C added (30 mg). The solution was degassed 3 times and the mixture 
left stirring under an atmosphere of hydrogen for 16 hours. Insoluble material was removed 
by filtration and the filtrate was evaporated to give an oil which was purified by dry flash 
chromatography eluting from ether / hexane. 
3.10.1.1 	Hydrogenation of 5-(spirocyclohexyl)-3-(4,6-O-isopropylidene-2-deoxy- 
1,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxazoline (200) 
Sample code: KWB3 15 
Molecular formula: C17H27N05 
Molecular weight: 325 
The glycal (200) (100 mg, 0.322 mmole) was dissolved in ethylacetate (4 cm3) and ethanol 
(4 cm3) and treated as described in the general procedure above. The product, 5-
(spirocyclohexyl)-3-(4,6-O-isopropylidene-2-deoxy-3-D-arabino-hexo-pyranosyl)-2- 
isoxazoline (216), along with an unidentified by-product (14 mg) (gave positive test with 
ninhydrin), was isolated by dry flash chromatography as a white solid (65 mg, 62%); [a]'8n-
10.0 (c = 0.8, CHCI3); mp 115-116 °C; 611  (360 MHz, CDC13) 1.22— 1.82 (10H, m, 6-H to 
10-H), 1.41, 1.50 (6H, 2 x s, C(CH3)2), 1.78 (1H, m, 2a'-H), 2.23 (1H, ddd, 2e'-H), 2.59 (1 H, 
br s, OH), 2.70 (2H, q, 4a-H, 4b-H), 3.26 (111, ddd, 5'-H), 3.46 (1H, t, 4'-H), 3.71 (1H, t, 6b-
H), 3.81 (1H, ddd, 3'-H), 3.87 (1H, dd, 6a'-H), 4.37 (IH, dd, 1'-H); .J(x,y)/Hz l'-2a' 11.9, 
1'-2e' 2.4, 2a'-3' 11.1, 2e'-3' 5.1, 3'-4' 8.8, 4'-5' 9.3, 5'-6a' 5.4, 5'-6b' 10.2, 6a'-6b' 10.7; 
öc (90 MHz, CDCI3) 19.0, 28.9 (C(CH3)2) 23.2, 36.1, 36.2 (C-6 to C-b), 24.8 (C-2'), 43.5 
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(C-4), 61.9 (C-6'), 69.1, 71.5, 72.0, 75.6 (C-I', C-3' to C-5'), 86.7 (C-5), 99.7 (C(CH3)2), 
157.2 (C-3); m/z (FAB) Found: M+H, 326.19755 C17H28N05 requires M+H 326.19675. 
3.10.1.2 	Hydrogenation of 5(spirocyclohexy1)-3-(3,4-di-O-methyl-2-deoxy-1-D- 
threo-pento-pyranosyl)-2-isoxazoline (211) 
Sample code: KWB339 
Molecular formula: C15H23N04 
Molecular weight: 283 
MeO' 
The glycal (211) (120 mg, 0.43 rnmole), was dissolved in ethylacetate (4 cm3) and ethanol (4 
cm3) and treated as described in the general procedure above. The product (217), along with 
an unidentified by-product (30 mg) (gave positive test with ninhydrin), was isolated by dry 
flash chromatography as a colourless oil (68 mg, 56 %); NI "D -26.5 (c = 1.36, CHC13); 6i-
(250 MHz, CDC13) 1.34— 1.66 (IOH, m, 6-H to 10-H), 1.50 (1H, m, 2ax'-H), 2.26 (IH, ddd, 
.Jl,2eq 2. 1, .J2eq,3  4.9 2eq'-H), 2.65 (2H, s, 4a-H, 4b-H), 3.10 (311, m, 4'-H, 5ax'-H, Seq'-H), 
3.22 (1 H, rn, 3'-H), 3.38 (6H, 2 x s, OMe), 4.09 (1 H, m, 1'-H); 6c  (90 MHz, CDCI3) 23.2, 
33.4, 36.1 (C-6 to C-b), 24.8 (C-2'), 43.5 (C-4), 56.8, 58.6 (2 x OCH3), 67.7 (C-5'), 72.2, 
79.2, 80.4(C-l'to C-4'), 86.6 (C-5), 157.7 (C-3); m/z (FAB) Found: M+H, 284.18557 
C201132N06 requires M+H 284.18616. 
3.10.2 Attempted hydroboration of 5-(spirocyclohexyl)-3-(4,6-O-isopropylidene-2-
deoxy-1 ,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxazoline (200) 
To a stirred solution of the glycal (200) (116 rng, 0.36 mmole, 1 equiv.) in dry THF (6 cm 3) 
was added borane-tetrahydofuran complex (0.72 cm 3,  0.72 mmole, 2 equiv.) in a drop-wise 
fashion. The mixture was stirred at 0°C for 4 hours and then treated with NaOH (0.24 cm3, 
0.72 mmole, 2 equiv.) and H,02 (0.24 cm', 30% w/w). The biphasic mixture was allowed to 
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warm to room temperature and stirred vigorously for an hour. The resulting solution was 
extracted with ether (3 x 20 CM),  the organic portion washed with NH4CI (20 cm3) and brine 
(20 cm3) and dried (MgSO4). Removal of solvent in vacuo yielded a white foam (100 mg) 
which was identified as starting material (200). 
3.10.3 Attempted 5-(spirocyctohexyt)-3-(4,6-O-isopropylidene-2-deoxy-1,2-didehydrO-
D-arabino-hexo-pyranosyl)-2-isoxazotine (200) 
To a solution of the glycal (200) (80 mg, 0.26 mmole, I equiv.) in THF (4 cm3) and t-BuOH 
(4 cm) were sequentially added pyridine (1 cm 3), water (2 cm3), NMNO (837 mg, 6.2 
mmole, 23 equiv.) and 0s04 (0.01 cm3). The mixture was heated to reflux for 1 hour, cooled 
to room temperature and quenched by the addition of aqueous NaHCO3 00 cm3, 20% w/v). 
The resulting brown mixture was stirred for 3 hours over ether (10 cm3) and extracted into 
ether (3 x 20 cm3). The combined ethereal extracts were washed with brine (50 cm3), dried 
(MgSO4) and concentrated in vacuo. TLC of the resultant oil showed two spots. The major 
spot was isolated and shown by 1 H NMR to be starting material (200) (65 mg). The more 
polar spot was isolated in 5 mg but could not be characterised. 
3.11 	Attempted Synthesis of Glycal nitrite oxide precursors. 
3.11.1 Synthesis of 3,4,5-tri-O-acetyl-2,6-anhydro-3-D-xyIopyranosylnitrile (221) 
Sample code: KWB 137 
Molecular formula: C12H15N07 




Using the procedure of Koll et al, 1 74  3,4,5-tri-O-acetyl-3-D-xylopyranosy1nitromethane (128) 
(150 mg, 0.47 mmole, 1 equiv.), was dissolved in pyridine (3 cm3) and cooled to 0°C (ice-
bath). To this PCI3 (0.045 cm3, 0.52 mmole, 1.1 equiv.) was added drop-wise and the mixture 
allowed to stir overnight. The resultant brown solution was re-cooled and ice cold 1M HC1 
added (20 cm) carefully and the mixture stirred for a further 20 minutes. The solution was 
extracted with chloroform (3 x 10 cm 3),  the organic layers combined and washed with 
NaHCO3 (2 x 10 cm), water (10 cm3) and dried (MgSO4). Removal of solvent in vacuo gave 
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the product, 2,6-anhydro-3 ,4,5 -tri-O-acetyl-D-xylopyranosylnitrile (221), as a white solid 
(114 mg, 85%); mp 128-129 °C (lit.176 131-132 °C); [a]'8u —36.7 (c = 1.0 CHCI3) {lit. ' 76 
[a]'8n —57.9 (c 0.8, CHCI3)}; ö,, (250 MHz, CDCI3) 2.03, 2.06, 2.07 (911, 3 X S, 3 X COCH3), 
3.56 (1H, dd, 6b-H), 4.18 (1H, dd, 6a-H), 4.46 (IH, d, 2-H), 4.86 (IH, in, 5-H), 5.04 - 5.07 
(2H, in, 3-H, 4-H); J(x,y)/Hz 2-3 6.9, 3-4 nd, 4-5 nd, 5-6a 4.01, 5-6b 6.8, 6a-6b 12.4; 6c  (63 
MHz, CDCI3) 20.3, 20.5 (COCH3), 65.1 (C-6), 65.3, 66.8, 67.6, 68.7 (C-2, C-3. C-4. C-5), 
114.3 (C EN), 16 8.8, 169.2, 169.4 (C=O) 
3.11.2 Synthesis of 1 ,3-diphenyl-2-(2,3,4-tri-O-acetyl-f3-D-xylopyranosyl)imidazolidine 
(222) 
Sample code: KWB 180 
Molecular formula: C26H30N207 










Using the procedure of Lehmann et al' 66, Raney nickel (2 g) was added to a vigorously 
stirred solution of pyridine (10 cm3), acetic acid (6 cm3) and water (6 cm3). Sodium 
hypophosphite monohydrate (1 g, 9.94 mmole) and NN'-diphenylethylenediamine (0.68 g, 
5.06 mmole) were added along with 3,4,5-tri-O-D-xylopyranosylnitrile (221) (300 mg, 1.05 
mmole). The reaction mixture was allowed to stir for 16 lirs, insoluble material was then 
removed by filtration and washed with dichloromethane (40 cm3). The organic layer was 
isolated, washed with water (6 x 10 cm3), dried (MgSO4) and the solvent removed in vacuo 
to 	give 	an 	oil. 	The 	product, 	1 ,3-diphenyl-2-(2,3 ,4-tri-O-acetyl-3-D- 
xylopyranosyl)imidazolidine (222), was isolated by dry flash chromatography eluting from 
hexane/ether (380 mg, 79%); mp 97-99 °C; [a]'8u 10.9 (c = 0.76 CHC13); S  (250 MHz, 
CDC13) 1.96, 1.99, 2.03 (9H, 3 x s, 3 x COCH3), 3.20 (111, t, 6a-H), 3.47 - 3.68 (411, in, 
NCH2CH2N), 3.83 (111, dd, 2-H), 4.21 (1H, dd, 6b-H), 4.91 (IH, in, 5-H), 4.98-5.11 (2H, 
in, 3-H, 4-H), 5.42 (111, s, 1-H), 6.67 - 7.32 (IOH, in, ArH); J(x,y)IHz 2-3 9.6, 3-4 nd, 4-5 
nd, 5-6a nd, 5-6b 5.6, 6a-6b 11.0; 6c  (63 MHz, CDCI3) 20.6,20.7(3 x COCH3), 46.4, 47.1 
(NCH2CH2N), 66.5 (C-6), 68.7, 69.8, 74.6, 75.5 (C-2, C-3, C-4, C-5) 79.0 (C-I), 112.7, 
113.7, 117.8, 118.2, 129.2. 129.3 (ArH), 145.5, 146.4 (ArC), 168.7, 168.7, 170.5 (3 x 
COCH3); m/z (FAB) Found: M+H, 483.21335 C26H31N207 requires M+H 483.213 13. 
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3.11.3 Synthesis of 3,4,5-tri-O-acetyl-2,6-anhydro-D-gulo-heptose (223) 
Sample code: KWB 182 
Molecular formula: C12H1608 
Molecular weight: 288 
H 
To a solution of 1,3 -diphenyl-2-(2,3 ,4tri-O-acetyl-3-D-xylopyranosyl)imidazoIidine (170 
mg, 0.35 mmole) in dichloromethane (4 cm 3)  was added a solution ofp-toluenesulfonic acid 
monohydrate (183 mg, 0.96 mmole, 2.75 equiv.) in acetone (1 cm3). After stirring for 20 
minutes, the precipitate was removed by filtration and washed with dichlorornethane (50 
cm3). The filtrate was washed with water (3 x 20 cm3), dried (MgSO4) and the solvent 
removed in vacuo to give 3,4,5-tri-O-acetyl-2,6-anhydro-D-gulo-heptose, as an oil (66.7 mg, 
60%); vjax/cni1 (DCM) 1739 (C=O ester and aldehyde); ö (250 MHz, CDCI3) 2.00, 2.01, 
2.13 (9H, 3 x s, 3 x COCI-13), 3.38 (1H, dd, 6a-H), 3.77 (1H, dd, 2-H), 4.20 (1 H, dd, 6b-H), 
4.94 (IH, m, 5-H), 5.03 - 5.26 (2H, m, 3-H, 4-H), 9.50 (lH, d, 1-H); J(x,y)/Hz 1-2 1.5, 2-3 
9.3, 3-4 nd, 4-5 nd, 5-6a nd, 5-6b 5.6, 6a-6b 11.4; 6c (63 MHz, CDCI3) 20.4, 20.5 (3 x 
COCH3), 66.0 (C-6), 67.4, 68.2, 72.0 (C-3, C-4, C-5), 80.3 (C-2), 169.5, 169.6, 169.8 (3 x 
COCH3), 196.0 (C-I); m/z (FAB) Found: M+H, 289.09345 C12H17N08 requires M+H 
289.09234. 
3.11.4 	Synthesis of 4,5-tri-O-acetyl-2,6-anhydro-3-deoxy-aldehydo-D-threo- 
hept-2-enose (224) 
Sample code: KWB 183 
Molecular formula: C10H1206 
Molecular weight: 204 
AcO" 
OAc 
3,4,5-tri-O-acetyl-f3-D-xylopyranosyl aldehyde (223) (67 mg, 0.23 mmole) was dissolved in 
pyridine (5 cm3) and acetic acid (5 cm3) and left to stir at room temperature for 5 days. 
Removal of solvent in vacuo with co-evaporation with tolouene gave 4,5-tri-O-acetyl-2,6-
anhydro-3-deoxy-aldehydo-D-threo-hept-2-enose (224) as a colourless oil (40 mg, 76%); 
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Vniax/Cfl1 1 (DCM) 1745 (C=O ester), 1709 (C=O, a,13-unsaturated aldehyde), 1643 (C=C in 
conjunction with aldehyde group); (250 MHz, CDCI3) 2.06, 20.9 (6H, 2 x s, 2 x COcH3), 
4.04 (1H, dd, 6a-H), 4.40 (1H, m, 6b-H), 5.02 (1H, ddd, 5-H), 5.19 (1H, m 4-H), 5.94 (1H, 
dd, 3-H), 9.24 (1H, s, 1-H); J(x,y)/Hz 3-4 5.0, 4-5 nd, 5-6a iid, 5-6b 4.8, 6a-6b 12.4; 8c (63 
MHz, CDCI3) 20.7, 20.7 (2 x COCH3), 63.2, 66.3 (C-4, C-5), 64.3 (C-6), 113.0 (C-3), 153.2 
(C-2), 169.4, 169.5 (2xCOCH3), 186.4 (C-I). 
3.12 	Protection reactions 
Various strategies for hydroxyl protection were utilised. 
3.12.1 Introduction of methyl ether protection 
Using the general procedure set out below, methyl ether protection was achieved to give 
compounds (209) and (206). 
General procedure: Powdered KOH (4 equiv. per OH) was added to DMSO (2 cm3) and 
stirred for 10 minutes. To this mixture was added the isoxazoline (1 equiv.) and the mixture 
stirred for a further 10 minutes. Finally Mel (2 equiv. per OH) was added and the mixture 
stirred for 20 minutes. The reaction was the poured into water, extracted with DCM (3 x 50 
cm 3),  the organic layers combined, washed with water (3 x 5 0cm3), dried (MgSO4) and the 
solvent removed in vacuo. The product was isolated by dry flash chromatography. 
3.12.1.1 	Formation 	of 	5-(spirocyclohexyl)-3-(2,3,4-tri-O-methyl--f3-D- 
xylopyranosyl)-2-isoxazoline (209) 
Sample code: KWB 169 
Molecular formula: C16H27N05 
Molecular weight: 313 	 MeO' 
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The isoxazoline (210) (50 mg, 0.18 mmole, 1 equiv.) was added to the suspension of 
powdered KOH (124 mg, 2,2 mmole, 12 equiv.) in DMSO (2 cm 
3)  followed by methyl 
iodide (0.07 cm3, 1.08 mmole, 6 equiv.). Removal of solvent in vacuo yielded the product 
(209) (42 mg, 75%); mp 98-99 °C; ö (250 MHz, CDC13)  1.22-1.73 (10H, m, 6-H to 10-H), 
2.67 (2H, dd, 4a-H, 4b-H) 3.06-3.25 (4H, m, 5a'-H, 5b'-H, 1'-H, 4'-H), 3.46, 3.48, 3.64 
(9H, 3 x S, 3 x OCH3), 3.90 (1 H, dd, J12 9.4, 2'-H), 4.01 (111, dd, J23 10.7, J ,4 5.7 3'-H); 6c  
(63 MHz, CDC13): 23.2, 24.8, 36.1, 36.3(C-6 to C-b), 43.9 (C-4) 58.7, 60.1, 60.7 (3 x 
OCH3), 67.5 (C-5'), 75.2, 79.5, 80.7, 87.2 (C-i' to C-4') 86.4 (C-5) 155.6 (C-4); m/z (FAB) 
Found: M +1,314.19674, C16H28N05 requires 314.19675. 
3.12.1.2 	Formation of 5-(spirocyclohexyl)-3-(4,6-O-isopropylidene-3-O-methyl-2- 
deoxy-1 ,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxaZolifle (206) 
Sample code: KWB 187 
Molecular formula: C18H27N05 
Molecular weight: 337 
OMe 
The glycal (200) (130 mg, 0.4 mmole) was added to a suspension of KOH (90 mg, 1.6 
mmole, 4 equiv.) in DMSO (6 cm 3)  followed by methyl iodide (0.04 cm3, 0.8 mmole, 2 
equiv.). Removal of solvent gave an oil which was purified by dry flash chromatography to 
give the product (206) as a white solid (47 mg, 42%); mp 120-122 °C; (250 MHz, CDC13) 
1.26 to 1.79 (1 OH, in, 6-H to 10-H), 1.47, 1.57 (6H, 2 x s, C(CH3)2) 2.80 (211, d, 4a-H, 4b-
H), 3.50 (3H, s, OMe), 3.85 (IH, in, 6a'-H), 3.94 to 4.03 (2H, m, 6b'-H, 4'-H), 4.10 (2H, m, 
3'-H, 5'H) 5.15 (1H, d, J23 2.3 2'-H); öc (63 MHz, CDC13) 18.9, 28.8 (2 x C(CH3)2), 23.2, 
23.2, 24.8, 36.1, 36.1 (C-6 to C-b), 43.7 (C-4), 57.4 (OMe), 61.4 (C-6') 69.8, 71.3, 75.7 (C-
2', C-3', C-4') 87.9 (C-5), 99.5(C(CH3)2), 104.7 (C-2'), 146.1 (C-l'), 151.6 (C-3); m/z 
(FAB) Found: M +1, 338.19644, C18H28N05 requires 338.19675. 
3.12.2 Introduction of acetate protection 
198 
Experimental Procedures 
Compound (200) was acetylated as described below: 
3.12.2.1 	Acetate protection of 5-(spirocyclohexyl)-3-(4,6-O-isopropylidene-2- 
deoxy-1,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxazOlifle (200) 
Sample code: KWB 117 
Molecular formula: C19H27N06 
Molecular weight: 365 
To the glycal (200) (100 mg, 0.3 mmole) in DCM (2 cm) was added triethylamine (0.33 
cm3, 2.3 mmole, 7.5 equiv.). DMAP (1.4 mg, 0.0012 mmole, 0.04 equiv.) was added and the 
solution cooled (ice-bath). After a 10 minutes stir, acetic anhydride (0.22 cm3, 2.3 mrnole, 
7.5 equiv.) was added and the reaction mixture allowed to stir overnight protected from 
moisture (N2). The mixture was poured into water, stirred for 1 hour, extracted with DCM (3 
X 50 cm), the organic layers combined, washed with NaHCO3 (3 x 50 cm3), dried (MgSO4) 
and the solvent removed in vacuo. Baseline impurities were removed by passing the oil 
obtained in ether through a pad of silica. Thus, 5-(spirocyclohexyl)-3-(4,6-O-isopropylidene-
3-O-acetyl-2-deoxy- I ,2-didehydro-D-arabino-hexo-pyranosyl)-2-isoxazoline (205) was 
obtained as white solid (93 mg, 82%); nip 82-84 °C 	(250 MHz, CDCI3) 1.28-1.78 (1 OH, 
in, 6a-H to lOb-H), 1.46, 1.46 (6H, 2 x s, 2 x CH3), 2.78 (2H, s, 4a-H, 4b-H), 3.91 - 4.02 
(2H, in, 6a'-H, 6b'-H), 4.08 - 4.15 (2H, in, 4'-H, 5'-H), 5.12 (1H, d, 2-H'), 5.45 (1H, dd, 3'-
H); J(x,y)/Hz 2'-3' 2.5, 3'-4' 7.9, 4'-5' 4.9, 5'-6a' tid, 5'-6b' 9.9, 6a'-6b' 10.4; 6C (63 MHz, 
CDC13) 18.8, 28.7 (2 x CCH3), 21.1 (CO0713), 23.1, 23.2, 24.7, 28.7, 36.1 (C-6 to C-b), 
43.6 (C-4),61.3 (C-6') 68.9, 69.7, 70.0 (C-2', C-3', C-4') 88.2 (C-5), 99.7 (CCH3), 103.5 (C-
2'), 147.0 (C-l'), 151.4 (C-3), 170.8 (COCH3); m/z (FAB) Found: M +1 366.19164 
C32H27N06 requires 366.19166. 
3.13 Reductive hydrolytic cleavage of 2-isoxazolines to -hydroxyketones 
Two 3-hydroxyketones were prepared from isoxazolines (160) and (155) by palladium 
charcoal and Raney nickel hydrogenolysis respectively. 
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3.13.1 Palladium charcoal hydrogenolysis of 5-(spirocylcohexy)-3-(2,3,4-tri-O-acetyl-
3-D-xy1opyranosyl)-2-isoxazoIine (160) 
Sample code: KWB287 
Molecular formula C19H2809 
Molecular weight: 400 	 AcO 
OAc 
The isoxazoline (160) (250 mg, 0.63 mmole, 1 equiv.) was suspended in water (6 cm3) and 
methanol (12 cm3) and TI-IF (15 cm3) added until the isoxazoline dissolved. Then boric acid 
(235 mg, 3.79 mmole, 6 equiv.) and Pd/C (5%, 100mg) were added and the mixture 
degassed 3 times and left under an atmosphere of hydrogen for 24 hours. The catalyst was 
then removed by filtration through a celite pad, and the solvent removed in vacuo to give an 
oil which was purified by dry flash chromatography to give a white solid (232) (34 mg, 14%) 
and recovered starting material (160) (47 mg) along with an unidentified baseline material 
(30 mg) that gave a positive result with ninhydrin; 6H  (360 MHz, CDCI3) 1.17-1.69(1011, 
m, 6-H to 10-H), 2.00, 2.02, 2.03(9H, 3 x s, 3 x COCH3), 2.76 (2H, d, 7a-H, 7b-H), 3.09 
(1H, br s, OH) 3.32 (IH, q, lax-H), 3.71 (1H, d, 5-H), 4.20 (1-H, dd, leq-H), 4.97 (IH, ddd, 
2-H,), 5.07 (IH, dd, 4-H), 5.23 (1H, dd, 3-H); .J(x,y)/Hz laq-1 eq 11.3, lax-2 10.2, leq-2 
5.5, 2-3 9.4, 3-4 9.2, 4-5 9.7; öc (63 MHz, CDC13) 20.7, 20.8 (3 x COCH3), 22.0, 25.7, 37.4, 
37.9 (C-6 to C-b), 48.04 (C-4), 66.6 (C-5'), 68.6, 68.8, 72.8, 82.4 (C-I' to C-4'), 70.9 (C-
5), 169.8, 170.0, 170.2 (3 x COCH3) 207.3 (C-3); m/z (FAB) Found: M +1 401.14888 
C19112909 requires 401.16193. M-18 peak at 383 amu. 
3.13.2 Raney nickel hydrogenolysis of 5-(spirocylcohexy)-3-(2,3:4,6-di-O-
isopropylidene-3-D-mannopyranosyI)-2-isoxazoline (155) 
Sample code: KWB18I 
Molecular formula: C17H2807 





The isoxazoline (155) (150 mg, 0.39 mmole) was dissolved in methanol (25 cm3) and water 
(8 ern).  To this boric acid (146 mg, 2.34 mrnole, 6 equiv.) along with 6 spatula tips of Raney 
nickel (prepared by washing with methanol 20 times and storing at 0°C for 3 weeks) was 
added and the reaction mixture degassed 3 times and placed under an atmosphere of 
hydrogen. After an 24 hours stir the catalyst was removed by filtration through a celite pad. 
The solvent was then removed in vacuo and the resulting oil purified by dry flash column 
chromatography to give the partially deprotected product (233) as an oil (83 mg, 62%) along 
with an unidentified by-product (47 mg); 6 (250 MHz, CDC13) 1.15 - 1.82 (1 OH, in, 10-H 
to 15-H), 1.40, 1.50 (6H, 2 x s, (CH3)2), 2.69 (2H, d, 8a-H, 8b-H), 2.72 (1H, br s, OH), 3.23 
(IH, dt, lb-H), 3.40 (IH, d, 6-H), 3.46 (1H, in la-H), 3.77 (2H, in, 5-H, 4-H), 3.91 (21-1, in, 
2-H, 3-H); & (63 MHz, CDCI3) 19.04, 28.9 (CCH3) 21.74, 25.5, 34.5, 37.5 (C-6 to C- 10), 
47.6 (C-4), 61.9 (C-6'), 69.3, 71.3, 75.6, 81.0 (C-I' to C-5'), 70.6 (C-5), 99.9 (CCH3), 209.9 
(C-3). 
3.14 	Addition reactions on nitrile oxides 
Addition of 4-tolylmethanethiol, thiophenol and aniline to 2,3,4,6-tetra-0-acetyl-3-
glucopyranosylnitrile oxide (115) was carried out using the general procedure described 
below. 
General Procedure: The hydroximoyl chloride (1 equiv.) was dissolved in dry ether (5 cm 
3). 
To this the nucleophule (1 - 3 equiv.) was added and the mixture stirred protected from 
moisture (N2). Then triethylamine (3 equiv.) was added via syringe pump over a 24 hr period 
and the reaction left for a further 6 hrs. It was then poured into water (50 cm3), extracted with 
DCM (3 x 50cm), the organic layers combined, dried (MgSO4) and the solvent removed in 
vacuo. The product was isolated from by-products using dry flash chromatography. 
3.14.1 Addition Reaction of 4-toiylmethane thiol with 3,4,5,7-tetra-O-acetyl-2,6-
anhydro-1-deoxy-1-chboro-1-hydroxyimino-D-glycero-D-gulo-heptitol (139). 
Sample code: KWB301 
Molecular formula: C23H29N010 S 





To the hydroximoyl chloride (139) (100 mg, 0.247 mole) in dry ether (5 cm) was added 4-
tolylmethane thiol (0.034 cm 3,  0.247 mmole, I equiv.) followed by triethylamine (0.1 cm3, 
0.741 mmole, 3 equiv.) in accordance with the general procedure above. The product (241) 
was isolated by dry flash chromatography as a white solid (95 mg, 79%); [a]D"  —21.4 (c = 
1.49, CHC13); 6F1  (250 MHz, CDCI3) 1.98, 2.03, 2.05, 2.09 (12H, 4 x s, 4 x COCH3), 2.35 
(3H, s, ArCH3), 3.72 (1H, ddd, 6-H), 4.11 - 4.36 (5H, m, 7a-H, 7b-H, 2-H, CH2Ar), 5.08 - 
5.31 (2H, in, 4-H, 5-H), 5.51 (1H, t, 3-H), 7.13 - 7.30 (5H, m, ArH), 8.96 (1H, br s, OH); 
J(x,y)IHz 2-3 9.9, 3-4 9.2, 4-5 9.8, 5-6 9.6, 6-7a 2.6, 6-7b 5.0, 7a-7b 12.4; 6c  (90 MHz, 
CDCI3) 20.4, 20.5, 20.6 (4 x COCH3), 21.0 (ArCH3), 34.3 (CH2Ar), 62.1 (C-7), 68.0, 69.1. 
74.1, 75.7, 77.7 (C-2 to C-6), 128.7, 129.3 (ArH), 132.9, 137.4 (ArC), 148.7 (C-I), 169.4, 
169.4, 170.4, 170.6 (4 x COCH3); m/z (FAB) Found: M+H, 512.15944 C23H30N010 S 
requires M+H 512.15904. 
3.14.2 Addition Reaction of thiophenol with 3,4,5,7-tetra-O-acetyi-2,6-anhydro-1-
deoxy-1-chloro-1-hydroxyimino-D-glycero-D-gu/o-heptitol (139). 
Sample code: KWB3 16 
Molecular formula: C21H26NO10S 
Molecular weight: 483 
To the hydroximoyl chloride (139) (96 mg, 0.235 mole) in dry ether (5 cm 3) was added 
thiophenol (0.04 cm3, 0.47 mmole, 2 equiv.) followed by triethylarnine (0.1 cm', 0.75 
mmole, 3 equiv.) in accordance to the general procedure above. The product (242) was 
isolated by dry flash chromatography as an white foam (96 mg, 85%); oH (250 MHz, CDCI3) 
1.90, 1.90, 1.92, 2.05 (12H, 4 x s,4 x COCH3), 2.79(111, ddd, 6-H), 3.67 (1 H, d, 2-H), 3.85 
(I H, dd, 7a-H), 4.01 (1H, dd, 7b-H) 4.83 —4.99 (2H, m, 4-H, 5-H), 5.38 (1 H, dd, 3-H), 7.20 
- 7.62 (5H, m, ArH), 8.96 (111, br s, OH); J(x,y)/Hz 2-3 9.8, 3-4 9.2, 4-5 10.0, 5-6 9.7, 6-7a 
2.4, 6-7b 4.5, 7a-7b 12.2; 0c  (90 MHz, CDCI3) 20.4, 20.5, 20.7 (4 x COd 3), 61.7 (C-7), 
67.6, 68.6, 74.3, 74.5, 75.4 (C-2 to C-6), 127.2(ArC), 129.1, 130.0, 136.5 (ArH), 148.6 (C-
1), 169.1, 169.3, 170.5, 170.5 (4 x COCH3); ni/z (FAB) Found: M+H, 484.12738 
C23H30N01 0S requires M+H 484.12774. 
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3.13.3 Addition Reaction of aniline with 3,4,5,7-tetra-O-acetyl-2,6-anhydro-1-deoxy-1-
chloro-1-hydroxyimino-D-glycero-D-gulo-heptitOl (139) 
Sample code: KWB324 
Molecular formula: C21H26N2010 
Molecular weight: 466 
OAc 
Following a modified version of the general procedure, aniline (0.07 cm 3, 0.74 mmole, 3 
equiv.) and triethylamine (0.07 cm3, 0.494 mmole, 2 equiv.) were added via syringe pump 
over a 24 hour period to the hydroximoyl chloride (139) (100 mg, 0.247 mole) in dry ether (5 
cm3). The product (243) was isolated by dry flash chromatography as solid (30 mg, 26%) 
along with furoxan (40 rng); mp = 80-82 °C; [a]018 —27.4 (c = 1.06, CHCI3); 61 (250 MHz, 
CDCI3), 2.16, 2.17. 2.18, 2.30 (12H, 4 x s, 4 x COCH3), 3.72 (11-1, ddd, 6-H), 4.22 - 4.36 
(2H, m, 7a-H, 7b-H), 4.40 (1 H, d, 2-H), 5.18-5.32 (2H, m, 4-H, 5-H), 5.66 (1H, dd, 3-H), 
7.25-7.70 (5H, in, ArH), 8.47 (1H, br s, OH); J(x,y)/Hz 2-3 10.1, 3-4 9.1, 4-5 nd, 5-6 9.4, 
6-7a 2.4, 6-7b 5.7, 7a-7b 12.4. 6c (90 MHz, CDCI3) 20.4, 20.5, 20.6 (4 x COCH3), 62.4 (C-
7), 75.9, 74.4, 72.8, 68.2, 68.0 (C-2 to C-6), 123.7, 125.0, 129.2 (ArH), 138.1 (ArC), 146.5 
(C-i), 169.1, 169.2, 170.3, 170.5 (4 x COCI-13); m/z (FAB) Found: M+H, 467.16605 
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Contact Simon Parsons, s.parsons@ed.ac.uk 
A. CRYSTAL DATA 
Empirical formula C15 521 N 010 
Reaction No: KB09. Cis/trans disordered 
Formula weight 375.33 
Wavelength 1.54178 A 
Temperature 220(2) 	K 
Crystal system Orthorhombic 
Space group P212121 
Unit cell dimensions a = 8.179(2) A 	alpha = 90 deg. 
b = 10.831(2) A beta = 90 deg. 
c = 20.801(7) A 	gamma = 90 deg. 
Volume 1842.8(9) 	A3 
Number of reflections for cell 54 (20 < theta < 22 deg.) 
Z 4 
Density (calculated) 1.353 Mg/m'3 
Absorption coefficient 0.993 mm-1 
F(000) 792 
DATA COLLECTION 
Crystal description 	 Colourless needle 
Crystal size 	 0.78 x 0.19 x 0.12 mm 
Theta range for data collection 4.25 to 70.13 deg. 
Index ranges 	 -9<h<8, -12(k<13, -18<1<25 
Reflections collected 	 2647 
Independent reflections 	 1899 [R(int) = 0.0843] 
Scan type 	 Omega-theta 
Absorption correction 	 Psi-scans (Tmin= 0.719, Tmax=0.788) 
SOLUTION AND REFINEMENT. 
Solution 	 direct (SRE1,XS-97 (Sheidrick, 1990)) 
Refinement type 	 Full-matrix least-squares on F2 
Program used for refinement 	SHELXL-97 
Hydrogen atom placement 	 geometric 
Hydrogen atom treatment 	 riding 
Data / restraints / parameters 	1899/2/244 
Gcodness-of-fit on F2 	 1.046 
Conventional R [F>4sigma(F)] 	I1 	0.0611 [1496 data] 
Weighted R (F2 and all data) 	wI2 = 0.1694 
Absolute structure parameter 	0.2(5) 
Extinction coefficient 	 0.0031(8) 
Final maximum delta/sigma 	0.000 
Weighting scheme 
calc 	 where P(Fo2+2Fc2)/3 
Largest diff. peak and hole 	0.308 and -0.217 e.A-3 
Table 2. Atomic coordinates ( x 10'4), equivalent isotropic 
displacement parameters (A2 x 103) and site occupancies for nokb09. 
tJ(eq) is defined as one third of the trace of the orthogonalized 
Uij tensor. 
x y z U(eq) 0cc 
C(1) 467(6) 348(5) 10521(2) 49(1) 1 
N(1) 591(8) -136(7) 11086(3) 53(2) 0.75 
0(1) 2154(6) 190(6) 11326(2) 62(2) 0.75 
N(1') 1180(20) 380(20) 11076(6) 60(6) 0.25 
0(1') 30(20) -258(16) 11463(9) 60(4) 0.25 
C(2) 1618(6) 1036(5) 10105(2) 42(1) 1 
C(3) 2956(6) 217(5) 9828(2) 38(1) 1 
0(31) 2158(4) -787(3) 9488(2) 39(1) 1 
 2899(6) -1913(5) 9505(2) 45(1) 1 
0(32) 4104(5) -2114(4) 9812(2) 66(1) 1 
 2001(7) -2800(5) 9093(3) 48(1) 1 
C(4) 3980(6) 932(4) 9341(2) 37(1) 1 
0(41) 5161(4) 161(3) 9027(2) 43(1) 1 
 6538(6) -76(5) 9379(3) 45(1) 1. 
0(42) 6752(4) 350(4) 9896(2) 58(1) 1 
 7668(7) -910(6) 9026(3) 65(2) 1 
C(5) 2863(6) 1438(4) 8832(2) 38(1) 1 
0(51) 3802(4) 2212(3) 8405(2) 48(1) 1 
 4002(8) 1824(7) 7798(3) 64(2) 1 
0(52) 3375(8) 888(5) 7590(2) 90(2) 1 
 4959(12) 2728(8) 7421(4) 94(3) 1 
C(6) 1569(6) 2260(5) 9144(2) 38(1) 1 
C(7) 374(6) 2774(5) 8661(2) 45(1) 1 
0(71) -357(5) 1775(3) 8310(2) 52(1) 1 
 -343(12) 1844(6) 7681(3) 78(2) 1. 
0(72) 123(13) 2714(5) 7385(2) 128(3) 1 
 -984(16) 682(6) 7383(4) 122(4) 1 
0(8) 651(4) 1555(3) 9597(2) 40(1) 1 



































































Symmetry transformations used to generate equivalent atoms: 
I 
Table 1. Crystal data and structure refinement for kwb28x. 
Contact 	 Simon Parsons, S.Parsons@ed.ac.uk 
A. CRYSTAL DATA 
Empirical formula 	 C30 538 N2 020 
KWB2 8 
Formula weight 746.62 
Wavelength 1.54184 A 
Temperature 150(2) 	IC 
Crystal system Triclinic 
Space group P1 
Unit cell dimensions a = 7.839(3) 	A alpha = 97.803(11) deg. 
b = 8.6191(18) A beta = 97.599(16) deg. 
c = 13.229(3) A gamma = 91.07(2) deg. 
Volume 877.2(4) 	A3 
Number of reflections for cell 50 (20 < theta < 22 deg.) 
Z 1 
Density (calculated) 1.413 Mg/m^3 
Absorption coefficient 1.043 mm'-1 
F(000) 392 
DATA COLLECTION 
Crystal description 	 Colourless block 
Crystal size 	 0.38 x 0.20 x 0.20 mm 
Theta range for data collection 3.40 to 70.16 deg. 
Index ranges 	 -9<=h<9, -9<=k<=10, -15<=l<16 
Reflections collected 	 4052 
Independent reflections 	 3093 [R(int) = 0.0293] 
Scan type 	 Omega-theta 
SOLUTION AND REFINEMENT. 
Solution 	 direct (SHELXS-97 (Sheldrick, 1990)) 
Refinement type 	 Full-matrix least-squares on F'2 
Program used for refinement 	SBELXL-97 
Hydrogen atom placement 	 geometric 
Hydrogen atom treatment 	 riding 
Data / restraints / parameters 
Goodness-of-fit on F2 
Conventional R [F>4sigma(F)] 
Weighted a (F2 and all data) 
Absolute structure parameter 
Extinction coefficient 
Final maximum delta/sigma 
3093/3/470 
1.038 
Rl = 0.0688 [2694 data] 





caic 	 where P=(Fo2+2Fc2)/3 
Largest diff. peak and hole 	0.527 and -0.354 e.A-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x 103) for kwb28x. 	tJ(eq) is defined 
as one third of the trace of the orthogonalized tJij tensor. 
x 	 y 	 z 	 U(eq) 
0(1) 16065(7) -4687(6) 2236(4) 56(1) 
N(2) 14817(7) -3923(6) 1558(4) 43(1) 
0(2) 14763(8) -4370(7) 670(4) 68(2) 
 14100(7) -2881(7) 2179(5) 39(1) 
 14854(7) -2964(7) 3205(5) 38(1) 
N(5) 16003(7) -4046(6) 3224(4) 45(1) 
0(1') 11446(5) -1833(5) 2471(3) 37(1) 
C(1') 12800(8) -1751(7) 1855(5) 37(1) 
C(2') 12042(7) -2031(7) 710(5) 36(1) 
0(21') 11106(5) -3539(5) 524(3) 40(1) 
 11026(9) -4352(9) -425(5) 47(2) 
0(22') 1.1.645(7) -3902(6) -1115(4) 58(1) 
 10043(13) -5870(10) -490(8) 69(2) 
C(3') 10800(7) -742(7) 541(5) 38(1) 
0(31') 9963(5) -932(5) -509(3) 41(1) 
 10912(9) -427(8) -1198(5) 47(2) 
0(32') 12293(7) 215(7) -953(4) 57(1) 
 9969(10) -800(12) -2255(6) 61(2) 
C(4') 9427(7) -733(7) 1232(5) 38(1) 
0(41') 8435(5) 623(5) 1097(3) 41(1) 
 6692(7) 429(8) 965(5) 41(1) 
0(42') 5948(5) -757(6) 1025(4) 49(1) 
 5867(11) 1924(11) 756(10) 78(3) 
C(5') 10253(7) -602(7) 2354(5) 37(1) 
C(6') 8964(8) -749(9) 3094(5) 45(2) 
0(61') 9605(6) -39(5) 4128(4) 44(1) 
 9272(8) 1523(8) 4356(5) 46(2) 
0(62') 8628(8) 2251(7) 3696(5) 64(2) 
 9855(11) 2147(9) 5448(6) 60(2) 
0(1") 14829(5) -384(5) 3981(3) 36(1) 
C(1") 14401(7) -1964(7) 4126(5) 36(1) 
C(2) 15236(7) -2350(7) 5176(5) 35(1) 
0(21) 17075(5) -2226(5) 5201(3) 38(1) 
C(22") 17958(8) -3432(8) 5566(5) 44(2) 
0(22") 17302(7) -4408(7) 5953(5) 64(2) 
C(23') 19803(8) -3324(9) 5369(6) 55(2) 
C(3") 14666(7) -1146(7) 5993(5) 38(1) 
0(31") 15517(5) -1324(5) 6988(3) 40(1) 
C(32) 14834(8) -2462(8) 7440(5) 44(1) 
0(32") 13601(7) -3273(7) 7036(4) 58(1) 
C(33") 15866(12) -2601(12) 8468(7) 64(2) 
C(4") 15036(7) 530(7) 5809(5) 37(1) 
0(41") 14244(6) 1583(5) 6531(3) 46(1) 
 15237(11) 2341(8) 7352(5) 50(2) 
0(42") 16802(7) 2252(7) 7491(5) 67(2) 
 14213(13) 3281(10) 8067(6) 64(2) 
C(5") 14170(7) 725(7) 4733(5) 37(1) 
C(6") 14477(9) 2345(8) 4451(5) 44(1) 
0(61") 13376(6) 2463(5) 3491(3) 46(1) 
 12514(7) 3799(7) 3436(5) 40(1) 
0(62") 12563(6) 4823(6) 4154(4) 52(1) 
 11465(10) 3810(10) 2404(6) 55(2) 







































































0(21' )-C(2' )-C(1') 107.2(5) 
C(3')-C(2')-C(1') 106.7(5) 
C(22')-0(21')-C(2') 116.9(5) 








0(32' )-C(32' )-C(33') 127.1(7) 
0(31' )-C(32' )-C(33') 109.9(6) 
0(41')-C(4')-C(3') 107.0(5) 















































Symmetry transformations used to generate equivalent atoms: 
Cl 	 Cie -4-. 
Cl 
O1OA 
Table 1. Crystal data and structure refinement for kwbl03. 
Contact 	 Simon Parsons, S.Parsons@ed.ac.uk 
A. CRYSTAL DATA 
Empirical formula 	 C17 R25 N 05 
KWB1O3 
Formula weight 323.38 
Wavelength 0.71073 A 
Temperature 150(2) K 
Crystal system Monoclinic 
Space group P21 
Unit cell dimensions a = 11.968(3) A 	alpha = 90 deg. 
b = 9.876(2) A beta = 96.883(3) deg. 
C = 14.233(3) A 	gamma = 90 deg. 
Volume 1670.2(6) 	A'3 
Number of reflections for cell 6396 	(2 < theta < 29 deg.) 
Z 4 
Density (calculated) 1.286 Hg/m'3 
Absorption coefficient 0.094 mm'-1 
F(000) 696 
B. DATA COLLECTION 
Crystal description Colourless tablet 
Crystal size 0.34 x 0.34 x 0.14 mm 
Instrument CCD area detector 
Theta range for data collection 2.68 to 28.99 deg. 
Index ranges -16<=h<=14, -13<k<13, -19<1<18 
Reflections collected 12358 
Independent reflections 7654 	[R(int) = 0.0275] 
Scan type phi and omega scans 
Absorption correction Sadabs 
(Tmin 	0.720, Tmaxl) 
C. SOLUTION AND REFINEMENT. 
Solution 	 direct (SRELXS-97 (Sheidrick, 1990)) 
Refinement type 	 Full-matrix least-squares on F2 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data / restraints / parameters 
Goodness-of-fit on F'2 
Conventional R [F>4sigma(F)] 
Weighted R (F2 and all data) 
Absolute structure parameter 
Final maximum delta/sigma 
SHELXL-9 7 
geometric/difmap (OH,Me) 
riding/rotating group (OH,Me) 
7654/1/421 
0.896 
RI = 0.0389 [6177 dnta] 
wR2 = 0.0800 
0.5(6) - meaningless! 
0.002 
Weighting scheme 
caic w=1/(\s'2(Fo'2)+(0.0376P)'2'+O.00OOP] where P(Fo'2'+2Fc'2")/3 
Largest diff. peak and hole 	0.253 and -0.183 e.A-3 
Table 2. Atomic coordinates ( x 10'4) and equivalent isotropic 
displacement parameters (A"2 x 10'3) for kwblO3. 	U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
x y z U(eq) 
N(1A) 9210(1) 7975(2) 9258(1) 29(1) 
0(2A) 8914(1) 7920(1) 10181(1) 32(1) 
C(3A) 9646(1) 8872(2) 10784(1) 26(1) 
C(31A) 8969(2) 10153(2) 10890(1) 31(1) 
C(32A) 7972(2) 9934(2) 11445(1) 40(1) 
C(33A) 8372(2) 9310(2) 12403(1) 42(1) 
C(34A) 8972(2) 7980(2) 12280(1) 36(1) 
C(35A) 9971(2) 8174(2) 11723(1) 31(1) 
C(4A) 10629(1) 9124(2) 10210(1) 31(1) 
C(5A) 10131(1) 8632(2) 9254(1) 24(1) 
C(6A) 10641(1) 8784(2) 8381(1) 24(1) 
 10013(1) 8157(1) 7629(1) 31(1) 
C(8A) 10330(1) 8582(2) 6731(1) 28(1) 
C(9A) 11595(1) 8472(2) 6738(1) 23(1) 
0(10A) 13342(1) 9349(1) 7612(1) 30(1) 
C(10A) 12162(1) 9501(2) 7424(1) 23(1) 
C(L1A) 11599(1) 9439(2) 8314(1) 25(1) 
C(12A) 9727(1) 7701(2) 5963(1) 39(1) 
0(13A) 10096(1) 8101(1) 5088(1) 36(1) 
C(14A) 11274(1) 7973(2) 5068(1) 28(1) 
0(15A) 11874(1) 8753(1) 5814(1) 24(1) 
C(16A) 11648(2) 6495(2) 5105(1) 36(1) 
C(17A) 11530(2) 8651(2) 4167(1) 38(1) 
N(1B) 4083(1) 7508(1) 9251(1) 29(1) 
0(2Z) 3759(1) 7595(1) 10163(1) 36(1) 
C(3B) 4559(2) 6807(2) 10826(1) 29(1) 
C(31B) 3969(2) 5504(2) 11044(1) 32(1) 
C(32B) 2940(2) 5774(2) 11557(1) 38(1) 
C(33B) 3274(2) 6552(2) 12463(1) 46(1) 
C(34B) 3843(2) 7882(2) 12263(1) 46(1) 
C(35B) 4849(2) 7651(2) 11716(1) 41(1) 
C(4B) 5556(2) 6562(2) 10269(1) 35(1) 
C(5B) 5060(1) 6950(2) 9291(1) 27(1) 
C(6B) 5626(1) 6868(2) 8442(1) 27(1) 
 4891(1) 6983(1) 7623(1) 31(1) 
C(8B) 5425(1) 7496(2) 6845(1) 26(1) 
C(9B) 6491(1) 6723(2) 6729(1) 24(1) 
0(10B) 8224(1) 5949(1) 7608(1) 32(1) 
C(10B) 7334(1) 6917(2) 7591(1) 26(1) 
C(11B) 6738(1) 6814(2) 8462(1) 28(1) 
C(12B) 4616(1) 7372(2) 5955(1) 31(1) 
0(13B) 5156(1) 7866(1) 5183(1) 31(1) 
C(14B) 6186(1) 7200(2) 5061(1) 28(1) 
0(15B) 6944(1) 7241(1) 5923(1) 27(1) 
C(16B) 5983(2) 5767(2) 4704(1) 35(1) 
C(17B) 6736(2) 8062(2) 4375(1) 41(1) 





































































































































Symmetry transformations used to generate equivalent atoms: 
0) 	 TETRAHEDRON LETTERS 
Pergamon Tetrahedron Letters 42 (2001) 4065-4068 
Generation and cycloaddition reactions of pyranose-1-carbonitrile 
oxides 
Kenneth W. J. Baker, Andrew Gibb, Andrew R. March and R. Michael Paton* 
Department of chemistry, The University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, UK 
Received 12 March 2001; accepted 11 April 2001 
Abstract—Stannate(I1) reduction of the 3-D-glucopyranosylnitromethane derivative 4 affords aldoxime 5, which provides access 
to the nitrile oxide 7, either on treatment with aq. hypochiorite, or via conversion to the hydroximoyl chloride 11 followed by 
base-mediated dehydrohalogenation. D-Galactose-, D-lnannose- and D-xylose-derived nitrile oxides are generated similarly. The 
nitrile oxides either dimerise to 3,4-dipyranosyl-1,2,5-oxadiazole N-oxides or are trapped as cycloadducts in the presence of 
dipolarophiles. © 2001 Elsevier Science Ltd. All rights reserved. 
There is considerable current interest in the chemistry 
of c-glycosides, and in methods for their synthesis in 
particular. One approach which has so far received 
little attention, but offers scope for the preparation of a 
variety of novel derivatives, makes use of nitrile oxide/ 
isoxazoline chemistry,2 and involves the generation of 
glycosyl nitrile oxides, their cycloaddition reactions 
with alkenes (or alkynes) and manipulation of the 
resulting isoxazoline (isoxazole) cycloadducts. In the 
literature there are occasional reports' of furanosyl 
nitrile oxide cycloadditions, and we have utilised',' the 
pyranosyl analogues I as key intermediates in a syn-
thetic sequence from readily accessible monosaccharide 
precursors to carbohydrate isoxazolines as precursors 
of carbon linked disaccharides (c-disaccharides). We 
previously employed',' a modified Mukaiyama 
procedure' for generating pyranosyl nitrile oxides 1, 
which involved tolylene diisocyanate-mediated dehydra-
tion of the corresponding nitromethyl compounds 2 
(Scheme 1, path a). The Mukaiyama route, however, 
has several limitations. Firstly, the use of isocyanates as 
the dehydrating agent is incompatible with free 
hydroxyl groups in either reactant—a disadvantage in 
carbohydrate synthesis—and elevated temperatures 
(80-100°C) and/or prolonged reaction times (3-5 days) 
are often required to achieve high conversions, so the 
method is not ideal for low boiling and thermally 
unstable dipolarophiles. An alternative approach is 
therefore needed to overcome these deficiencies. We 
now report that carbohydrate nitrile oxides such as 1 
can readily be generated form the corresponding oxime 
3, either by oxidation with aq. hypochlorite, or by base 
mediated dehydrohalogenation of its hydroximoyl chlo-
ride derivative (Scheme 1, path b). 
The first requirement was to develop an effective route 
to the oximes.7 The method selected was based on the 
observation' that primary aliphatic nitro compounds 
are reduced to aldoximes by stannate(II) complexes 
generated from SnCl2/PhSH/Et3N. Treatment of SnC12 
(363 mg, 1.92 mmol) in dry THF (6 ml) at 0°C with 
Et3N (648 mg, 6.40 mmol) and thiophenol (635 mg, 
5.76 mmol) afforded a yellow solution of the stannate 
(II) complex [Et3NH][(PhS)3SnJ, to which was added a 
R 	 RO— 	 RO 
ath a 
 RCNO2 <p 	
RO*C_NtO pb RO
CH=NOH 
-MOSS 	 2H 
RO OR 	 RO OR RO OR 
Scheme 1 
Keywords: cycloadditions; C-glycosides; nitrile oxides; isoxazoles; isoxazolines. 
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solution of 3-D-glucopyranosyl-nitromethane derivative 
49 (500 mg, 1.28 mmol). After stirring for 16 h the 
solvent was removed in vacuo and the residue purified 
by chromatography (silica, hexane/Et70) and recrys-
tallisation (hexane/Et20) to afford tetra- O-acety1-3-D-
glucopyranosylformaldoxime (5)10 as a 4:1 mixture of 
E- and Z-isomers" in a 761X, combined yield. In the 'H 
NMR spectrum there are characteristic doublet signals 
(J 6.8 Hz) for the imino proton of the E- and Z-iso-
mers at 7.30 and 6.7 ppm, respectively, and correspond-
ing broad singlet peaks at 8.40 and 8.62 ppm for the 
OH groups. D-Galactose-, D-mannose- and D-xylose-
derived oximes were prepared similarly in 80-90°/ 
yields from the corresponding pyranosylnitromethanes. 
The first method utilised for nitrile oxide generation 
involved oxidation of the oximes with aqueous 
hypochlorite.'2 In a typical experiment, a solution of 
the oxime (1 mmol) in CH,C12 (5 ml) was added 
dropwise to a well stirred mixture of the dipolarophile 
(3 mmol), Et3N (0.1 ml), CH2CI1  (30 ml) and 8% aq. 
NaOCl (15 ml) at 0°C. After 2 h TLC indicated com-
plete consumption of the oxime, and the reaction was 
then worked up and the products separated by chro-
matography. To test the efficiency of nitrile oxide for-
mation a reaction was first carried out in the absence of 
a dipolarophile. Under these conditions glucose oxime 
5 gave diglucopyranosylfuroxan 6'' (88%), which was 
identified from its spectroscopic properties (Table 1, 
entry 1, Scheme 2). In both the 'H and '3C NMR 
spectra there are distinct and independent sets of sig-
nals for the two glucosyl fragments, and in the carbon 
spectrum peaks are observed at 111.6 (C-3) and 153.4 
(C-4) ppm, which are characteristic of the 1,2,5-oxadia-
zole ring. 15  Further evidence is provided by the mass 
spectrum which shows, in addition to the parent ion, a 
significant peak at M-60 corresponding to loss of 
N202; this mode of fragmentation is typical for furox-
ans.'5 It is well established 16  that nitrile oxides readily 
dimerise to furoxans, and isolation of compound 6 
provides unambiguous evidence for efficient generation 
of the nitrile oxide 7. The oximes derived form D-galac-
tose and D-xylose reacted similarly affording the corre-
sponding furoxans (Table 1, entries 2 and 3). The 
pyranosylfuroxans are of interest in their own right, 
and they can be regarded as C-disaccharides with func-
tionalised ethylene bridges between the two anomeric 
positions. 
Generating nitrile oxide 7 in the presence of an excess 
of methylenecyclohexane (1:5) afforded a mixture of 
furoxan 6 (53%) and the isoxazoline 8 (32%) resulting 
from regiospecific cycloaddition to the alkene. The 
more reactive dipolarophiles styrene and norbornene 
afforded correspondingly greater yields of cycloadducts 
9 (53%) and 10 (76%), respectively (Table 1, entries 6 
and 7). 
The second method for generating nitrile oxide 7 
involved initial conversion of oxime 5 to the corre-
sponding hydroximoyl chloride 11. This was achieved 
by bubbling chlorine through a solution of the oxime (1 
mmol) in CH2Cl2 (5 ml) at —78°C, and allowing the 
mixture to warm to room temperature. After stirring 
for 16 h the solvent was removed in vacuo to yield 11 
Table 1. Generation and reactions of pyranosyl nitrile oxides 
AcO 
AcO CCJ=NOH 













12 R'R'CO2Me 	 15 
13 R=H,R'=CO2B 
14 R"=CO2Et,R=H 
Entry 	Nitrile oxide 	Method' 	Dipolarophile 	 Cycloadduct 	Yield/'A (d.r.) 	 Furoxan yield/% 
1 	n-GIc A/B None - 88/96 
2 D-Gal A None - 90 
3 	D-Xy! A None - 89 
4 D-Man B None - 95 
5 	D-Glc A Methylenecyclohexane 8 32 53 
6 D-GlC A CH,=CHPh 9 53(55:45) 21 
7 	D-Glc A Norbornene 10 76 (61:39) 5 
8 D-Man A/B CH2 =CHPh 85 (53:47)/95 (56:44) Traces 
9 	D-Glc B MeO,CCO,Me 12 98 6 
10 D-Glc B HCCCO,Et 13+14 69 (85:15)b 15 
11 	D-Man B CH,=CHCH,OH 15 30 14 
12 n-Glc B 16 17 40 (72:28) 26 
13 	n-Gal B 16 36 (75:25) 33 
'(A) RCH=NOH+aq. NaOCI; (B) RCCI=N0H+Et1N 
Ratio of regioisorners 13 and 14. 
QAc 
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Scheme 2. Reagents: (a) SnCl2/PhSH/Et3N, THF; (b) aq. NaOCl2 CH2Cl2; (c) methylenecyclohexane or styrene; (d) norbornene. 
AcO 
AcO OAc HO 
16 
Scheme 3. 
(90°/) as a white solid which was recrystallised from 
hexane/Et20. Similar yields (90-95%) were obtained for 
the hydroximoyl chlorides'4 derived from the D-Gal, 
D-Man and D-Xyl. The nitrile oxides were then gener-
ated from the hydroximoyl chlorides by base-mediated 
dehydrochlorination. Typically, the hydroximoyl chlo-
ride (1 mmol) and the dipolarophile (5 mmol) were 
dissolved in dry Et20 (20 ml) and Et3N (1.1 mmol) in 
dry CH2Cl2 (40 ml) added at 0°C via a syringe over 24 
h. The solvent was then removed in vacuo and the 
products separated by chromatography. Improved 
yields were achieved by this method, which also allowed 
a wider range of dipolarophiles to be employed. Repre-
sentative examples are shown in Table 1, entries 8-13, 
Scheme 3. The formation of 15 from allyl alcohol and 
C-disaccharide precursor'°'5 17 from D-Glc-derived 
alkene 16 represent examples of isoxazolines which 
could not be prepared directly from the nitromethyl 
compound by the Mukaiyama method.' The nitrile 
oxide derived from D-Gal reacted similarly (Table 1, 
entry 13). Dipyranosylfuroxans were also readily pre-
pared by this approach (Table 1, entries 1 and 4). 
In conclusion, hypochiorite oxidation of pyranose-1-
carbaldoximes and base-induced dehydrochlorination 
of the corresponding hydroximoyl chlorides provide 
effective means of generating pyranosyl nitrile oxides 
suitable for the synthesis of a range of C-glycosides. 
This approach is complementary to the current litera-
ture procedure based on isocyanate-mediated dehydra- 
17 
tion of pyranosylnitromethanes, and also provides easy 
access to novel dipyranosylfuroxans. 
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Abstract-3,4-Di(2,3,4,6-tetra-O-acetyl-13-D-mannopyranosyl)-1,2,5-oxadiazole 2-oxide (7) has been synthesised from D-rnaflflOSe by a 
route involving as the key step dimerisation of mannopyranosyl nitrile oxide 2. Three methods were used for the generation of the nitrile 
oxide: isocyanate-inediated dehydration of nitromethylmannose derivative 4, treatment of aldoxitne 5 with aq. hypochiorite, and base-
induced dehydrochiorination of hydroximoyl chloride 6. D-Gluco, 0-galacto, D-xylo, and L-fucopyranosyl analogues 8-11 were prepared 
similarly. The structure of o-mannose-derived 1,2,5-oxadiazole 2-oxide 7 was established by X-ray crystallography. © 2002 Elsevier 
Science Ltd. All rights reserved. 
1. Introduction 
1,2,5-Oxadiazole 2-oxides (furoxans, 1) have been known 
since 1850s and much attention has been paid to structure 
determination, development of preparative methods, and 
examining their reactions.' A wide variety of substituents 
can be accommodated at the 3- and 4-positions, including 
alkyl, aryl, amino, halogeno, nitro and thio groups. To date, 
however, there have been few examples of carbohydrate-
substituted furoxans.4 While investigating synthetic routes 
to C-glycosides and carbon-linked disaccharides (C-disac-
charides), we have sought novel methods for forming 
functionalised carbon bridges between pyranose rings, and 
now report that furoxans bearing pyranosyl substituents at 
both the 3- and 4-positions can readily be prepared in two 
steps from the parent monosaccharide. 
2. Results and discussion 
The furoxan ring can be constructed by various methods,' 
the most synthetically useful of which are: the oxidative 
cyclisation of 1,2-dioximes, the dehydration of tz-nitro-
ketoximes and, for symmetrically substituted furoxans, the 
dimerisation of nitrile oxides (Scheme 1). As suitably 
substituted carbohydrate dioxime and nitroketoxime pre-
cursors are not readily available we selected the nitrile oxide 
dimerisation approach. 
Nitrile oxides have been identified as intermediates in 
various reactions,5 and of these three provide synthetically 
useful methods of generation (Scheme 2). Hydroximoyl 
chlorides (RCCINOH), which can be prepared from the 
parent aldoxime using chlorine, N-chlorosuccinirnide, or 
nitrosyl chloride, undergo facile dehydrochlorination to the 
RCCI=NOH 
A 	 + - 	 -HOH 
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Scheme 3. Reagents: (a) MeNO2/NaOMe, MeOH; (b) H20, reflux; (c) Ac20/CF1SO1H; (d) SnCl2/PhSHJEt1N, THF; (e) C12, CH202; (I) TDI/Et3N, PhMe, 
reflux, quench with H2NCH2CH2NH2; (g) aq NaOCI, C1-12C12; (h) Et3N, Et20. 
nitrite oxide in the presence of triethylamine; in the absence 
of base the nitrile oxide may be released by thermotysis in an 
inert solvent such as toluene.6 There are also several one-pot 
methods 7,1  for generation of nitrite oxides from aldoximes 
including treatment with Chloramine-T or aq. NaOCl/ 
CH2Cl2. The third approach, which was originally reported 
by Mukaiyama and Hoshino,9 involves dehydration of 
the corresponding nitromethyl compound (RCH2NO2) with 
phenyl isocyanate; alternative dehydrating agents include 
POCI3 ,10  TsOH," CICO7Me12 and PhSO5CI.'3  
For the present work the choice of method is determined by 
the accessibility of the precursors. We initially considered a 
conventional approach to pyranose-1 -carbaldoximes—and 
hence to the corresponding hydroximoyl chlorides—via 
oximation of C-pyranosyl aldehydes. The literature 
routes '4 '6 to the aldehydes, however, all require several 
stages, some of which need expensive reagents and/or 
forcing conditions, and the products are prone to oxidation 
and hydration. We therefore selected pyranosylnitro-
methanes (2,6-anhydro- I -deoxy- I -nitroalditols) as the 
sources of the target pyranosyl nitrile oxides. These can 
readily be prepared 17  from the parent monosaccharide by 
base-catalysed addition of nitromethane (the Fischer—
Sowden reaction). Subsequent reduction to the aldoximes, 
followed by chlorination should then afford the correspond-
ing hydroximoyl chlorides. This sequence can thus provide 
access to all three potential precursors of the pyranosyl 
nitrile oxides. These approaches are illustrated in Scheme 3 
for generation of nitrite oxide 2 derived from D-mannose. 
D-Mannose was converted into -D-mannopyranosylnitro-
methane (3) using the general procedure of Köll et al.17 
which involves reaction with nitromethane and sodium 
methoxide in methanol, followed by heating the resulting 
adduct to achieve dehydration and cyclisation. As an 
isocyanate was to be used as the dehydrating agent it was 
necessary to protect all free hydroxyl groups, and compound 
3 was therefore converted into its peracetate derivative 4 
using Ac20/MeSO7H. The aldoxime 5 was prepared from 
the nitromethyl compound by reduction with SnCl2/PhSH/ 
Et7N. We have found that this protocol, which is based on 
a report by Bartra et at.,18 and depends on the reducing 
ability of the stannate species (PhS)7Sn, is an effective and 
general method for reducing nitromethyl monosaccharides. 
Hydroximoyl chloride 6, the third potential precursor for 
nitrite oxide 2, was prepared by chlorination of oxime 5. 
Although direct chlorination of aldoximes can be a 
capricious reaction, and alternative reagents such as NCS 
and NOCI are often used,' it proved to be very successful in 
this case. Bubbling chlorine through a solution of the oxime 
in CH2Cl2 at —78°C resulted in a colour change 
(colourless—.blue—.green) attributable to formation of the 
nitroso tautomer of the hydroximoyl chloride, and work-up 
of the reaction mixture afforded the desired product 6 as a 
white solid in 87% yield. Complete aldoxime to hydroxi-
moyl chloride conversion is evident from the NMR spectra. 
In the proton spectrum the 1-H signal at 7.37 ppm for the 
aldoxime is absent and the 2-H signal simplifies from a 
doublet of doublets to a doublet (1.9 Hz); and in the carbon 
spectrum the aldoxime CH peak at 146.1 ppm is replaced by 
a new quaternary carbon signal at 134.6 ppm. Although the 
starting material was a mixture of E- and Z-oximes, NMR 
spectroscopy showed the product to be a single isomer. 
The same approach was used to prepare the aldoximes 
and hydroximoyl chlorides from n-glucose, D-galactose, 
D-xylose and L-fucOse. 
The nitrite oxide 2 was first generated by heating under 
reflux a toluene solution of nitromethyl compound 4 and 
tolylene diisocyanate (TDI) (3 equiv.) with a catalytic 
amount of triethylamine. On completion the reaction was 
quenched by addition of 1 ,2-diaminoethane to remove 
excess isocyanate, and the solvent evaporated to afford 
the nitrite oxide dimer 3,4-di-(tetra-0-acetyl--D-manno-
pyranosyl)furoxan (7) as a crystalline solid in 90% yield 
(Table 1, entry 1). TDI was used for the dehydration in place 
of the traditional phenyl isocyanate for ease of work-up, as 
the by-product is then a polymeric urea which is readily 
separated by filtration)9 The second approach to the nitrite 
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D-XyI-Ac5 	 1,Fuc-Ac3 	
D-Gal-(CMe2)2 
Entry 	 Furoxans 	 R 	 Method 	 Yield (%) 
1 	 7 	 a-Man-Ac4 	 A 	 90 
2 7 a-Man-Ac4 B 75 
3 	 7 	 a-Man-Ac4 	 C 	 95 
4 8 a-Glc-Ac4 B 88 
5 	 8 	 a-Glc-Ac4 	 C 	 96 
6 9 a-Gal-Ac4 B 90 
7 	 10 	 D-Xyl-Ac3 	 A 	 81 
8 10 a-Xyl-Aci B 89 
9 	 11 	 L-Ric-Ac1 	 A 	 79 
10 15 a-Man-(CMe2)2 	 A 92 
Method A: RCH2N021TDI; Method B: RCI-l=NOH/NaOCI; Method C: RCC1NOH/EtN 
oxide involved oxidation of the aldoxime with hypochiorite 
using the two-phase procedure reported by Lee et al.8 A 
solution of oxime Sin dichloromethane was added dropwise 
to a stirred mixture of aqueous sodium hypochiorite and 
dichioromethane containing a catalytic amount of triethyl-
amine. Separation of the phases and work-up of the organic 
layer afforded furoxan 7 in 75% yield (Table 1, entry 2). 
Finally the nitrile oxide was generated by base-mediated 
dehydrochiorination of hydroximoyl chloride 6. A solution 
of triethylamine (1.1 equiv.) in Et20 was added to a solution 
of 6 (1.0 equiv.) in Et20 at 0°C and the mixture stirred at 
room temperature for 16 h. After filtration and washing with 
water to remove triethylamine hydrochloride, the solution 
was concentrated to afford furoxan 7 (95%) (Table 1, 
entry 3). 
D-Glucose, D-galactose, D-xylose and L-fucose-derived 
furoxans 8-11 were prepared similarly (Table 1, entries 
4-9) and in all cases the yields were very good (75-96%). 
The products were identified by their analytical and 
spectroscopic properties. '3C NMR spectroscopy is of 
particular value in identifying these compounds. In addition 
to resonances attributable to the two peracetylpyranosyl 
substitutents, there are characteristic peaks in the ranges 
110.5-111.6 (C-3) and 152.7-153.4 ppm (C-4) for the 
carbons of the oxadiazole ring. These values are typical for 
unstrained furoxans.2 In the proton NMR spectrum of 
dimannosylfuroxan 7 in CDC13 the two non-equivalent 
pyranosyl substituents lead to overlapping and only partially 
resolved signals. There are, however, distinct doublets for 
protons H(l') and H(l°), which are attached to the carbons 
adjacent to C(3) and C(4), respectively, of the furoxan ring; 
the observed 1 Hz couplings to H(2')JH(2") are in accord 
with the -D-manno configuration of the pyranoid rings. 
The higher chemical shift doublet was assigned to H(l") by 
analogy with data reported for other dialkylfuroxans.1 '2 A 
fuller analysis was performed for diglucosylfuroxan 8. In 
CDC13 the spectra were again poorly resolved and 
alternative solvents were therefore examined, including 
C6D6 and CD3COCD3. In all solvents the expected 10 Hz 
doublet signals are observed for protons H(l') and H(l°). 
Acetone-d6 provided the best overall resolution and a near 
complete proton and carbon assignment was achieved from 
COSY and HETCOR spectra. Identical proton—proton 31 
couplings are observed for the two pyranoid frameworks 
[H(l)—H(2) 10.0, H(2)—H(3) 9.3, H(3)—H(4) 9.3, H(4)—
H(5) 10.1 Hz]; these values are typical of C-glucosides. The 
separation of the H(l) signals proved to be solvent 
dependent 	0.01 ppm in CDC13, 0.06 ppm in 
CD1COCD3, 0.14 ppm in C6D6 —CDCI1). Smaller AS values 
are found for the ring protons H(2)—H(5). In the 13C spectra 
the C(l) signals are well separated (8c 2.1 ppm in 
CD3COCD3), but the remaining carbon signals are near 
equivalent (L6:50.1 ppm). Their mass spectra are also 
typical of this class of heterocycle;1,2 in addition to the 
molecular ion peak (M+ 1)+ in the FAB spectrum, there is a 
022' 
9032'j 
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Figure 1. Structure of 7.02 and 05 are disordered in the ratio 0.85:0.15. 
Table 2. Selected bond lengths, bond angles and torsion angles for furoxan 7 
Bond lengths (A) Bond angles (°) Torsion angles (') 
0(l)-N(2) 1.465(7) 0(l)-N(2)-C(3) 105.1(5) 0(1)-N(2)-C(3)-C(4) 0.16 
N(2)-C(3) 1.319(8) N(2)-C(3)-C(4) 108.3(5) N(2)-C(3)-C(4)-N(5) 0.29 
C(3)-C(4) 1.418(9) C(3)-C(4)-N(5) 110.6(5) C(3)-C(4)-N(5)--0(1) -0.68 
C(4)-N(5) 1.309(7) C(4)-N(5)-0(l) 107.3(5) Q4)-N(5)-0(l)-N(2) 0.76 
N(5)-O(I) 1.355(8) N(5)-0(1)-N(2) 108.7(4) N(5)-0(1)--N(2)-C(3) -0.57 
N(2)-0(2) 1.180(7) 0(l)-N(2)-0(2) 115.2(5) 0(1)-N(2)-C(3)-C(l1) 177.51 
C(3)-N(2).-0(2) 139.7(6) 0(2)-N(2)-C(3)-C(1') -1.19 
0(l)-N(5)-C(4)-C(1") -179.63 
distinctive fragment peak at (M-59)1 corresponding to loss 
of N202, whereas the peak due to loss of 0, which is usually 
present for heterocyclic N-oxides, is weak. 
The structure of D-mannose-derived furoxan 7 was 
confirmed by X-ray crystallography (Fig. 1). A noteworthy 
feature of the crystal structure is disorder in the furoxan 
moiety, with the N-oxide substituent being located at the 2-
and 5-positions in the ratio 0.85:0.15. Disorder of this type 
has also been reported20'21 for diphenyl- and tetramethyl-
ene-furoxans [1, R=Ph, (CH2)4] and some norbomane-
fused furoxans.22 Selected bond lengths, bond angles and 
torsion angles for the furoxan ring system are given in Table 
2. The atoms of the furoxan unit 0(1), N(2), C(3), C(4), 
N(5), 0(2) are near planar (maximum deviation 0.004 A), as 
are the atoms C(1'), C(3), C(4), C(l") linking the oxadiazole 
to the two pyranoid substituents. The bond lengths are 
typical of furoxans2 and indicate 'if-electron delocalisation 
over all six atoms with the exocyclic oxygen attached to 
N(2) causing significant distortion of the oxadiazole ring. Of 
particular note is the long 0(l)-N(2) and short N(2)-0(2) 
bonds. C(3)-C(4) is also shortened corresponding to 
partial double bond character, and N(2)-C(3) is longer 
than C(4)-N(5), consistent with contributions from 
12b-12d to the resonance hybrid. The bond angles of 
the C=NO2 unit are also typical of 3,4-disubstituted 
furoxans, with 0(2)-N(2) -C(3) significantly larger than 
0(2)-N(2)-0(1) [139.7° cf 115.2°1. 
0 
:x 
0 0 	 0 
o+ :x : 'IN 
12a 12b 12c 	 12d 
The Cramer and Pople23 puckering parameters for the two 
pyranoid rings are given in Table 3. Ring A attached to C-3 
of the furoxan has 98% of the puckering of an ideal 
cyclohexane chair conformation, with Q=0.596 A and 
0=175.7° compared with Q=0.630 A and 0=180° for the 
ideal chair. Similarly for ring B attached to C-4 with 
Table 3. Cremer and Pople puckering parameters for pyranoid rings of 
furoxan 7 
Ring 	 Atoms 	 Q (A) 0 C) 	P (°) 
A 	0(1')-C(5')-C(4')-C(3')-C(2')--C( 1') 	0.596 175.7 105.1 
B 0(1°)-C(5")-C(4")-C(3")-C(2°)-C( 1") 0.593 176.7 213.7 
Ref. 23. 
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Scheme 4. 
Q=0.593 A and 0=176.7°. Such values are typical of 
pyranoid rings.24 
All the dipyranosylfuroxans described so far have been 
prepared as their peracetate derivatives using the acetylated 
nitromethylpyranose as the starting material. In order to 
widen the range of protecting groups, and thus ultimately 
increase the scope for transformations that might be 
accomplished on the resulting furoxans, we investigated 
diisopropylidene-mannose analogue 13 as a possible pre-
cursor of nitrile oxide 14 (Scheme 4). Compound 13 was 
prepared from f3-D-mannopyranosylnitromethane (3) by 
treatment with 2-methoxypropene/TsOH/CaSO4/DME as 
previously reported.24 The nitrile oxide was then generated 
from the nitromethyl compound 13 in the usual way using 
TDI/EI3N, and from the reaction mixture was isolated the 
nitrile oxide dimer 15 (92%), which was identified from its 
NMR and mass spectra. The 'H NMR signals for the 
pyranoid ring protons were best resolved in CDCI3 and a full 
analysis was possible from the 600 MHz COSY and 
1D-TOCSY spectra. The signals for H(V) and H(V) are 
well separated (61-10. 16 ppm) and show the expected small 
couplings (2.5 Hz) to H(2')/H(2"). As expected, the 
presence of the dioxolane ring fused at C(2)/C(3) results 
in some distortion of the regular 4C, conformation, as 
evidenced by the proton-proton 3J couplings [H(1)-H(2) 
2.6, H(2)-H(3) 5.2, H(3)-H(4) 7.9, H(4)-H(5) 10.1 Hz]. 
The chemical shifts for the isopropylidene ketal carbons 
provide definitive evidence for the presence of both 1,3-
dioxane and 1 ,3-di-oxolane rings attached to both pyranosyl 
substituents. For the 1 ,3-dioxane units protecting 0(4)/0(6) 
there are characteristic signals for the ketal carbons at 99.9 
and 100.0 ppm and for the isopropylidene methyl carbons at 
18.7, 18.7, 28.7 and 28.9 ppm. Corresponding signals for the 
dioxolane unit protecting 0(2)/0(3) are observed at 110.4, 
110.5 (ketal carbons) and 26.4,27.3,28.3, 28.4 ppm (methyl 
carbons). Such values are typical25 of 2,2-dimethyl-1,3-di-
oxolanes and 2,2-dirnethyl- I ,3-dioxanes, respectively 
(Scheme 4). 
Finally, the unprotected 3,4-di-D-glucosyl-furoxan 16 was 
prepared by treatment of the octa-acetyl derivative 8 with 
NH-,/MeOH (Scheme 5). The product was identified from its 
spectroscopic properties. In the '3C NMR spectrum in D20 
there are diagnostic peaks for the oxadiazole ring carbons 
C(3) and C(4) at 115.4 and 156.0 ppm, respectively, which 
are 3-4 ppm higher than those found for the peracetyl 
analogue in acetone-d6. The glucosyl H(l')/l-l(l") doublet 
signals in the proton spectrum are well separated at 4.56 and 
4.60 ppm, and both show the expected trans-diaxial 10 Hz 
coupling to H(2')/H(2"). The product, which was isolated 
in high yield (91 %), represents a rare example of a water-
soluble furoxan. 
In conclusion, dipyranosylfuroxans can be synthesised in 
good yield from the parent monosaccharide. Of the three 
procedures examined the two-step route involving con-
version of the monosaccharide to a suitably protected 
nitromethylpyranose, followed by dehydration to the 
pyranosyl nitrile oxide, is in most cases the most efficient. 
As furoxan rings are readily reduced,' 2 e.g. to 1,2,5-
oxadiazoles (furazans) and 1,2-dioximes, there should be 
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K. W. J. Baker et al. / Tetrahedron 58 (2002) 8505-8513 
obtained using a Perkin—Elmer 2400 instrument. Optical 
rotations were measured at 21°C on a Perkin—Elmer 141 
polarimeter using 1.8 ml of filtered solution. The 'H and '3C 
NMR spectra were recorded with Brucker WP200SY, 
AX250, WH360 or Varian VXR600 spectrometers on 
solutions in CDC11  (unless otherwise stated) with Me4Si 
as internal standard. Positive-ion FAB and high resolution 
mass spectra were obtained on a Kratos MS50TC instru-
ment using either glycerol or thioglycerol matrices. Infrared 
spectra were recorded as films or nujol mulls using a 
Perkin—Elmer 781 spectrometer. Merck aluminium-backed 
plates coated with Kieselgel GF254 (0.2 mm) were used for 
analytical TLC; detection was by UV or sulfuric acid 
charring. Dry flash chromatography was carried out using 
Kieselgel GF254 and eluted under water pump vacuum. 
3.2. Pyranosylnitromethanes 
2,3,4,6-Tetra-0-acetyl-f3-D-mannopyranosylnitromethane 
(4) was prepared from D-mannose by reaction with 
MeNO2/NaOMe/MeOH and acetylation of the resulting 





nitrornethane were prepared similarly from D-glucose, 
D-galactose, D-xylose, and L-fucose, respectively. 2,3:4,6-
Di-0-isopropylidene-3-D-mannopyranosylnitromethane 
(13) was synthesised from -D-mannopyranosylnitro-
methane by treatment with 2-methoxypropene/TsOH/ 
CaSO4/DME as described in the literature. 24 
3.3. General procedure for the synthesis of the 
pyranosylformaldoximes 
Triethylamine (0.2 ml, 1.5 mmol) and thiophenol (0.14 ml, 
1.35 mmol) were added to a solution of tin(II) chloride 
(100 mg, 0.45 mmol) in dry THF (6 ml) under nitrogen at 
0°C. To the resulting solution was added a solution of the 
pyranosylnitromethane (0.3 mmol) and the mixture stirred 
for 16 h. After removal of the solvent in vacuo, the residue 
was washed with hexane to remove excess thiophenol, and 
the product separated by dry-flash chromatography (silica, 
hexane/Et20 gradient elution) to afford compound as a 
mixture of E- and Z-isomers. The isomer ratio was 
determined by comparison of the 1-H peaks at —7.3 and 
—6.7 ppm. 
3.3.1. 2,3,4,6-Tetra-0-acetyl--D-mannopyranosylform-
aldoxime (5). 89%; white solid; mp 154-156°C (from 
hexane/Et20) (lit.26 152-154°C); E/Z=2.3: I. 
3.3.2. Tetra-O-acetyl--D-glucopyranosylformaldoxime. 
76%; mp 139-140°C (from hexane/Et20) (lit.26 155-
157°C); EIZ=5:1. 
3.3.3. Tetra-O-acetyl--D-galactopyranosylformaldoxime. 
89%; mp 184-185°C (from hexanefEt2O) (lit.26 170-
172°C); E/Z=9:1. 
3.3.4. Tri-O-acetyl-3-n-xylopyranosylformaldoxime. 83%, 
mp 135-137°C (from hexane/Et20) (lit.26 160-163°C). 
3.3.5. Tri-O-acetyl--L-fucopyranosylformaldoxime. 90%; 
mp 37-39°C; E-isomer: [a], 8=-22 (c=1.0, CHCI3); '-',x 
(cm', Nujol) 3311 (OH), 1744 (C0); el,, (250 MHz, 
CDC13) 1.17, (3H, d, 7-H), 1.97, 2.00, 2.17, (9H, 3s, 
3xCOCH3), 3.83 (IH, td, 6-H), 3.98 (IH, dd, 2-H), 5.07, 
(IH, dd, 4-H), 5.13-5.27, (2H, m, 3-H and 5-H), 7.33, (IH, 
d, IH), 8.54, (lH broad s, NOH); J(x—y, Hz) 1-2 6.9, 2-3 
9.7, 3-4 10.2, 4-5 3.3, 5-6 1.0, 6-7 6.4; Sc (63 MHz, 
CDC17) 16.2 (C-7), 20.5, 20.6 (3xCOCH1), 66.8, 70.4, 71.7, 
72.9, 75.9, (C-2—C-6), 147.2 (C-I), 169.9, 170.1, 170.6 
(3XCOCH1); HRMS (FAB) Found: M+l, 318.1180. 
C,7H20N08 requires 318.11889; E/Z=7:I. 
3.4. General procedure for the synthesis of the 
hydroximoyl chlorides 
Dry chlorine gas was bubbled through a solution of the 
pyranosyl form aldoxime (ca I mmol) in dry dichioro-
methane (15 ml) at —78°C until the colour changed from 
blue to green. On warming to room temperature the colour 
faded and the solvent was removed in vacuo to afford an oil. 
The product was dissolved in ca 1 ml of dichloromethane 
and allowed to crystallise. 
3.4.1. 3,4,5,7-Tetra-O-acetyl-2,6-anhydro- 1-deoxy-1-
chloro-1-hydroxyimino-D-glycero-D-galacto-heptitol (6). 
87%; white powder; mp 102-103'C; [a] 8=1ll.8 (c=0.7, 
CHCI1); 	(cm, Nujol) 3503 (OH), 1744 (C0); 6H 
(250MHz, CDCI1) 1.98, 2.04, 2.09, 2.12 (12H, 4s, 
4xCOCH3), 3.73, (IH, ddd, 6-H), 4.23 (IH, dd, 7a-H), 
4.29 (IH, dd, 7b-H), 5.06-5.33 (3H, m, 2-H, 4-H, 5-H) 5.73 
(111, t, 3-H), 8.80 (1H, broad s, NOH); J(x—y, Hz) 2-3 1.9, 
3-4 3.3, 4-5 nd, 5-6 9.8, 6-7a 2.5, 6-7b 5.6, 7a-7b 12.3; 
8c (90 MHz, CDCI7) 20.38, 20.44, 20.55 (4xCOCH3), 
62.4 (C-7), 65.5, 67.7, 71.6, 76.5, 77.1 (C-2—C-6), 134.6 
(C-i) 169.4, 169.5, 169.9, 170.2 (4xCOCH 3); HRMS 
(FAB) Found: M+l, 410.08545. C15H21NO35  Cl requires 




white needles; mp 157-159°C (from CH2C12); umax 
(cm', Nujol) 3311 (OH), 1747 (C=O); [a], 8=-5.0 (c= 
1.0, CHCI3); 6H  (250 MHz, CDCI3) 1.97, 2.00, 2.03, 2.07 
(I 2H, 4s, 4XCOCH3), 3.80 (1H, dd, 6-H), 4.14 (IH, dd, 7a-
H), 4.23 (1H, dd, 7b-H), 4.31 (1H, d, 2-H), 5.14, 5.26, 5.36 
(3H, 3dd, 3-H, 4-H, 5-H), 8.93 (1H, br s, NOH); J(x—y, Hz) 
2-3 9.6, 3-4 nd, 4-5 nd, 5-6 9.8, 6-7a 2.4, 6-7b 4.6, 
7a-7b 12.5; 8 (63 MHz, CDCI3) 20.4, 20.5, 20.5, 
20.6 (4xCOCH3), 61.8 (C-7), 67.8, 68.8, 73.7, 75.7, 78.3 
(C-2—C-6), 136.2 (C-i), 169.2, 169.5, 170.5, 170.8 (4x 
COCH3); HRMS (FAB) Found: M+1, 410.08565. 
C,5H2 ,NOC1 requires 410.08540. Found: M+ 1, 
412.08226. C15H21NO10  Cl requires 412.08245. 
3.5. Synthesis of the dipyranosylfuroxans (3,4-dipyrano-
syl-1,2,5-oxadiazole 2-oxides) 
The furoxans were prepared by dimerisation of the 
corresponding nitrile oxides, which were generated either 
by dehydration of the pyranosylnitromethane (Method A), 
or dehydrogenation of the pyranosylformaldoxime (Method 
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B), or dehydrochlorination of the pyranosyl hydroximoyl 
chloride (Method Q. The yields are shown in Table 1. 
Method A. To a solution of the pyranosylnitromethane 
(0.5 mmol, 1 equiv.) in dry toluene (20 ml) under nitrogen 
was added triethylamine (0.1-0.2 ml) and tolylene diiso-
cyanate (3 equiv.), and the mixture heated under reflux for 7 
days. After cooling to 0°C 1,2-diaminoethane (3 equiv.) was 
added dropwise with stirring. After I h the mixture was 
filtered through a celite pad to remove the precipitated 
polymeric urea. The pad was washed with toluene and 
chloroform and the combined organic layers evaporated to 
afford the product which was purified by chromatography 
and/or recrystallisation. 
Method B. Aqueous sodium hypochlorite (5%, 16.2 mmol, 
60 equiv.) was added dropwise to a stirred solution of 
the pyranosylformaldoxime (0.26 mmol, 1 equiv.) in 
H20/CH2Cl2 (1:1, 20 ml). After stirring overnight the 
organic layer was separated and the aqueous layer extracted 
with chloroform (3X50 ml). The combined organic layers 
were dried (MgSO4) and the solvent removed in vacuo to 
yield the product, which was recrystallised from the 
appropriate solvent. 
Method C. To a solution of the pyransoyl hydroximoyl 
chloride (0.22 mmol, 1 equiv.) in dry Et20 (10 in]) triethyl-
amine (0.25 mmol, 1.1 equiv.) was added dropwise via a 
syringe and the solution left to stir overnight. The mixture 
was then poured into water, the organic layer separated and 
the aqueous layer extracted with chloroform (3X50 ml). The 
combined organic layers were dried (MgSO4) and the 
solvent removed in vacuo to yield the product, which was 
purified by recry stall isation. 
3.5.1. 3,4-Di(2,3,4,6-tetra-O-acetyl--D-mannopyrano-
syl)-1,2,5-oxadiazole 2-oxide (7). White needles, mp 
213-215°C (from EtOH) (Found: C, 47.9; H, 5.0, N, 3.8. 
C30H38N2020 requires C, 48.2; H, 5.1, N, 3.7); [a]D"=— 14.0 
(c=1.0, CHCI1); 	(cm, Nujol) 1743 (C0), 1606 
(CN); 8 (250 MHz, CDCI3) 1.93, 1.93, 1.96, 2.02, 2.03, 
2.05, 2.05, 2.06, 2.07, 2.11 (24H, 8s, 8XCOCH3), 3.80-3.94 
(2H, in, 5'-H, 5°-H), 4.17-4.36 (4H, in, 6'a-H, 6'b-H, 6°a-H, 
6°b-H), 4.93 (IH, d, J1 _2' 0.9, l'-H), 5.17 (1H, d, J 1"_ 2" 1.0, 
I"-H), 5.10-5.36 (4H, m, 2'-H, 2°-H, 4'-H, 4°-H), 5.68-
5.74 (2H, in, 3'-H, 3"-H); 5c  (63 MHz, CDC11) 20.3, 20.3, 
20.4, 20.4, 20.6, 20.6 (8xCOCH1), 62.1, 62.7 (C-6', C-6°), 
64.9, 65.4, 66.0, 67.3, 70.5, 71.0, 71.6, 76.8, 77.1 (C-I', 
C-2', C-3', C-4', C-5', C-I", C-2°, C-3°, C-4", C-5"), 110.5 
(C-3), 152.7 (C-4), 169.2, 169.3, 169.6, 169.7, 169.9, 170.2, 
170.3 (8XCOCH3); m/z (FAB) 747 (M+1), 687 [(M—
N202)+1]; HRMS (FAB) Found: M+1, 747.20920. 
C10H39N2020 requires 747.20962. The structure of com-
pound 7 was confirmed by X-ray crystallography. 
3.5.2. 3,4-Di(2,3,4,6-tetra-O-acetyI--n-glucopyranosyI)-
1,2,5-oxadiazole 2-oxide (8). White solid, mp 118-120°C 
(from Et20—hexane) (Found: C, 47.9; H, 5.0, N, 3.4. 
C10H38N2020 requires C, 48.2; H, 5. 1, N, 3.7); [a]D'8= —40.4 
(c=0.74, CHC1); Vn,ax (cm, Nujol) 1747 (C0), 1599 
(CN); hH (360 MHz, CD3COCD3) 1.94, 1.95, 2.00, 2.05, 
2.06, 2.08, 2.14, 2.15 (24H, 8s, 8XCOCH3), 4.18-4.22 (2H, 
in, 6'b-H, 6°b-H), 4.27 (2H, in, 5'-H, 5"-H), 4.46-4.54 (2H, 
in, 6'a-H, 6"a-H), 5.16 (1H, d, 1'-H), 5.22 (IH, d, l"-H), 5.33 
(1H, dd, 4'-H), 5.36 (IH, dd, 4"-H), 5.53 (2H, dd, 3'-H, 
3"-H), 5.64 (IH, dd, 2"-H), 5.65 (IH, dd, 2'-H); Ax—y, Hz) 
1'2' 10.0, 2'-3' 93, 3'-4' 93, 4'-5' 9.3, 5'-6a' nd, 5'-6a' 
nd, 6a'-6b' nd, l"2" 10.0, 2"-3" 9.3, 3"-4" 9.3, 4"-5° 9.3, 
5"-6a" nd, 5"-6a° nd, 6a°-6b° nd; 8c  (63 MHz, 
CD1COCD1) 18.6, 18.7, 18.8, 18.8, 19.1, 19.1 (8X 
COCH3), 60.9 (C-6', C-6"), 66.9, 67.0 (C-4', C-4°), 68.9, 
69.0 (C-2', C-2"), 69.6 (C-l'), 71.7 (C-I"), 72.6, 72.7 (C-3', 
C-3"), 75.4, 75.5 (C-5', C-5"), 111.6 (C-3), 153.4 (C-4), 
168.0, 168.1, 168.6, 168.6, 169.2 (8XCOCH3); in/z (FAB) 
747 (M-+I), 687 (M—N202)+l]; HRMS (FAB) Found: 
M+1, 747.20936. C30H39N2020 requires 747.20962. 
3.5.3. 3,4-Di(2,3,4,6-tetra-O-acetyl--D-galactopyrano-
syl)-1,2,5-oxadiazole 2-oxide (9). White solid, mp 167-
168°C (from Et20—hexane); [a]1 ,8=-6.4 (c=0.14, CHC13); 
81, (250 MHz, CDCI3) 1.96, 1.97, 1.98, 1.99, 2.03, 2.04, 
2.21, 2.22 (24H, 8s, 8XCOCH3), 4.03-4.24 (6H, m), 4.79 
(IH, d, J,'_2'=10.0 Hz, 1'-H), 4.82 (IH, d, J 1"_ 2 =l0.0 I-lz, 
l"-H), 5.12-5.19 (2H, in), 5.47-5.66 (4H, m); 5c  (63 MHz, 
CDCI1) 20.3, 20.4, 20.5 (8XCOCH3), 61.1 (C-6', C-6"), 
65.7, 66.7, 67.0, 67.1, 70.6, 71.5, 72.7, 75.0, 75.1 (C- I'-C-5', 
C-1"-C-5"), 111.5 (C-3), 153.0 (C-4), 169.0, 169.3, 169.8, 
169.9, 170.2 (8XCOCH); m/z (FAB) 748 (M+2), 687 
[(M —N2O2)+ 1]; HRMS (FAB) Found: (M - N2O2)+ I, 
687.21371. C301-139018 requires 687.21364. 
3.5.4. 3,4-Di(2,3,4-tri-O-acetyl-f3-D-xylopyranosyl)-1,2,5-
oxadiazole 2-oxide (10). White solid; mp 190°C; [a] D"= 
—33 (c°1.0, CHCI3); umax  (cm, Nujol) 1759 (C=O), 
1600 (C°N); 8.i  (250 MHz, CDCI1) 1.94, 2.03, 2.06, 2.07, 
2.07 (18H, 6s, 6XCOCH1), 3.40-3.52 (2H, m), 4.10-4.22 
(1H, m), 4.29-4.38 (IH, in), 4.62 (2H, 2d, JI'.2'=9.5  Hz, 
J1°_ 2"=9.6 Hz, l'-H, 1"-H), 5.00-5.10 (2H, m), 5.28-5.43 
(4H, m); 6  (63 MHz, CDCI3) 20.0, 20.3, 20.5 (6XCOCH3), 
66.9, 66.9 (C-6', C-6"), 68.3, 69.7, 70.2, 71.6, 72.3, 72.4, 
73.9, 76.3 (C-1'-C-5', C-l°-C-5°), 112.7 (C-3), 153.7 (C-4), 
169.3, 169.5, 169.6, 169.8, 169.9 (6xCOCH3); 'n/z (FAB) 
603 (M-+ 1), 543 [(M—N2O2)+l]; HRMS (FAB) Found: 
M+ 1, 603.17504. C24H33N2016 requires 603.17518. 
3.5.5. 3,4-Di(2,3,4-tri-O-acety1--L-fucopyranosy1)-1,2,5-
oxadiazole 2-oxide (11). White solid; mp 213°C (from 
hexane—EtOAc); [a]j 8=278 (c=0.29, CHCI3); 8H 
(250 MHz, CDC13) 1.23-1.28 (6H, 2t, 2XCH3), 2.01, 
2.02, 2.03, 2.04, 2.26, 2.28 (18H, 6s, 6XCOCH1), 3.87-
4.00 (2H, 2dd, 5'-H, 5"-H), 4.85 (2H, 2dd, l'-H, 1"-H), 5.19 
(2H, 2dd, 4'-H, 4"-H), 5.39 (2H, dd, 3'-H, 3"-H), 5.63 (2H, 
2dd, 2'-H, 2"-H); J(x—y, Hz) 1'-2' 10.1, 2'-3' nd, 3'-4' nd, 
4'—S' 1.0, 5'-6' 6.4, l°2" 10. 1, 2"-3" nd, 3"-4" nd, 4"—S" 
1.0, 5"-6° 6.4; h (63 MHz, CDCI1) 16.7, 16.8 (2XCH1), 
20.8, 21.0, 21.1, 21.2 (6xCOCH3), 66.4, 67.0, 70.7, 70.7, 
71.1, 72.4, 72.7, 72.9, 74.2, 74.3 (C-1'-C-5', C-l"-C-5"), 
112.5 (C-3), 153.8 (C-4), 169.7, 170.0, 170.5, 170.6, 170.9, 
170.9 (6XCOCH1); nz/z (FAB) 681 (M+l), 571 [(M—
N202)+1]; HRMS (FAB) Found: M+1, 631.19732. 
C26H35N2016 requires 63 1.19866. 
3.5.6. 3,4-Di(2,3:4,6-di-O-isopropylidene--D-manno-
pyranosyl)-1,2,5-oxadiazole 2-oxide (15). White solid; 
mp 131-133T (from hexane) (Found: C, 54.7; H, 6.8, N, 
4.8. C20H35N2012 requires C, 54.7; H, 6.7, N, 4.9); 
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[a] 8=29.1 (c=0.23, CHCI3); r' jnax (cm', Nujol) 1606 
(CN); 6H  (600 MHz, CDCI3) 1.35, 1.37, 1.48, 1.48, 1.57, 
1.58, 1.58, 1.64 (24H, 8s, 8XCCH3), 3.28 (111, dt, 5"-H), 
3.33 (1H, dt, 5'-H), 3.73 (1H, t, 6ax'-H), 3.80 (IH, dd, 4'-H), 
3.90 (IH, t, 6ax"-H), 3.97 (dd, 0-H), 3.99 (IH, dd, 6eq"-H), 
4.01 (IH, dd, 6eq'-H), 4.18 (IH, dd, 3°-H), 4.21 (IH, dd, 
3'-H), 4.53 (1H, t, 2'-H), 4.54 (1H, t, 2"-H), 5.05 (H, d, l'-H), 
5.21 (IH, d, l"-H); J(x-y, Hz) 1'-2' 2.6, 2'-3' 5.2, 3/_41 
7.9, 4'-5' 10. 1, 5'-6ax' 10.7, 5'-6eq' 5.5, 6ax'-6eq' 10.2, 
1"-2" 2.4, 2"-3° 5.1, 3°-4" 7.9, 4°-5" 10.1, 5"-6ax" 10.7, 
5"-6eq°  5.5, 6ax"-6eq" 10.1; 8 (600 MHz, CD3COCD3) 
1.31, 1.32, 1.35, 1.36, 1.52, 1.53, 1.54, 1.56 (24H, 8s, 
8xCCH3), 3.39 (1H, dt, 5"-H), 3.48 (1H, dt, 5'-H), 3.82 (IH, 
t, 6ax"-H), 3.85-3.96 (5H, m, 4'-H, 4°-H, 6ax'-H, 6eq'-H, 
6eq°-H), 4.19 (IH, dd, 3°-H), 4.28 (1H, dd, 3'-H), 4.64 (1H, 
dd, 2"-H), 4.68 (1H, dd, 2'-H), 5.31 (H, d, 1'-H), 5.46 (1 H, d, 
1°-H); Ax-y, Hz) V-22.7, 2'-3'5.3, 3'-4'7.9,4'-5' 10.0, 
5'-6ax' 10.0, 5'-eq' 5.7, 6ax°-6eq" nd, 1°-.2" 2.5, 2°-3°  
5.2, 3°_4" 79, 0-5" 10.0, 5°-6ax" 10.1, 5°-6eq" 5.7, 
6ax°-eq° 10.7; 8 (63 MHz, CDCI3) 18.7, 18.7, 26.4, 27.3, 
28.3, 28.4, 28.7, 28.9 (8xCCFI3), 61.5, 61.6, 71.1, 71.4, 
72.3, 72.5, 72.6, 73.8, 75.4, 75.8 (C-1' -C-S', C-1°-C-5°), 
61.5, 61.6 (C-6', C-6"), 99.9, 100.0, 110.4, 110.5 (4xCCH1), 
112.X (C-3), 153.1 (C-4); HRMS (FAB) Found: M+1, 
571.24946. C20H39N2012 requires 571.25030. 
3.6. Preparation of 3,4-di(-D-gIucopyranosyl)-1,2,5-
oxadiazole 2-oxide (16) 
A solution of 3,4-di(2,3,4,6-tetra-O-acety1-3-D-glucopyrano-
syl)-1,2,5-oxadiazole 2-oxide (8) (30 mg, 0.04 mmol) in 
methanol (10 ml) was treated with a saturated ammonia 
solution in methanol (10 ml). After stirring overnight TLC 
indicated the absence of starting material and formation a 
more polar product. The reaction mixture was concentrated 
in vacuo and co-evaporated with methanol (3X10 ml) 
to afford 3,4-di-(3-D-glucopyranosyl)-1,2,5-oxadiazole 
2-oxide (16) as an oil (15 mg, 91%); [a] 8=+35.7 
(c=0.14, H20); 8j  (250MHz, D20) 3.36-3.70, 3.83-
4.01 (12H, 2m, 2'-H, 3'-H, 4'-H, 5'-H, 6'a-H, 6'b-H, 2"H, 
3°-H, 4°-H, 5"-H, 6°a-H, 6°b-H), 4.56, 4.60 (2H, 2d, 
J1'_2'=10.0 Hz, J 1"_ 2"=10.0 Hz, l'-H, l"-H); Sc (90 MHz, 
D20) 61.4, 61.4 (C-6', C-6°), 69.9, 70.0, 70.7, 71.8, 72.5, 
74.5, 77.2, 77.2, 80.9, 81.1 (C-l'-05', C-l°-C-5°), 115.4 
(C-3), 156.0 (C-4); m/z (FAB) Found: M+l, 411.12501. 
C I4H23N2012  requires M+l 411.12510. 
3.7. Crystal structure of furoxan 7 
Diffraction data were collected with graphite-monochro-
mated Cu Ka radiation (A= 1.54184 A) on a Stoe Stadi-4 
diffractometer equipped with an Oxford Cryosystems low-
temperature device operating at 150 K. The structure was 
solved by direct methods and refined by full-matrix least-
squares against F 2 (Shelxtl).27 The 2-oxide substituent of 
the 1,2,5-oxadiazole ring is disordered over the 2- and 5-
positions in the ratio 0.85:0.15(2). All non-H atoms except 
for the minor component 0-atom were refined with 
anisotropic displacement parameters; H-atoms were placed 
in idealised positions. Crystal data: C30H38N2020, M= 
746.62, triclinic, a=7.839(3), b=8.6191(18), c 
13.229(3) A, cx=97.803(11)°, 	6=97.599(16)°, 	y 
91.07(2)°, V=877.2(4) A3, space group P1 (the compound 
was known to be chiral); T=150 K, Z=l, D= 
1.413 Mgm 3, colourless block, 0.38x0.20x0.20 mm3. 
The final conventional R-factor (based on F and 2694 data 
with F>4o(F) was 6.71%; wR2 (based on F 2 and all 3093 
data used in refinement) was 18.37%. The final difference 
map extremes were 0.44 and -0.37e A 3. The Flack 
parameter25 was 0.1(3); this means that the diffraction data 
do not establish the 'hand' of the structure, although this is 
unambiguous from the synthetic route used. 
Crystallographic data (excluding structure factors) for the 
structure reported in this paper have been deposited at the 
Cambridge Crystallographic Data Centre as supplementary 
publication number 186410. Copies can be obtained free 
of charge on application to CCDC, 12 Union Road, 
Cambridge CB2 IEZ, UK (fax: +44-1223-336-033 or 
email: deposit@ccdc.cam.ac.uk).  
Acknowledgements 
We thank Dr I. H. Sadler for help with NMR spectra. We are 
grateful to the EPSRC for research and maintenance 
(K. W. J. B.) grants. 
References 
I. Gasco, A.; Boultori, A. J. Adv. Heterocycl. Chem. 1981, 29, 
251-340. 
Paton, R. M. In Comprehensive Heterocyclic Chemistry H; 
Katritzky, A. R., Rees, C. W., Scriven, E. F. V., Eds.; 
Pergamon: Oxford, 1996; Chapter 4.05 and references therein. 
Friedrichsen, W. Methoden Org. Chem. (Houben-Wehi) 1994, 
E 12. 
For rare examples see: (a) Tronchet, J. M. J.; Jotterand, A.; 
LeHong, N.; Perret, M. F.; Thomdahl-Jaccard, S.; Tronchet, J.; 
Chalet, J. M.; Faivre, L.; Hausser, C.; Sébestian, C. HeIv. 
C/mini. Acta 1970, 53, 1484-1489. (b) Tronchet, J. M. J.; 
Le-Hong, N. Carbohydr. Res. 1973, 29, 2311-2323. 
(a) Grundmann, C.; Grilnanger, P. The Nitrile Oxides; 
Springer: Heidelberg, 1971. (b) Caramella, P.; Grunanger, P. 
In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.; 
Wiley: New York, 1984; Chapter 3. (c) Torssell, K. B. G. 
Nitrile Oxides, Nitrones, and Nitronates in Organic Synthesis; 
VCH: Weinheim, 1988. (d) Paton, R. M. In Comprehensive 
Organic Functional Group Transformations; Kaitzky, A. R., 
Meth-Cohn, 0., Rees, C. W., Eds.; Pergamon: Oxford, 1995; 
Chapter 3.20. 
(a) Eloy, F.; Lenaers, R. !-Jelv. Chim. Acta 1963, 46, 
1067-1073. (b) Sasaki, T.; Yoshioka, T. Bull. Chem. Soc. 
.Jpn 1967, 40, 2604-2607. 
Hassner, A.; Rai, K. M. L. Synthesis 1989, 57-59. 
Lee, G. A. Synthesis 1982, 508-509. 
Mukaiyama, T.; Hoshino, T. J. Am. Chem. Soc. 1960, 82, 
5339-5342. 
(a) McMurry. J. E. Org. Synth. 1973,53,59-62. (b) Bachrnnn, 
G. B.; Strom, L. J. Org. Chem. 1963, 28, 1150-1152. 
Shimizu, T.; Hayashi, Y.; Teramura, K. Bull. Chem. Soc. Jpn 
1984, 57, 2531-2534. 
Yoshioaka, T.; Yamamoto, K-i.; Shimnauchi, Y.; Fukagawa, 
K. W. J. Baker et al. / Tetrahedron 58 (2002) 8505-8513 
	
8513 
Y.; Ishikura, T. J. Chem. Soc., Chem. Commun. 1984, 
1513-1514. 
Shimizu, T.; Hayashi, Y.; Shibafuchi, H.; Teramura, K. Bull. 
Chem. Soc. Jpn 1986, 59, 2827-283 1. 
(a) Kobertz, W. R.; Bertozzi, C. R.; Bednarski, M. D. 
Tetrahedron Lett. 1992, 33, 737-740. (b) Bertozzi, C. R.; 
Bednarski, M. D. Tetrahedron Lett. 1992, 33, 3109-3112. 
(c) Kobertz, W. R.; Bertozzi, C. R.; Bednarski, M. D. J. Org. 
Chem. 1996, 61, 1894-1897. 
(a) Dondoni, A.; Scherrman, M.-C. J. Org. Chem. 1994, 59, 
6404-6412. (b) Dondoni, A.; Maria, A. J. C/win. Soc., Chein. 
Com,nun. 1999, 2133-2145. 
Petrusova, M.; BeMiller, J. N.; Krihova, A.; Petrus, L. 
Carbohydr. Res, 1996, 295, 57-67. 
Förtsch, A.; Kogelberg, H.; Kbll, P. Carbohydr. Res. 1987, 
264, 391-402, and references therein. 
Bartra, M.; Romea, P.; Urpi, F.; Vilarrasa, J. Tetrahedron 
1990, 46, 587-594. 
Dawson, 1. M.; Johnson, T.; Paton, R. M.; Rennie, R. A. C. 
J. Chem. Soc., Chem. Commun. 1988, 1339-1340. 
Sillitoe, A. K.; Harding, M. M. Acta Crystallogr., Sect. B 
1978, 34, 2021-2022. 
Barrow, M. J. Acta Crystallogr., Sect. B 1982, 38, 308-3 10. 
Barnes, J. F.; Barrow, M. J.; Harding, M. M.; Paton, R. M.; 
Ashcroft, P. L.; Bradbury, R.; Crosby, J.; Joyce, C. J.; Holmes, 
D. R.; Milner, J. J. Chem. Soc., Perkin Trans. 1 1983, 
293-296. 
Cremer, D.; Pople, J. A. J. Am. Chem. Soc. 1975, 97, 
1354-1358. 
Pham-Huu, D.-P.; Petrusova, M.; BeMiller, J. N.; Kdll, P.; 
Kopf, J.; Petrus, L. Carbohydr. Res. 1998, 306, 45-55. 
Buchanan, J. G.; Edgar, A. R.; Rawson, D. 1.; Shahadi, P.; 
Wightman, R. H. Carbohydr. Res. 1982, 100, 75-86. 
Pham-Huu, D.-P.; Petrusova, M.; BeMiller, J. N.; Petrus, L. 
J. Carbohydr. Chen,. 2000, 19, 93-110. 
Sheldrick, G. M. Sheixtl version 5; Bruker Analytical Xray 
Systems: Madison WI, 1995. 
Flack, H. D. Acta Crystallogr., Sect. A 1983, 39, 876-881. 
